id	sid	tid	token	lemma	pos
aiua-8115	1	1	167archivio	167archivio	NUM
aiua-8115	1	2	italiano	italiano	NOUN
aiua-8115	1	3	di	di	X
aiua-8115	1	4	urologia	urologia	PROPN
aiua-8115	1	5	e	e	PROPN
aiua-8115	1	6	andrologia	andrologia	NOUN
aiua-8115	1	7	2019	2019	NUM
aiua-8115	1	8	;	;	PUNCT
aiua-8115	1	9	91	91	NUM
aiua-8115	1	10	,	,	PUNCT
aiua-8115	1	11	3	3	NUM
aiua-8115	1	12	original	original	ADJ
aiua-8115	1	13	paper	paper	NOUN
aiua-8115	1	14	role	role	NOUN
aiua-8115	1	15	of	of	ADP
aiua-8115	1	16	sterile	sterile	ADJ
aiua-8115	1	17	pyuria	pyuria	NOUN
aiua-8115	1	18	in	in	ADP
aiua-8115	1	19	association	association	NOUN
aiua-8115	1	20	to	to	ADP
aiua-8115	1	21	elevated	elevated	ADJ
aiua-8115	1	22	psa	psa	NOUN
aiua-8115	1	23	values	value	NOUN
aiua-8115	1	24	in	in	ADP
aiua-8115	1	25	the	the	DET
aiua-8115	1	26	diagnosis	diagnosis	NOUN
aiua-8115	1	27	of	of	ADP
aiua-8115	1	28	non	non	ADJ
aiua-8115	1	29	-	-	ADJ
aiua-8115	1	30	palpable	palpable	ADJ
aiua-8115	1	31	prostate	prostate	NOUN
aiua-8115	1	32	cancer	cancer	NOUN
aiua-8115	1	33	?	?	PUNCT
aiua-8115	2	1	selamettin	selamettin	PROPN
aiua-8115	2	2	demir	demir	PROPN
aiua-8115	2	3	department	department	PROPN
aiua-8115	2	4	of	of	ADP
aiua-8115	2	5	urology	urology	NOUN
aiua-8115	2	6	,	,	PUNCT
aiua-8115	2	7	the	the	DET
aiua-8115	2	8	ministry	ministry	PROPN
aiua-8115	2	9	of	of	ADP
aiua-8115	2	10	health	health	PROPN
aiua-8115	2	11	,	,	PUNCT
aiua-8115	2	12	university	university	NOUN
aiua-8115	2	13	of	of	ADP
aiua-8115	2	14	health	health	PROPN
aiua-8115	2	15	sciences	sciences	PROPN
aiua-8115	2	16	,	,	PUNCT
aiua-8115	2	17	van	van	NOUN
aiua-8115	2	18	education	education	NOUN
aiua-8115	2	19	and	and	CCONJ
aiua-8115	2	20	research	research	NOUN
aiua-8115	2	21	hospital	hospital	NOUN
aiua-8115	2	22	,	,	PUNCT
aiua-8115	2	23	van	van	NOUN
aiua-8115	2	24	,	,	PUNCT
aiua-8115	2	25	turkey	turkey	PROPN
aiua-8115	2	26	.	.	PUNCT
aiua-8115	3	1	objectives	objective	NOUN
aiua-8115	3	2	:	:	PUNCT
aiua-8115	3	3	although	although	SCONJ
aiua-8115	3	4	cancer	cancer	NOUN
aiua-8115	3	5	is	be	AUX
aiua-8115	3	6	believed	believe	VERB
aiua-8115	3	7	to	to	PART
aiua-8115	3	8	develop	develop	VERB
aiua-8115	3	9	and	and	CCONJ
aiua-8115	3	10	progress	progress	VERB
aiua-8115	3	11	with	with	ADP
aiua-8115	3	12	the	the	DET
aiua-8115	3	13	involvement	involvement	NOUN
aiua-8115	3	14	of	of	ADP
aiua-8115	3	15	inflammation	inflammation	NOUN
aiua-8115	3	16	,	,	PUNCT
aiua-8115	3	17	it	it	PRON
aiua-8115	3	18	is	be	AUX
aiua-8115	3	19	still	still	ADV
aiua-8115	3	20	unclear	unclear	ADJ
aiua-8115	3	21	what	what	PRON
aiua-8115	3	22	the	the	DET
aiua-8115	3	23	correlation	correlation	NOUN
aiua-8115	3	24	between	between	ADP
aiua-8115	3	25	inflammation	inflammation	NOUN
aiua-8115	3	26	and	and	CCONJ
aiua-8115	3	27	prostate	prostate	NOUN
aiua-8115	3	28	cancer	cancer	NOUN
aiua-8115	3	29	is	be	AUX
aiua-8115	3	30	.	.	PUNCT
aiua-8115	4	1	this	this	DET
aiua-8115	4	2	study	study	NOUN
aiua-8115	4	3	based	base	VERB
aiua-8115	4	4	on	on	ADP
aiua-8115	4	5	results	result	NOUN
aiua-8115	4	6	of	of	ADP
aiua-8115	4	7	transrectal	transrectal	ADJ
aiua-8115	4	8	ultrasound	ultrasound	NOUN
aiua-8115	4	9	-	-	PUNCT
aiua-8115	4	10	guided	guide	VERB
aiua-8115	4	11	prostate	prostate	NOUN
aiua-8115	4	12	biopsies	biopsy	NOUN
aiua-8115	4	13	aimed	aim	VERB
aiua-8115	4	14	to	to	PART
aiua-8115	4	15	determine	determine	VERB
aiua-8115	4	16	whether	whether	SCONJ
aiua-8115	4	17	c	c	NOUN
aiua-8115	4	18	-	-	ADJ
aiua-8115	4	19	reactive	reactive	ADJ
aiua-8115	4	20	protein	protein	NOUN
aiua-8115	4	21	(	(	PUNCT
aiua-8115	4	22	crp	crp	NOUN
aiua-8115	4	23	)	)	PUNCT
aiua-8115	4	24	and	and	CCONJ
aiua-8115	4	25	sterile	sterile	ADJ
aiua-8115	4	26	pyuria	pyuria	NOUN
aiua-8115	4	27	were	be	AUX
aiua-8115	4	28	clinically	clinically	ADV
aiua-8115	4	29	useful	useful	ADJ
aiua-8115	4	30	in	in	ADP
aiua-8115	4	31	the	the	DET
aiua-8115	4	32	evaluation	evaluation	NOUN
aiua-8115	4	33	of	of	ADP
aiua-8115	4	34	patients	patient	NOUN
aiua-8115	4	35	with	with	ADP
aiua-8115	4	36	suspect	suspect	NOUN
aiua-8115	4	37	of	of	ADP
aiua-8115	4	38	prostate	prostate	NOUN
aiua-8115	4	39	cancer	cancer	NOUN
aiua-8115	4	40	.	.	PUNCT
aiua-8115	5	1	materials	material	NOUN
aiua-8115	5	2	and	and	CCONJ
aiua-8115	5	3	methods	method	NOUN
aiua-8115	5	4	:	:	PUNCT
aiua-8115	5	5	this	this	DET
aiua-8115	5	6	study	study	NOUN
aiua-8115	5	7	is	be	AUX
aiua-8115	5	8	a	a	DET
aiua-8115	5	9	cross	cross	ADJ
aiua-8115	5	10	-	-	ADJ
aiua-8115	5	11	sectional	sectional	ADJ
aiua-8115	5	12	prospective	prospective	ADJ
aiua-8115	5	13	study	study	NOUN
aiua-8115	5	14	of	of	ADP
aiua-8115	5	15	patients	patient	NOUN
aiua-8115	5	16	without	without	ADP
aiua-8115	5	17	clinical	clinical	ADJ
aiua-8115	5	18	prostatitis	prostatitis	NOUN
aiua-8115	5	19	symptoms	symptom	NOUN
aiua-8115	5	20	.	.	PUNCT
aiua-8115	6	1	characteristics	characteristic	NOUN
aiua-8115	6	2	of	of	ADP
aiua-8115	6	3	the	the	DET
aiua-8115	6	4	200	200	NUM
aiua-8115	6	5	consecutive	consecutive	ADJ
aiua-8115	6	6	patients	patient	NOUN
aiua-8115	6	7	recruited	recruit	VERB
aiua-8115	6	8	were	be	AUX
aiua-8115	6	9	3	3	NUM
aiua-8115	6	10	-	-	SYM
aiua-8115	6	11	20	20	NUM
aiua-8115	6	12	ng	ng	PROPN
aiua-8115	6	13	/	/	SYM
aiua-8115	6	14	ml	ml	NOUN
aiua-8115	6	15	value	value	NOUN
aiua-8115	6	16	of	of	ADP
aiua-8115	6	17	serum	serum	NOUN
aiua-8115	6	18	prostate	prostate	NOUN
aiua-8115	6	19	-	-	PUNCT
aiua-8115	6	20	specific	specific	ADJ
aiua-8115	6	21	antigen	antigen	NOUN
aiua-8115	6	22	(	(	PUNCT
aiua-8115	6	23	psa	psa	NOUN
aiua-8115	6	24	)	)	PUNCT
aiua-8115	6	25	,	,	PUNCT
aiua-8115	6	26	normal	normal	ADJ
aiua-8115	6	27	digital	digital	ADJ
aiua-8115	6	28	rectal	rectal	ADJ
aiua-8115	6	29	examination	examination	NOUN
aiua-8115	6	30	finding	finding	NOUN
aiua-8115	6	31	,	,	PUNCT
aiua-8115	6	32	and	and	CCONJ
aiua-8115	6	33	sterile	sterile	ADJ
aiua-8115	6	34	urine	urine	NOUN
aiua-8115	6	35	culture	culture	NOUN
aiua-8115	6	36	result	result	NOUN
aiua-8115	6	37	.	.	PUNCT
aiua-8115	7	1	all	all	DET
aiua-8115	7	2	patients	patient	NOUN
aiua-8115	7	3	underwent	undergo	VERB
aiua-8115	7	4	12	12	NUM
aiua-8115	7	5	-	-	PUNCT
aiua-8115	7	6	core	core	NOUN
aiua-8115	7	7	prostatic	prostatic	ADJ
aiua-8115	7	8	biopsy	biopsy	NOUN
aiua-8115	7	9	.	.	PUNCT
aiua-8115	8	1	163	163	NUM
aiua-8115	8	2	of	of	ADP
aiua-8115	8	3	the	the	DET
aiua-8115	8	4	200	200	NUM
aiua-8115	8	5	patients	patient	NOUN
aiua-8115	8	6	had	have	VERB
aiua-8115	8	7	benign	benign	ADJ
aiua-8115	8	8	prostatic	prostatic	ADJ
aiua-8115	8	9	hyperplasia	hyperplasia	NOUN
aiua-8115	8	10	confirmed	confirm	VERB
aiua-8115	8	11	through	through	ADP
aiua-8115	8	12	histology	histology	NOUN
aiua-8115	8	13	,	,	PUNCT
aiua-8115	8	14	while	while	SCONJ
aiua-8115	8	15	the	the	DET
aiua-8115	8	16	residual	residual	ADJ
aiua-8115	8	17	37	37	NUM
aiua-8115	8	18	patients	patient	NOUN
aiua-8115	8	19	had	have	VERB
aiua-8115	8	20	prostate	prostate	NOUN
aiua-8115	8	21	cancer	cancer	NOUN
aiua-8115	8	22	.	.	PUNCT
aiua-8115	9	1	patients	patient	NOUN
aiua-8115	9	2	with	with	ADP
aiua-8115	9	3	pre	pre	ADJ
aiua-8115	9	4	-	-	ADJ
aiua-8115	9	5	treatment	treatment	ADJ
aiua-8115	9	6	urinary	urinary	ADJ
aiua-8115	9	7	leukocyte	leukocyte	NOUN
aiua-8115	9	8	count	count	NOUN
aiua-8115	9	9	≤	≤	ADV
aiua-8115	9	10	3	3	NUM
aiua-8115	9	11	/	/	SYM
aiua-8115	9	12	high	high	ADJ
aiua-8115	9	13	power	power	NOUN
aiua-8115	9	14	field	field	NOUN
aiua-8115	9	15	were	be	AUX
aiua-8115	9	16	categorized	categorize	VERB
aiua-8115	9	17	as	as	ADP
aiua-8115	9	18	non	non	ADJ
aiua-8115	9	19	-	-	ADJ
aiua-8115	9	20	pyuria	pyuria	ADJ
aiua-8115	9	21	,	,	PUNCT
aiua-8115	9	22	whilst	whilst	SCONJ
aiua-8115	9	23	those	those	PRON
aiua-8115	9	24	with	with	ADP
aiua-8115	9	25	pre	pre	ADJ
aiua-8115	9	26	-	-	ADJ
aiua-8115	9	27	treatment	treatment	ADJ
aiua-8115	9	28	urinary	urinary	ADJ
aiua-8115	9	29	leukocyte	leukocyte	NOUN
aiua-8115	9	30	count	count	NOUN
aiua-8115	9	31	>	>	X
aiua-8115	9	32	3	3	NUM
aiua-8115	9	33	/	/	SYM
aiua-8115	9	34	high	high	ADJ
aiua-8115	9	35	power	power	NOUN
aiua-8115	9	36	field	field	NOUN
aiua-8115	9	37	were	be	AUX
aiua-8115	9	38	categorized	categorize	VERB
aiua-8115	9	39	as	as	ADP
aiua-8115	9	40	pyuria	pyuria	PROPN
aiua-8115	9	41	.	.	PUNCT
aiua-8115	10	1	the	the	DET
aiua-8115	10	2	serum	serum	PROPN
aiua-8115	10	3	crp	crp	PROPN
aiua-8115	10	4	level	level	NOUN
aiua-8115	10	5	was	be	AUX
aiua-8115	10	6	also	also	ADV
aiua-8115	10	7	used	use	VERB
aiua-8115	10	8	to	to	PART
aiua-8115	10	9	differentiate	differentiate	VERB
aiua-8115	10	10	patients	patient	NOUN
aiua-8115	10	11	before	before	ADP
aiua-8115	10	12	the	the	DET
aiua-8115	10	13	biopsy	biopsy	NOUN
aiua-8115	10	14	.	.	PUNCT
aiua-8115	11	1	subgroups	subgroup	NOUN
aiua-8115	11	2	were	be	AUX
aiua-8115	11	3	compared	compare	VERB
aiua-8115	11	4	regarding	regard	VERB
aiua-8115	11	5	a	a	DET
aiua-8115	11	6	number	number	NOUN
aiua-8115	11	7	of	of	ADP
aiua-8115	11	8	clinical	clinical	ADJ
aiua-8115	11	9	variables	variable	NOUN
aiua-8115	11	10	.	.	PUNCT
aiua-8115	12	1	results	result	NOUN
aiua-8115	12	2	:	:	PUNCT
aiua-8115	12	3	histology	histology	NOUN
aiua-8115	12	4	revealed	reveal	VERB
aiua-8115	12	5	that	that	SCONJ
aiua-8115	12	6	70	70	NUM
aiua-8115	12	7	%	%	NOUN
aiua-8115	12	8	of	of	ADP
aiua-8115	12	9	pyuria	pyuria	PROPN
aiua-8115	12	10	patients	patient	NOUN
aiua-8115	12	11	and	and	CCONJ
aiua-8115	12	12	38.5	38.5	NUM
aiua-8115	12	13	%	%	NOUN
aiua-8115	12	14	of	of	ADP
aiua-8115	12	15	non	non	ADJ
aiua-8115	12	16	-	-	ADJ
aiua-8115	12	17	pyuria	pyuria	ADJ
aiua-8115	12	18	patients	patient	NOUN
aiua-8115	12	19	presented	present	VERB
aiua-8115	12	20	inflammation	inflammation	NOUN
aiua-8115	12	21	(	(	PUNCT
aiua-8115	12	22	p	p	NOUN
aiua-8115	12	23	=	=	NOUN
aiua-8115	12	24	0.001	0.001	NUM
aiua-8115	12	25	)	)	PUNCT
aiua-8115	12	26	.	.	PUNCT
aiua-8115	13	1	the	the	DET
aiua-8115	13	2	pyuria	pyuria	PROPN
aiua-8115	13	3	group	group	NOUN
aiua-8115	13	4	exhibited	exhibit	VERB
aiua-8115	13	5	significantly	significantly	ADV
aiua-8115	13	6	higher	high	ADJ
aiua-8115	13	7	total	total	ADJ
aiua-8115	13	8	psa	psa	NOUN
aiua-8115	13	9	compared	compare	VERB
aiua-8115	13	10	to	to	ADP
aiua-8115	13	11	the	the	DET
aiua-8115	13	12	non	non	ADJ
aiua-8115	13	13	-	-	ADJ
aiua-8115	13	14	pyuria	pyuria	ADJ
aiua-8115	13	15	group	group	NOUN
aiua-8115	13	16	(	(	PUNCT
aiua-8115	13	17	p	p	X
aiua-8115	13	18	=	=	NOUN
aiua-8115	13	19	0.044	0.044	NUM
aiua-8115	13	20	)	)	PUNCT
aiua-8115	13	21	.	.	PUNCT
aiua-8115	14	1	the	the	DET
aiua-8115	14	2	two	two	NUM
aiua-8115	14	3	groups	group	NOUN
aiua-8115	14	4	did	do	AUX
aiua-8115	14	5	not	not	PART
aiua-8115	14	6	differ	differ	VERB
aiua-8115	14	7	significantly	significantly	ADV
aiua-8115	14	8	regarding	regard	VERB
aiua-8115	14	9	cancer	cancer	NOUN
aiua-8115	14	10	detection	detection	NOUN
aiua-8115	14	11	rate	rate	NOUN
aiua-8115	14	12	(	(	PUNCT
aiua-8115	14	13	p	p	NOUN
aiua-8115	14	14	=	=	NOUN
aiua-8115	14	15	0.752	0.752	NUM
aiua-8115	14	16	)	)	PUNCT
aiua-8115	14	17	.	.	PUNCT
aiua-8115	15	1	crp	crp	PROPN
aiua-8115	15	2	groups	group	NOUN
aiua-8115	15	3	were	be	AUX
aiua-8115	15	4	similar	similar	ADJ
aiua-8115	15	5	regarding	regard	VERB
aiua-8115	15	6	cancer	cancer	NOUN
aiua-8115	15	7	detection	detection	NOUN
aiua-8115	15	8	and	and	CCONJ
aiua-8115	15	9	histologically	histologically	ADV
aiua-8115	15	10	-	-	PUNCT
aiua-8115	15	11	detected	detect	VERB
aiua-8115	15	12	inflammation	inflammation	NOUN
aiua-8115	15	13	rates	rate	NOUN
aiua-8115	15	14	.	.	PUNCT
aiua-8115	16	1	conclusion	conclusion	NOUN
aiua-8115	16	2	:	:	PUNCT
aiua-8115	16	3	in	in	ADP
aiua-8115	16	4	patients	patient	NOUN
aiua-8115	16	5	with	with	ADP
aiua-8115	16	6	no	no	DET
aiua-8115	16	7	evidence	evidence	NOUN
aiua-8115	16	8	of	of	ADP
aiua-8115	16	9	clinical	clinical	ADJ
aiua-8115	16	10	prostatitis	prostatitis	NOUN
aiua-8115	16	11	,	,	PUNCT
aiua-8115	16	12	sterile	sterile	ADJ
aiua-8115	16	13	pyuria	pyuria	NOUN
aiua-8115	16	14	should	should	AUX
aiua-8115	16	15	be	be	AUX
aiua-8115	16	16	considered	consider	VERB
aiua-8115	16	17	as	as	ADP
aiua-8115	16	18	a	a	DET
aiua-8115	16	19	cause	cause	NOUN
aiua-8115	16	20	of	of	ADP
aiua-8115	16	21	increased	increase	VERB
aiua-8115	16	22	psa	psa	NOUN
aiua-8115	16	23	.	.	PUNCT
aiua-8115	17	1	although	although	SCONJ
aiua-8115	17	2	sterile	sterile	ADJ
aiua-8115	17	3	pyuria	pyuria	NOUN
aiua-8115	17	4	can	can	AUX
aiua-8115	17	5	not	not	PART
aiua-8115	17	6	predict	predict	VERB
aiua-8115	17	7	non	non	ADJ
aiua-8115	17	8	-	-	ADJ
aiua-8115	17	9	palpable	palpable	ADJ
aiua-8115	17	10	prostate	prostate	NOUN
aiua-8115	17	11	cancer	cancer	NOUN
aiua-8115	17	12	,	,	PUNCT
aiua-8115	17	13	it	it	PRON
aiua-8115	17	14	should	should	AUX
aiua-8115	17	15	be	be	AUX
aiua-8115	17	16	taken	take	VERB
aiua-8115	17	17	into	into	ADP
aiua-8115	17	18	account	account	NOUN
aiua-8115	17	19	in	in	ADP
aiua-8115	17	20	urological	urological	ADJ
aiua-8115	17	21	evaluation	evaluation	NOUN
aiua-8115	17	22	in	in	ADP
aiua-8115	17	23	order	order	NOUN
aiua-8115	17	24	to	to	PART
aiua-8115	17	25	demonstrate	demonstrate	VERB
aiua-8115	17	26	minute	minute	VERB
aiua-8115	17	27	prostatic	prostatic	ADJ
aiua-8115	17	28	inflammation	inflammation	NOUN
aiua-8115	17	29	due	due	ADP
aiua-8115	17	30	to	to	ADP
aiua-8115	17	31	its	its	PRON
aiua-8115	17	32	simplicity	simplicity	NOUN
aiua-8115	17	33	,	,	PUNCT
aiua-8115	17	34	convenience	convenience	NOUN
aiua-8115	17	35	and	and	CCONJ
aiua-8115	17	36	non	non	ADJ
aiua-8115	17	37	-	-	ADJ
aiua-8115	17	38	invasiveness	invasiveness	ADJ
aiua-8115	17	39	.	.	PUNCT
aiua-8115	18	1	key	key	ADJ
aiua-8115	18	2	words	word	NOUN
aiua-8115	18	3	:	:	PUNCT
aiua-8115	18	4	prostate	prostate	NOUN
aiua-8115	18	5	cancer	cancer	NOUN
aiua-8115	18	6	;	;	PUNCT
aiua-8115	18	7	inflammation	inflammation	NOUN
aiua-8115	18	8	;	;	PUNCT
aiua-8115	18	9	biopsy	biopsy	NOUN
aiua-8115	18	10	;	;	PUNCT
aiua-8115	18	11	c	c	X
aiua-8115	18	12	-	-	PUNCT
aiua-8115	18	13	reactive	reactive	ADJ
aiua-8115	18	14	protein	protein	NOUN
aiua-8115	18	15	;	;	PUNCT
aiua-8115	18	16	pyuria	pyuria	PROPN
aiua-8115	18	17	.	.	PROPN
aiua-8115	18	18	submitted	submit	VERB
aiua-8115	18	19	16	16	NUM
aiua-8115	18	20	february	february	NOUN
aiua-8115	18	21	2019	2019	NUM
aiua-8115	18	22	;	;	PUNCT
aiua-8115	18	23	accepted	accept	VERB
aiua-8115	18	24	2	2	NUM
aiua-8115	18	25	april	april	PROPN
aiua-8115	18	26	2019	2019	NUM
aiua-8115	18	27	summary	summary	NOUN
aiua-8115	18	28	no	no	DET
aiua-8115	18	29	conflict	conflict	NOUN
aiua-8115	18	30	of	of	ADP
aiua-8115	18	31	interest	interest	NOUN
aiua-8115	18	32	declared	declare	VERB
aiua-8115	18	33	.	.	PUNCT
aiua-8115	19	1	ularly	ularly	ADV
aiua-8115	19	2	non	non	ADJ
aiua-8115	19	3	-	-	ADJ
aiua-8115	19	4	palpable	palpable	ADJ
aiua-8115	19	5	pca	pca	NOUN
aiua-8115	19	6	has	have	AUX
aiua-8115	19	7	been	be	AUX
aiua-8115	19	8	increasingly	increasingly	ADV
aiua-8115	19	9	identified	identify	VERB
aiua-8115	19	10	at	at	ADP
aiua-8115	19	11	an	an	DET
aiua-8115	19	12	early	early	ADJ
aiua-8115	19	13	stage	stage	NOUN
aiua-8115	19	14	thanks	thank	NOUN
aiua-8115	19	15	to	to	ADP
aiua-8115	19	16	the	the	DET
aiua-8115	19	17	common	common	ADJ
aiua-8115	19	18	practice	practice	NOUN
aiua-8115	19	19	of	of	ADP
aiua-8115	19	20	screening	screen	VERB
aiua-8115	19	21	for	for	ADP
aiua-8115	19	22	serum	serum	NOUN
aiua-8115	19	23	prostate	prostate	NOUN
aiua-8115	19	24	-	-	PUNCT
aiua-8115	19	25	specific	specific	ADJ
aiua-8115	19	26	antigen	antigen	NOUN
aiua-8115	19	27	(	(	PUNCT
aiua-8115	19	28	psa	psa	NOUN
aiua-8115	19	29	)	)	PUNCT
aiua-8115	19	30	.	.	PUNCT
aiua-8115	20	1	however	however	ADV
aiua-8115	20	2	,	,	PUNCT
aiua-8115	20	3	some	some	PRON
aiua-8115	20	4	have	have	AUX
aiua-8115	20	5	argued	argue	VERB
aiua-8115	20	6	that	that	SCONJ
aiua-8115	20	7	biopsies	biopsy	NOUN
aiua-8115	20	8	should	should	AUX
aiua-8115	20	9	not	not	PART
aiua-8115	20	10	be	be	AUX
aiua-8115	20	11	performed	perform	VERB
aiua-8115	20	12	unnecessarily	unnecessarily	ADV
aiua-8115	20	13	(	(	PUNCT
aiua-8115	20	14	4	4	NUM
aiua-8115	20	15	,	,	PUNCT
aiua-8115	20	16	5	5	NUM
aiua-8115	20	17	)	)	PUNCT
aiua-8115	20	18	,	,	PUNCT
aiua-8115	20	19	because	because	SCONJ
aiua-8115	20	20	,	,	PUNCT
aiua-8115	20	21	besides	besides	SCONJ
aiua-8115	20	22	pca	pca	PROPN
aiua-8115	20	23	,	,	PUNCT
aiua-8115	20	24	non	non	ADJ
aiua-8115	20	25	-	-	ADJ
aiua-8115	20	26	malignant	malignant	ADJ
aiua-8115	20	27	prostate	prostate	NOUN
aiua-8115	20	28	conditions	condition	NOUN
aiua-8115	20	29	,	,	PUNCT
aiua-8115	20	30	such	such	ADJ
aiua-8115	20	31	as	as	ADP
aiua-8115	20	32	inflammation	inflammation	NOUN
aiua-8115	20	33	,	,	PUNCT
aiua-8115	20	34	may	may	AUX
aiua-8115	20	35	be	be	AUX
aiua-8115	20	36	associated	associate	VERB
aiua-8115	20	37	with	with	ADP
aiua-8115	20	38	high	high	ADJ
aiua-8115	20	39	serum	serum	NOUN
aiua-8115	20	40	psa	psa	NOUN
aiua-8115	20	41	as	as	ADV
aiua-8115	20	42	well	well	ADV
aiua-8115	20	43	(	(	PUNCT
aiua-8115	20	44	6	6	NUM
aiua-8115	20	45	,	,	PUNCT
aiua-8115	20	46	7	7	NUM
aiua-8115	20	47	)	)	PUNCT
aiua-8115	20	48	.	.	PUNCT
aiua-8115	21	1	the	the	DET
aiua-8115	21	2	general	general	ADJ
aiua-8115	21	3	assumption	assumption	NOUN
aiua-8115	21	4	is	be	AUX
aiua-8115	21	5	that	that	SCONJ
aiua-8115	21	6	pca	pca	PROPN
aiua-8115	21	7	develops	develop	VERB
aiua-8115	21	8	and	and	CCONJ
aiua-8115	21	9	progresses	progress	NOUN
aiua-8115	21	10	due	due	ADJ
aiua-8115	21	11	to	to	ADP
aiua-8115	21	12	inflammatory	inflammatory	ADJ
aiua-8115	21	13	processes	process	NOUN
aiua-8115	21	14	that	that	PRON
aiua-8115	21	15	disrupt	disrupt	VERB
aiua-8115	21	16	the	the	DET
aiua-8115	21	17	function	function	NOUN
aiua-8115	21	18	of	of	ADP
aiua-8115	21	19	oncogenes	oncogene	NOUN
aiua-8115	21	20	and	and	CCONJ
aiua-8115	21	21	tumor	tumor	NOUN
aiua-8115	21	22	inhibitors	inhibitor	NOUN
aiua-8115	21	23	,	,	PUNCT
aiua-8115	21	24	thus	thus	ADV
aiua-8115	21	25	damaging	damage	VERB
aiua-8115	21	26	dna	dna	NOUN
aiua-8115	21	27	and	and	CCONJ
aiua-8115	21	28	activating	activate	VERB
aiua-8115	21	29	processes	process	NOUN
aiua-8115	21	30	that	that	PRON
aiua-8115	21	31	can	can	AUX
aiua-8115	21	32	trigger	trigger	VERB
aiua-8115	21	33	tumor	tumor	NOUN
aiua-8115	21	34	cells	cell	NOUN
aiua-8115	21	35	to	to	PART
aiua-8115	21	36	grow	grow	VERB
aiua-8115	21	37	and	and	CCONJ
aiua-8115	21	38	proliferate	proliferate	VERB
aiua-8115	21	39	(	(	PUNCT
aiua-8115	21	40	8	8	NUM
aiua-8115	21	41	,	,	PUNCT
aiua-8115	21	42	9	9	NUM
aiua-8115	21	43	)	)	PUNCT
aiua-8115	21	44	.	.	PUNCT
aiua-8115	22	1	therefore	therefore	ADV
aiua-8115	22	2	,	,	PUNCT
aiua-8115	22	3	pca	pca	NOUN
aiua-8115	22	4	risk	risk	NOUN
aiua-8115	22	5	is	be	AUX
aiua-8115	22	6	considered	consider	VERB
aiua-8115	22	7	to	to	PART
aiua-8115	22	8	be	be	AUX
aiua-8115	22	9	elevated	elevate	VERB
aiua-8115	22	10	in	in	ADP
aiua-8115	22	11	men	man	NOUN
aiua-8115	22	12	with	with	ADP
aiua-8115	22	13	intraprostatic	intraprostatic	ADJ
aiua-8115	22	14	conditions	condition	NOUN
aiua-8115	22	15	like	like	ADP
aiua-8115	22	16	proliferative	proliferative	ADJ
aiua-8115	22	17	inflammatory	inflammatory	ADJ
aiua-8115	22	18	atrophy	atrophy	NOUN
aiua-8115	22	19	,	,	PUNCT
aiua-8115	22	20	prostatic	prostatic	ADJ
aiua-8115	22	21	intraepithelial	intraepithelial	ADJ
aiua-8115	22	22	neoplasia	neoplasia	NOUN
aiua-8115	22	23	,	,	PUNCT
aiua-8115	22	24	and	and	CCONJ
aiua-8115	22	25	prostatitis	prostatitis	NOUN
aiua-8115	22	26	,	,	PUNCT
aiua-8115	22	27	which	which	PRON
aiua-8115	22	28	may	may	AUX
aiua-8115	22	29	be	be	AUX
aiua-8115	22	30	induced	induce	VERB
aiua-8115	22	31	by	by	ADP
aiua-8115	22	32	acute	acute	ADJ
aiua-8115	22	33	or	or	CCONJ
aiua-8115	22	34	chronic	chronic	ADJ
aiua-8115	22	35	inflammation	inflammation	NOUN
aiua-8115	22	36	and	and	CCONJ
aiua-8115	22	37	are	be	AUX
aiua-8115	22	38	believed	believe	VERB
aiua-8115	22	39	to	to	PART
aiua-8115	22	40	be	be	AUX
aiua-8115	22	41	pca	pca	NOUN
aiua-8115	22	42	precursors	precursor	NOUN
aiua-8115	22	43	(	(	PUNCT
aiua-8115	22	44	9	9	NUM
aiua-8115	22	45	,	,	PUNCT
aiua-8115	22	46	10	10	NUM
aiua-8115	22	47	)	)	PUNCT
aiua-8115	22	48	.	.	PUNCT
aiua-8115	23	1	abnormal	abnormal	ADJ
aiua-8115	23	2	digital	digital	ADJ
aiua-8115	23	3	rectal	rectal	ADJ
aiua-8115	23	4	examination	examination	NOUN
aiua-8115	23	5	(	(	PUNCT
aiua-8115	23	6	dre	dre	NOUN
aiua-8115	23	7	)	)	PUNCT
aiua-8115	23	8	results	result	NOUN
aiua-8115	23	9	and/or	and/or	CCONJ
aiua-8115	23	10	psa	psa	VERB
aiua-8115	23	11	higher	high	ADJ
aiua-8115	23	12	than	than	ADP
aiua-8115	23	13	4.0	4.0	NUM
aiua-8115	23	14	ng	ng	NOUN
aiua-8115	23	15	/	/	SYM
aiua-8115	23	16	ml	ml	X
aiua-8115	23	17	are	be	AUX
aiua-8115	23	18	among	among	ADP
aiua-8115	23	19	the	the	DET
aiua-8115	23	20	main	main	ADJ
aiua-8115	23	21	markers	marker	NOUN
aiua-8115	23	22	warranting	warrant	VERB
aiua-8115	23	23	a	a	DET
aiua-8115	23	24	prostate	prostate	NOUN
aiua-8115	23	25	biopsy	biopsy	NOUN
aiua-8115	23	26	.	.	PUNCT
aiua-8115	24	1	if	if	SCONJ
aiua-8115	24	2	dre	dre	PROPN
aiua-8115	24	3	suggests	suggest	VERB
aiua-8115	24	4	that	that	SCONJ
aiua-8115	24	5	pca	pca	PROPN
aiua-8115	24	6	is	be	AUX
aiua-8115	24	7	likely	likely	ADJ
aiua-8115	24	8	,	,	PUNCT
aiua-8115	24	9	then	then	ADV
aiua-8115	24	10	biopsy	biopsy	NOUN
aiua-8115	24	11	is	be	AUX
aiua-8115	24	12	vital	vital	ADJ
aiua-8115	24	13	.	.	PUNCT
aiua-8115	25	1	on	on	ADP
aiua-8115	25	2	the	the	DET
aiua-8115	25	3	other	other	ADJ
aiua-8115	25	4	hand	hand	NOUN
aiua-8115	25	5	,	,	PUNCT
aiua-8115	25	6	psa	psa	VERB
aiua-8115	25	7	is	be	AUX
aiua-8115	25	8	the	the	DET
aiua-8115	25	9	sole	sole	ADJ
aiua-8115	25	10	basis	basis	NOUN
aiua-8115	25	11	for	for	ADP
aiua-8115	25	12	deciding	decide	VERB
aiua-8115	25	13	performance	performance	NOUN
aiua-8115	25	14	on	on	ADP
aiua-8115	25	15	non	non	ADJ
aiua-8115	25	16	-	-	ADJ
aiua-8115	25	17	palpable	palpable	ADJ
aiua-8115	25	18	case	case	NOUN
aiua-8115	25	19	biopsy	biopsy	NOUN
aiua-8115	25	20	,	,	PUNCT
aiua-8115	25	21	although	although	SCONJ
aiua-8115	25	22	it	it	PRON
aiua-8115	25	23	frequently	frequently	ADV
aiua-8115	25	24	yields	yield	VERB
aiua-8115	25	25	false	false	ADJ
aiua-8115	25	26	positives	positive	NOUN
aiua-8115	25	27	because	because	SCONJ
aiua-8115	25	28	its	its	PRON
aiua-8115	25	29	levels	level	NOUN
aiua-8115	25	30	are	be	AUX
aiua-8115	25	31	increased	increase	VERB
aiua-8115	25	32	by	by	ADP
aiua-8115	25	33	inflammation	inflammation	NOUN
aiua-8115	25	34	(	(	PUNCT
aiua-8115	25	35	11	11	NUM
aiua-8115	25	36	)	)	PUNCT
aiua-8115	25	37	.	.	PUNCT
aiua-8115	26	1	thus	thus	ADV
aiua-8115	26	2	,	,	PUNCT
aiua-8115	26	3	it	it	PRON
aiua-8115	26	4	is	be	AUX
aiua-8115	26	5	important	important	ADJ
aiua-8115	26	6	to	to	PART
aiua-8115	26	7	prevent	prevent	VERB
aiua-8115	26	8	performing	perform	VERB
aiua-8115	26	9	unnecessary	unnecessary	ADJ
aiua-8115	26	10	biopsy	biopsy	NOUN
aiua-8115	26	11	for	for	ADP
aiua-8115	26	12	non	non	ADJ
aiua-8115	26	13	-	-	ADJ
aiua-8115	26	14	palpable	palpable	ADJ
aiua-8115	26	15	case	case	NOUN
aiua-8115	26	16	,	,	PUNCT
aiua-8115	26	17	and	and	CCONJ
aiua-8115	26	18	for	for	ADP
aiua-8115	26	19	this	this	DET
aiua-8115	26	20	purpose	purpose	NOUN
aiua-8115	26	21	,	,	PUNCT
aiua-8115	26	22	a	a	DET
aiua-8115	26	23	number	number	NOUN
aiua-8115	26	24	of	of	ADP
aiua-8115	26	25	psa	psa	NOUN
aiua-8115	26	26	derived	derive	VERB
aiua-8115	26	27	parameters	parameter	NOUN
aiua-8115	26	28	have	have	AUX
aiua-8115	26	29	been	be	AUX
aiua-8115	26	30	considered	consider	VERB
aiua-8115	26	31	,	,	PUNCT
aiua-8115	26	32	including	include	VERB
aiua-8115	26	33	free	free	ADJ
aiua-8115	26	34	-	-	PUNCT
aiua-8115	26	35	to	to	ADP
aiua-8115	26	36	-	-	PUNCT
aiua-8115	26	37	total	total	NOUN
aiua-8115	26	38	psa	psa	NOUN
aiua-8115	26	39	ratio	ratio	NOUN
aiua-8115	26	40	,	,	PUNCT
aiua-8115	26	41	psa	psa	VERB
aiua-8115	26	42	density	density	NOUN
aiua-8115	26	43	(	(	PUNCT
aiua-8115	26	44	psad	psad	ADJ
aiua-8115	26	45	)	)	PUNCT
aiua-8115	26	46	and	and	CCONJ
aiua-8115	26	47	psa	psa	VERB
aiua-8115	26	48	velocity	velocity	NOUN
aiua-8115	26	49	(	(	PUNCT
aiua-8115	26	50	12	12	NUM
aiua-8115	26	51	,	,	PUNCT
aiua-8115	26	52	13	13	NUM
aiua-8115	26	53	)	)	PUNCT
aiua-8115	26	54	.	.	PUNCT
aiua-8115	27	1	this	this	DET
aiua-8115	27	2	study	study	NOUN
aiua-8115	27	3	sought	seek	VERB
aiua-8115	27	4	to	to	PART
aiua-8115	27	5	determine	determine	VERB
aiua-8115	27	6	the	the	DET
aiua-8115	27	7	extent	extent	NOUN
aiua-8115	27	8	to	to	PART
aiua-8115	27	9	which	which	PRON
aiua-8115	27	10	the	the	DET
aiua-8115	27	11	impact	impact	NOUN
aiua-8115	27	12	of	of	ADP
aiua-8115	27	13	inflammation	inflammation	NOUN
aiua-8115	27	14	on	on	ADP
aiua-8115	27	15	detection	detection	NOUN
aiua-8115	27	16	of	of	ADP
aiua-8115	27	17	cancer	cancer	NOUN
aiua-8115	27	18	in	in	ADP
aiua-8115	27	19	specimens	specimen	NOUN
aiua-8115	27	20	of	of	ADP
aiua-8115	27	21	prostate	prostate	NOUN
aiua-8115	27	22	biopsy	biopsy	NOUN
aiua-8115	27	23	could	could	AUX
aiua-8115	27	24	be	be	AUX
aiua-8115	27	25	gauged	gauge	VERB
aiua-8115	27	26	based	base	VERB
aiua-8115	27	27	on	on	ADP
aiua-8115	27	28	serum	serum	NOUN
aiua-8115	27	29	c	c	NOUN
aiua-8115	27	30	-	-	PUNCT
aiua-8115	27	31	reactive	reactive	ADJ
aiua-8115	27	32	protein	protein	NOUN
aiua-8115	27	33	(	(	PUNCT
aiua-8115	27	34	crp	crp	NOUN
aiua-8115	27	35	)	)	PUNCT
aiua-8115	27	36	level	level	NOUN
aiua-8115	27	37	and	and	CCONJ
aiua-8115	27	38	urinary	urinary	ADJ
aiua-8115	27	39	leukocyte	leukocyte	NOUN
aiua-8115	27	40	count	count	NOUN
aiua-8115	27	41	.	.	PUNCT
aiua-8115	28	1	materials	material	NOUN
aiua-8115	28	2	and	and	CCONJ
aiua-8115	28	3	methods	method	NOUN
aiua-8115	28	4	ethics	ethic	NOUN
aiua-8115	28	5	committee	committee	PROPN
aiua-8115	28	6	approval	approval	NOUN
aiua-8115	28	7	was	be	AUX
aiua-8115	28	8	received	receive	VERB
aiua-8115	28	9	for	for	ADP
aiua-8115	28	10	this	this	DET
aiua-8115	28	11	study	study	NOUN
aiua-8115	28	12	from	from	ADP
aiua-8115	28	13	the	the	DET
aiua-8115	28	14	hospita	hospita	PROPN
aiua-8115	28	15	ethics	ethics	PROPN
aiua-8115	28	16	committee	committee	PROPN
aiua-8115	28	17	(	(	PUNCT
aiua-8115	28	18	number	number	NOUN
aiua-8115	28	19	:	:	PUNCT
aiua-8115	28	20	218/13	218/13	NUM
aiua-8115	28	21	)	)	PUNCT
aiua-8115	28	22	.	.	PUNCT
aiua-8115	29	1	written	write	VERB
aiua-8115	29	2	informed	informed	ADJ
aiua-8115	29	3	consent	consent	NOUN
aiua-8115	29	4	was	be	AUX
aiua-8115	29	5	obtained	obtain	VERB
aiua-8115	29	6	from	from	ADP
aiua-8115	29	7	patients	patient	NOUN
aiua-8115	29	8	who	who	PRON
aiua-8115	29	9	participated	participate	VERB
aiua-8115	29	10	in	in	ADP
aiua-8115	29	11	this	this	DET
aiua-8115	29	12	study	study	NOUN
aiua-8115	29	13	.	.	PUNCT
aiua-8115	30	1	a	a	DET
aiua-8115	30	2	number	number	NOUN
aiua-8115	30	3	of	of	ADP
aiua-8115	30	4	200	200	NUM
aiua-8115	30	5	consecutive	consecutive	ADJ
aiua-8115	30	6	patients	patient	NOUN
aiua-8115	30	7	were	be	AUX
aiua-8115	30	8	recruited	recruit	VERB
aiua-8115	30	9	for	for	ADP
aiua-8115	30	10	this	this	DET
aiua-8115	30	11	study	study	NOUN
aiua-8115	30	12	.	.	PUNCT
aiua-8115	31	1	all	all	PRON
aiua-8115	31	2	of	of	ADP
aiua-8115	31	3	them	they	PRON
aiua-8115	31	4	had	have	VERB
aiua-8115	31	5	serum	serum	NOUN
aiua-8115	31	6	psa	psa	NOUN
aiua-8115	31	7	levels	level	NOUN
aiua-8115	31	8	in	in	ADP
aiua-8115	31	9	the	the	DET
aiua-8115	31	10	range	range	NOUN
aiua-8115	31	11	3	3	NUM
aiua-8115	31	12	-	-	SYM
aiua-8115	31	13	20	20	NUM
aiua-8115	31	14	ng	ng	PROPN
aiua-8115	31	15	/	/	SYM
aiua-8115	31	16	ml	ml	PROPN
aiua-8115	31	17	,	,	PUNCT
aiua-8115	31	18	normal	normal	ADJ
aiua-8115	31	19	dre	dre	PROPN
aiua-8115	31	20	findings	finding	NOUN
aiua-8115	31	21	and	and	CCONJ
aiua-8115	31	22	sterile	sterile	ADJ
aiua-8115	31	23	urine	urine	NOUN
aiua-8115	31	24	culture	culture	NOUN
aiua-8115	31	25	results	result	NOUN
aiua-8115	31	26	and	and	CCONJ
aiua-8115	31	27	underwent	undergo	VERB
aiua-8115	31	28	transrectal	transrectal	ADJ
aiua-8115	31	29	ultrasound	ultrasound	NOUN
aiua-8115	31	30	-	-	PUNCT
aiua-8115	31	31	guided	guide	VERB
aiua-8115	31	32	12	12	NUM
aiua-8115	31	33	-	-	PUNCT
aiua-8115	31	34	core	core	NOUN
aiua-8115	31	35	prostatic	prostatic	ADJ
aiua-8115	31	36	biopsy	biopsy	NOUN
aiua-8115	31	37	(	(	PUNCT
aiua-8115	31	38	trus	trus	NOUN
aiua-8115	31	39	-	-	PUNCT
aiua-8115	31	40	bx	bx	NOUN
aiua-8115	31	41	)	)	PUNCT
aiua-8115	31	42	beetwen	beetwen	PROPN
aiua-8115	31	43	januray	januray	NOUN
aiua-8115	31	44	2018	2018	NUM
aiua-8115	31	45	and	and	CCONJ
aiua-8115	31	46	february	february	PROPN
aiua-8115	31	47	2019	2019	NUM
aiua-8115	31	48	.	.	PUNCT
aiua-8115	32	1	the	the	DET
aiua-8115	32	2	study	study	NOUN
aiua-8115	32	3	did	do	AUX
aiua-8115	32	4	not	not	PART
aiua-8115	32	5	include	include	VERB
aiua-8115	32	6	patients	patient	NOUN
aiua-8115	32	7	with	with	ADP
aiua-8115	32	8	clinical	clinical	ADJ
aiua-8115	32	9	signs	sign	NOUN
aiua-8115	32	10	of	of	ADP
aiua-8115	32	11	doi	doi	NOUN
aiua-8115	32	12	:	:	PUNCT
aiua-8115	32	13	10.4081	10.4081	NUM
aiua-8115	32	14	/	/	SYM
aiua-8115	32	15	aiua.2019.3.167	aiua.2019.3.167	ADJ
aiua-8115	32	16	introduction	introduction	NOUN
aiua-8115	32	17	in	in	ADP
aiua-8115	32	18	the	the	DET
aiua-8115	32	19	us	us	PROPN
aiua-8115	32	20	,	,	PUNCT
aiua-8115	32	21	prostate	prostate	NOUN
aiua-8115	32	22	cancer	cancer	NOUN
aiua-8115	32	23	(	(	PUNCT
aiua-8115	32	24	pca	pca	PROPN
aiua-8115	32	25	)	)	PUNCT
aiua-8115	32	26	continues	continue	VERB
aiua-8115	32	27	to	to	PART
aiua-8115	32	28	be	be	AUX
aiua-8115	32	29	the	the	DET
aiua-8115	32	30	cancer	cancer	NOUN
aiua-8115	32	31	with	with	ADP
aiua-8115	32	32	the	the	DET
aiua-8115	32	33	second	second	ADJ
aiua-8115	32	34	highest	high	ADJ
aiua-8115	32	35	mortality	mortality	NOUN
aiua-8115	32	36	rate	rate	NOUN
aiua-8115	32	37	in	in	ADP
aiua-8115	32	38	men	man	NOUN
aiua-8115	32	39	,	,	PUNCT
aiua-8115	32	40	despite	despite	SCONJ
aiua-8115	32	41	the	the	DET
aiua-8115	32	42	fact	fact	NOUN
aiua-8115	32	43	that	that	SCONJ
aiua-8115	32	44	the	the	DET
aiua-8115	32	45	number	number	NOUN
aiua-8115	32	46	of	of	ADP
aiua-8115	32	47	men	man	NOUN
aiua-8115	32	48	dying	die	VERB
aiua-8115	32	49	because	because	SCONJ
aiua-8115	32	50	of	of	ADP
aiua-8115	32	51	it	it	PRON
aiua-8115	32	52	is	be	AUX
aiua-8115	32	53	not	not	PART
aiua-8115	32	54	as	as	ADV
aiua-8115	32	55	high	high	ADJ
aiua-8115	32	56	as	as	ADP
aiua-8115	32	57	the	the	DET
aiua-8115	32	58	number	number	NOUN
aiua-8115	32	59	of	of	ADP
aiua-8115	32	60	those	those	PRON
aiua-8115	32	61	dying	die	VERB
aiua-8115	32	62	with	with	ADP
aiua-8115	32	63	it	it	PRON
aiua-8115	32	64	for	for	ADP
aiua-8115	32	65	other	other	ADJ
aiua-8115	32	66	causes	cause	NOUN
aiua-8115	32	67	(	(	PUNCT
aiua-8115	32	68	1	1	NUM
aiua-8115	32	69	,	,	PUNCT
aiua-8115	32	70	2	2	NUM
aiua-8115	32	71	)	)	PUNCT
aiua-8115	32	72	.	.	PUNCT
aiua-8115	33	1	pca	pca	NOUN
aiua-8115	33	2	risk	risk	NOUN
aiua-8115	33	3	is	be	AUX
aiua-8115	33	4	believed	believe	VERB
aiua-8115	33	5	to	to	PART
aiua-8115	33	6	be	be	AUX
aiua-8115	33	7	heightened	heighten	VERB
aiua-8115	33	8	by	by	ADP
aiua-8115	33	9	genetic	genetic	ADJ
aiua-8115	33	10	and	and	CCONJ
aiua-8115	33	11	environmental	environmental	ADJ
aiua-8115	33	12	factors	factor	NOUN
aiua-8115	33	13	,	,	PUNCT
aiua-8115	33	14	but	but	CCONJ
aiua-8115	33	15	the	the	DET
aiua-8115	33	16	exact	exact	ADJ
aiua-8115	33	17	etiology	etiology	NOUN
aiua-8115	33	18	remains	remain	VERB
aiua-8115	33	19	unclear	unclear	ADJ
aiua-8115	33	20	(	(	PUNCT
aiua-8115	33	21	3	3	NUM
aiua-8115	33	22	)	)	PUNCT
aiua-8115	33	23	.	.	PUNCT
aiua-8115	34	1	nevertheless	nevertheless	ADV
aiua-8115	34	2	,	,	PUNCT
aiua-8115	34	3	pca	pca	NOUN
aiua-8115	34	4	and	and	CCONJ
aiua-8115	34	5	particdemir_stesura	particdemir_stesura	NOUN
aiua-8115	34	6	seveso	seveso	NOUN
aiua-8115	34	7	30/09/19	30/09/19	PROPN
aiua-8115	34	8	18:21	18:21	NUM
aiua-8115	34	9	pagina	pagina	NOUN
aiua-8115	34	10	167	167	NUM
aiua-8115	34	11	archivio	archivio	NOUN
aiua-8115	34	12	italiano	italiano	X
aiua-8115	34	13	di	di	X
aiua-8115	34	14	urologia	urologia	PROPN
aiua-8115	34	15	e	e	PROPN
aiua-8115	34	16	andrologia	andrologia	NOUN
aiua-8115	34	17	2019	2019	NUM
aiua-8115	34	18	;	;	PUNCT
aiua-8115	34	19	91	91	NUM
aiua-8115	34	20	,	,	PUNCT
aiua-8115	34	21	3	3	NUM
aiua-8115	34	22	s.	s.	PROPN
aiua-8115	34	23	demir	demir	PROPN
aiua-8115	34	24	168	168	NUM
aiua-8115	34	25	prostatitis	prostatitis	NOUN
aiua-8115	34	26	,	,	PUNCT
aiua-8115	34	27	macroscopic	macroscopic	ADJ
aiua-8115	34	28	pyuria	pyuria	NOUN
aiua-8115	34	29	,	,	PUNCT
aiua-8115	34	30	bacteria	bacteria	NOUN
aiua-8115	34	31	isolated	isolate	VERB
aiua-8115	34	32	in	in	ADP
aiua-8115	34	33	urine	urine	NOUN
aiua-8115	34	34	culture	culture	NOUN
aiua-8115	34	35	or	or	CCONJ
aiua-8115	34	36	systemic	systemic	ADJ
aiua-8115	34	37	inflammatory	inflammatory	ADJ
aiua-8115	34	38	conditions	condition	NOUN
aiua-8115	34	39	with	with	ADP
aiua-8115	34	40	potential	potential	ADJ
aiua-8115	34	41	impact	impact	NOUN
aiua-8115	34	42	on	on	ADP
aiua-8115	34	43	serum	serum	PROPN
aiua-8115	34	44	crp	crp	PROPN
aiua-8115	34	45	.	.	PUNCT
aiua-8115	35	1	the	the	DET
aiua-8115	35	2	medication	medication	NOUN
aiua-8115	35	3	regimen	regiman	NOUN
aiua-8115	35	4	consisted	consist	VERB
aiua-8115	35	5	of	of	ADP
aiua-8115	35	6	500	500	NUM
aiua-8115	35	7	mg	mg	NOUN
aiua-8115	35	8	ciprofloxacin	ciprofloxacin	PROPN
aiua-8115	35	9	administered	administer	VERB
aiua-8115	35	10	orally	orally	ADV
aiua-8115	35	11	twice	twice	ADV
aiua-8115	35	12	daily	daily	ADV
aiua-8115	35	13	over	over	ADP
aiua-8115	35	14	a	a	DET
aiua-8115	35	15	period	period	NOUN
aiua-8115	35	16	of	of	ADP
aiua-8115	35	17	one	one	NUM
aiua-8115	35	18	week	week	NOUN
aiua-8115	35	19	,	,	PUNCT
aiua-8115	35	20	with	with	ADP
aiua-8115	35	21	the	the	DET
aiua-8115	35	22	first	first	ADJ
aiua-8115	35	23	dose	dose	NOUN
aiua-8115	35	24	being	be	AUX
aiua-8115	35	25	given	give	VERB
aiua-8115	35	26	24	24	NUM
aiua-8115	35	27	hours	hour	NOUN
aiua-8115	35	28	before	before	ADP
aiua-8115	35	29	the	the	DET
aiua-8115	35	30	procedure	procedure	NOUN
aiua-8115	35	31	.	.	PUNCT
aiua-8115	36	1	patients	patient	NOUN
aiua-8115	36	2	with	with	ADP
aiua-8115	36	3	pretreatment	pretreatment	NOUN
aiua-8115	36	4	urinary	urinary	ADJ
aiua-8115	36	5	leukocyte	leukocyte	NOUN
aiua-8115	36	6	count	count	NOUN
aiua-8115	36	7	≤	≤	ADV
aiua-8115	36	8	3	3	NUM
aiua-8115	36	9	/	/	SYM
aiua-8115	36	10	high	high	ADJ
aiua-8115	36	11	power	power	NOUN
aiua-8115	36	12	field	field	NOUN
aiua-8115	36	13	(	(	PUNCT
aiua-8115	36	14	h.p.f	h.p.f	ADJ
aiua-8115	36	15	.	.	PUNCT
aiua-8115	36	16	)	)	PUNCT
aiua-8115	36	17	were	be	AUX
aiua-8115	36	18	categorized	categorize	VERB
aiua-8115	36	19	as	as	ADP
aiua-8115	36	20	non	non	ADJ
aiua-8115	36	21	-	-	ADJ
aiua-8115	36	22	pyuria	pyuria	ADJ
aiua-8115	36	23	,	,	PUNCT
aiua-8115	36	24	whilst	whilst	SCONJ
aiua-8115	36	25	those	those	PRON
aiua-8115	36	26	with	with	ADP
aiua-8115	36	27	pre	pre	ADJ
aiua-8115	36	28	-	-	ADJ
aiua-8115	36	29	treatment	treatment	ADJ
aiua-8115	36	30	urinary	urinary	ADJ
aiua-8115	36	31	leukocyte	leukocyte	NOUN
aiua-8115	36	32	count	count	NOUN
aiua-8115	36	33	>	>	X
aiua-8115	36	34	3	3	X
aiua-8115	36	35	/	/	SYM
aiua-8115	36	36	h.p.f	h.p.f	NOUN
aiua-8115	36	37	.	.	PUNCT
aiua-8115	37	1	were	be	AUX
aiua-8115	37	2	categorized	categorize	VERB
aiua-8115	37	3	as	as	ADP
aiua-8115	37	4	pyuria	pyuria	PROPN
aiua-8115	37	5	.	.	PUNCT
aiua-8115	38	1	furthermore	furthermore	ADV
aiua-8115	38	2	,	,	PUNCT
aiua-8115	38	3	a	a	DET
aiua-8115	38	4	positive	positive	ADJ
aiua-8115	38	5	group	group	NOUN
aiua-8115	38	6	with	with	ADP
aiua-8115	38	7	serum	serum	PROPN
aiua-8115	38	8	crp	crp	PROPN
aiua-8115	38	9	of	of	ADP
aiua-8115	38	10	0.30	0.30	NUM
aiua-8115	38	11	mg	mg	PROPN
aiua-8115	38	12	/	/	SYM
aiua-8115	38	13	dl	dl	PROPN
aiua-8115	38	14	or	or	CCONJ
aiua-8115	38	15	higher	high	ADJ
aiua-8115	38	16	and	and	CCONJ
aiua-8115	38	17	a	a	DET
aiua-8115	38	18	negative	negative	ADJ
aiua-8115	38	19	group	group	NOUN
aiua-8115	38	20	with	with	ADP
aiua-8115	38	21	serum	serum	PROPN
aiua-8115	38	22	crp	crp	PROPN
aiua-8115	38	23	of	of	ADP
aiua-8115	38	24	less	less	ADJ
aiua-8115	38	25	than	than	ADP
aiua-8115	38	26	0.30	0.30	NUM
aiua-8115	38	27	mg	mg	PROPN
aiua-8115	38	28	/	/	SYM
aiua-8115	38	29	dl	dl	PROPN
aiua-8115	38	30	were	be	AUX
aiua-8115	38	31	distinguished	distinguish	VERB
aiua-8115	38	32	as	as	ADV
aiua-8115	38	33	well	well	ADV
aiua-8115	38	34	(	(	PUNCT
aiua-8115	38	35	25	25	NUM
aiua-8115	38	36	)	)	PUNCT
aiua-8115	38	37	.	.	PUNCT
aiua-8115	39	1	elecsys	elecsys	PROPN
aiua-8115	39	2	psa	psa	PROPN
aiua-8115	39	3	kit	kit	PROPN
aiua-8115	39	4	(	(	PUNCT
aiua-8115	39	5	roche	roche	PROPN
aiua-8115	39	6	cobas	cobas	PROPN
aiua-8115	39	7	411	411	NUM
aiua-8115	39	8	,	,	PUNCT
aiua-8115	39	9	tokyo	tokyo	PROPN
aiua-8115	39	10	,	,	PUNCT
aiua-8115	39	11	japan	japan	PROPN
aiua-8115	39	12	)	)	PUNCT
aiua-8115	39	13	was	be	AUX
aiua-8115	39	14	used	use	VERB
aiua-8115	39	15	for	for	ADP
aiua-8115	39	16	measurement	measurement	NOUN
aiua-8115	39	17	of	of	ADP
aiua-8115	39	18	free	free	ADJ
aiua-8115	39	19	and	and	CCONJ
aiua-8115	39	20	total	total	ADJ
aiua-8115	39	21	psa	psa	NOUN
aiua-8115	39	22	values	value	NOUN
aiua-8115	39	23	.	.	PUNCT
aiua-8115	40	1	alongside	alongside	ADP
aiua-8115	40	2	the	the	DET
aiua-8115	40	3	blood	blood	NOUN
aiua-8115	40	4	sample	sample	NOUN
aiua-8115	40	5	,	,	PUNCT
aiua-8115	40	6	urine	urine	NOUN
aiua-8115	40	7	culture	culture	NOUN
aiua-8115	40	8	and	and	CCONJ
aiua-8115	40	9	urine	urine	NOUN
aiua-8115	40	10	samples	sample	NOUN
aiua-8115	40	11	were	be	AUX
aiua-8115	40	12	also	also	ADV
aiua-8115	40	13	acquired	acquire	VERB
aiua-8115	40	14	prior	prior	ADV
aiua-8115	40	15	to	to	ADP
aiua-8115	40	16	dre	dre	PROPN
aiua-8115	40	17	.	.	PUNCT
aiua-8115	41	1	latex	latex	PROPN
aiua-8115	41	2	crp	crp	PROPN
aiua-8115	41	3	immunoturbidimetric	immunoturbidimetric	PROPN
aiua-8115	41	4	kit	kit	NOUN
aiua-8115	41	5	(	(	PUNCT
aiua-8115	41	6	crp	crp	PROPN
aiua-8115	41	7	-	-	PUNCT
aiua-8115	41	8	latex	latex	PROPN
aiua-8115	41	9	‘	'	PUNCT
aiua-8115	41	10	crplx	crplx	NOUN
aiua-8115	41	11	’	'	PUNCT
aiua-8115	41	12	,	,	PUNCT
aiua-8115	41	13	roche	roche	PROPN
aiua-8115	41	14	,	,	PUNCT
aiua-8115	41	15	germany	germany	PROPN
aiua-8115	41	16	,	,	PUNCT
aiua-8115	41	17	and	and	CCONJ
aiua-8115	41	18	model	model	NOUN
aiua-8115	41	19	no	no	PROPN
aiua-8115	41	20	.	.	PROPN
aiua-8115	41	21	6000	6000	NUM
aiua-8115	41	22	;	;	PUNCT
aiua-8115	41	23	hitachi	hitachi	PROPN
aiua-8115	41	24	,	,	PUNCT
aiua-8115	41	25	tokyo	tokyo	PROPN
aiua-8115	41	26	,	,	PUNCT
aiua-8115	41	27	japan	japan	PROPN
aiua-8115	41	28	)	)	PUNCT
aiua-8115	41	29	permitted	permit	VERB
aiua-8115	41	30	measurement	measurement	NOUN
aiua-8115	41	31	of	of	ADP
aiua-8115	41	32	serum	serum	PROPN
aiua-8115	41	33	crp	crp	PROPN
aiua-8115	41	34	before	before	ADP
aiua-8115	41	35	treatment	treatment	NOUN
aiua-8115	41	36	,	,	PUNCT
aiua-8115	41	37	with	with	ADP
aiua-8115	41	38	0.30	0.30	NUM
aiua-8115	41	39	mg	mg	PROPN
aiua-8115	41	40	/	/	SYM
aiua-8115	41	41	dl	dl	PROPN
aiua-8115	41	42	cut	cut	VERB
aiua-8115	41	43	-	-	PUNCT
aiua-8115	41	44	off	off	ADP
aiua-8115	41	45	value	value	NOUN
aiua-8115	41	46	with	with	ADP
aiua-8115	41	47	93	93	NUM
aiua-8115	41	48	%	%	NOUN
aiua-8115	41	49	specificity	specificity	NOUN
aiua-8115	41	50	(	(	PUNCT
aiua-8115	41	51	25	25	NUM
aiua-8115	41	52	)	)	PUNCT
aiua-8115	41	53	.	.	PUNCT
aiua-8115	42	1	furthermore	furthermore	ADV
aiua-8115	42	2	,	,	PUNCT
aiua-8115	42	3	a	a	DET
aiua-8115	42	4	centrifugal	centrifugal	ADJ
aiua-8115	42	5	automatic	automatic	ADJ
aiua-8115	42	6	analyzer	analyzer	NOUN
aiua-8115	42	7	and	and	CCONJ
aiua-8115	42	8	a	a	DET
aiua-8115	42	9	light	light	ADJ
aiua-8115	42	10	microscope	microscope	NOUN
aiua-8115	42	11	(	(	PUNCT
aiua-8115	42	12	roche	roche	PROPN
aiua-8115	42	13	miditron	miditron	PROPN
aiua-8115	42	14	®	®	PROPN
aiua-8115	42	15	junior	junior	PROPN
aiua-8115	42	16	ii	ii	PROPN
aiua-8115	42	17	,	,	PUNCT
aiua-8115	42	18	germany	germany	PROPN
aiua-8115	42	19	)	)	PUNCT
aiua-8115	42	20	was	be	AUX
aiua-8115	42	21	used	use	VERB
aiua-8115	42	22	for	for	ADP
aiua-8115	42	23	urine	urine	NOUN
aiua-8115	42	24	analysis	analysis	NOUN
aiua-8115	42	25	,	,	PUNCT
aiua-8115	42	26	while	while	SCONJ
aiua-8115	42	27	a	a	DET
aiua-8115	42	28	scanner	scanner	NOUN
aiua-8115	42	29	with	with	ADP
aiua-8115	42	30	a	a	DET
aiua-8115	42	31	6.5	6.5	NUM
aiua-8115	42	32	mhz	mhz	NOUN
aiua-8115	42	33	transrectal	transrectal	ADJ
aiua-8115	42	34	probe	probe	NOUN
aiua-8115	42	35	enabled	enable	VERB
aiua-8115	42	36	performance	performance	NOUN
aiua-8115	42	37	of	of	ADP
aiua-8115	42	38	prostate	prostate	NOUN
aiua-8115	42	39	transrectal	transrectal	ADJ
aiua-8115	42	40	ultrasonography	ultrasonography	NOUN
aiua-8115	42	41	(	(	PUNCT
aiua-8115	42	42	trus	trus	NOUN
aiua-8115	42	43	)	)	PUNCT
aiua-8115	42	44	.	.	PUNCT
aiua-8115	43	1	prostate	prostate	NOUN
aiua-8115	43	2	scanning	scanning	NOUN
aiua-8115	43	3	was	be	AUX
aiua-8115	43	4	performed	perform	VERB
aiua-8115	43	5	in	in	ADP
aiua-8115	43	6	both	both	PRON
aiua-8115	43	7	transverse	transverse	NOUN
aiua-8115	43	8	and	and	CCONJ
aiua-8115	43	9	sagittal	sagittal	ADJ
aiua-8115	43	10	planes	plane	NOUN
aiua-8115	43	11	whilst	whilst	SCONJ
aiua-8115	43	12	the	the	DET
aiua-8115	43	13	patient	patient	NOUN
aiua-8115	43	14	was	be	AUX
aiua-8115	43	15	lying	lie	VERB
aiua-8115	43	16	on	on	ADP
aiua-8115	43	17	his	his	PRON
aiua-8115	43	18	left	left	ADJ
aiua-8115	43	19	side	side	NOUN
aiua-8115	43	20	.	.	PUNCT
aiua-8115	44	1	the	the	DET
aiua-8115	44	2	formula	formula	NOUN
aiua-8115	44	3	for	for	ADP
aiua-8115	44	4	a	a	DET
aiua-8115	44	5	prostate	prostate	NOUN
aiua-8115	44	6	ellipsoid	ellipsoid	NOUN
aiua-8115	44	7	(	(	PUNCT
aiua-8115	44	8	width	width	VERB
aiua-8115	44	9	×	×	NOUN
aiua-8115	44	10	length	length	NOUN
aiua-8115	44	11	×	×	NOUN
aiua-8115	44	12	height	height	NOUN
aiua-8115	44	13	×	×	NOUN
aiua-8115	44	14	0.523	0.523	NUM
aiua-8115	44	15	)	)	PUNCT
aiua-8115	44	16	helped	help	VERB
aiua-8115	44	17	to	to	PART
aiua-8115	44	18	calculate	calculate	VERB
aiua-8115	44	19	the	the	DET
aiua-8115	44	20	prostate	prostate	NOUN
aiua-8115	44	21	volume	volume	NOUN
aiua-8115	44	22	and	and	CCONJ
aiua-8115	44	23	the	the	DET
aiua-8115	44	24	total	total	ADJ
aiua-8115	44	25	psa	psa	NOUN
aiua-8115	44	26	was	be	AUX
aiua-8115	44	27	divided	divide	VERB
aiua-8115	44	28	by	by	ADP
aiua-8115	44	29	the	the	DET
aiua-8115	44	30	prostate	prostate	NOUN
aiua-8115	44	31	volume	volume	NOUN
aiua-8115	44	32	to	to	PART
aiua-8115	44	33	obtain	obtain	VERB
aiua-8115	44	34	the	the	DET
aiua-8115	44	35	psad	psad	NOUN
aiua-8115	44	36	.	.	PUNCT
aiua-8115	45	1	moreover	moreover	ADV
aiua-8115	45	2	,	,	PUNCT
aiua-8115	45	3	an	an	DET
aiua-8115	45	4	automatic	automatic	ADJ
aiua-8115	45	5	biopsy	biopsy	NOUN
aiua-8115	45	6	gun	gun	NOUN
aiua-8115	45	7	and	and	CCONJ
aiua-8115	45	8	an	an	DET
aiua-8115	45	9	18	18	NUM
aiua-8115	45	10	-	-	PUNCT
aiua-8115	45	11	gauge	gauge	NOUN
aiua-8115	45	12	needle	needle	NOUN
aiua-8115	45	13	were	be	AUX
aiua-8115	45	14	employed	employ	VERB
aiua-8115	45	15	to	to	PART
aiua-8115	45	16	conduct	conduct	VERB
aiua-8115	45	17	the	the	DET
aiua-8115	45	18	12	12	NUM
aiua-8115	45	19	-	-	PUNCT
aiua-8115	45	20	quadrant	quadrant	NOUN
aiua-8115	45	21	biopsy	biopsy	NOUN
aiua-8115	45	22	under	under	ADP
aiua-8115	45	23	trus	trus	PROPN
aiua-8115	45	24	guidance	guidance	NOUN
aiua-8115	45	25	.	.	PUNCT
aiua-8115	46	1	prostate	prostate	NOUN
aiua-8115	46	2	chronic	chronic	ADJ
aiua-8115	46	3	inflammation	inflammation	NOUN
aiua-8115	46	4	was	be	AUX
aiua-8115	46	5	considered	consider	VERB
aiua-8115	46	6	to	to	PART
aiua-8115	46	7	be	be	AUX
aiua-8115	46	8	present	present	ADJ
aiua-8115	46	9	when	when	SCONJ
aiua-8115	46	10	inflammatory	inflammatory	ADJ
aiua-8115	46	11	cells	cell	NOUN
aiua-8115	46	12	,	,	PUNCT
aiua-8115	46	13	lymphocytes	lymphocyte	NOUN
aiua-8115	46	14	,	,	PUNCT
aiua-8115	46	15	plasma	plasma	NOUN
aiua-8115	46	16	cells	cell	NOUN
aiua-8115	46	17	and/or	and/or	CCONJ
aiua-8115	46	18	histiocytes	histiocyte	NOUN
aiua-8115	46	19	infiltrated	infiltrate	VERB
aiua-8115	46	20	prostatic	prostatic	ADJ
aiua-8115	46	21	biopsy	biopsy	NOUN
aiua-8115	46	22	specimens	specimen	NOUN
aiua-8115	46	23	(	(	PUNCT
aiua-8115	46	24	14	14	NUM
aiua-8115	46	25	)	)	PUNCT
aiua-8115	46	26	.	.	PUNCT
aiua-8115	47	1	data	datum	NOUN
aiua-8115	47	2	were	be	AUX
aiua-8115	47	3	expressed	express	VERB
aiua-8115	47	4	as	as	SCONJ
aiua-8115	47	5	means	mean	VERB
aiua-8115	47	6	±	±	NUM
aiua-8115	47	7	sd	sd	NOUN
aiua-8115	47	8	.	.	PUNCT
aiua-8115	48	1	spss	spss	PROPN
aiua-8115	48	2	(	(	PUNCT
aiua-8115	48	3	ibm	ibm	PROPN
aiua-8115	48	4	spss	spss	PROPN
aiua-8115	48	5	for	for	ADP
aiua-8115	48	6	windows	window	NOUN
aiua-8115	48	7	,	,	PUNCT
aiua-8115	48	8	ver.24	ver.24	NOUN
aiua-8115	48	9	)	)	PUNCT
aiua-8115	48	10	was	be	AUX
aiua-8115	48	11	used	use	VERB
aiua-8115	48	12	for	for	ADP
aiua-8115	48	13	comparison	comparison	NOUN
aiua-8115	48	14	of	of	ADP
aiua-8115	48	15	the	the	DET
aiua-8115	48	16	variables	variable	NOUN
aiua-8115	48	17	associated	associate	VERB
aiua-8115	48	18	with	with	ADP
aiua-8115	48	19	the	the	DET
aiua-8115	48	20	different	different	ADJ
aiua-8115	48	21	groups	group	NOUN
aiua-8115	48	22	via	via	ADP
aiua-8115	48	23	student	student	NOUN
aiua-8115	48	24	’s	’s	PART
aiua-8115	48	25	t	t	PROPN
aiua-8115	48	26	-	-	PUNCT
aiua-8115	48	27	test	test	NOUN
aiua-8115	48	28	and	and	CCONJ
aiua-8115	48	29	chisquare	chisquare	PROPN
aiua-8115	48	30	test	test	NOUN
aiua-8115	48	31	.	.	PUNCT
aiua-8115	49	1	statistical	statistical	ADJ
aiua-8115	49	2	significance	significance	NOUN
aiua-8115	49	3	was	be	AUX
aiua-8115	49	4	indicated	indicate	VERB
aiua-8115	49	5	by	by	ADP
aiua-8115	49	6	p	p	NOUN
aiua-8115	49	7	value	value	NOUN
aiua-8115	49	8	of	of	ADP
aiua-8115	49	9	less	less	ADJ
aiua-8115	49	10	than	than	ADP
aiua-8115	49	11	0.05	0.05	NUM
aiua-8115	49	12	.	.	PUNCT
aiua-8115	50	1	results	result	VERB
aiua-8115	50	2	the	the	DET
aiua-8115	50	3	characteristics	characteristic	NOUN
aiua-8115	50	4	of	of	ADP
aiua-8115	50	5	every	every	DET
aiua-8115	50	6	recruited	recruit	VERB
aiua-8115	50	7	patient	patient	NOUN
aiua-8115	50	8	are	be	AUX
aiua-8115	50	9	shown	show	VERB
aiua-8115	50	10	in	in	ADP
aiua-8115	50	11	table	table	NOUN
aiua-8115	50	12	1	1	NUM
aiua-8115	50	13	.	.	PUNCT
aiua-8115	51	1	a	a	DET
aiua-8115	51	2	proportion	proportion	NOUN
aiua-8115	51	3	of	of	ADP
aiua-8115	51	4	81.5	81.5	NUM
aiua-8115	51	5	%	%	NOUN
aiua-8115	51	6	of	of	ADP
aiua-8115	51	7	patients	patient	NOUN
aiua-8115	51	8	(	(	PUNCT
aiua-8115	51	9	n	n	NOUN
aiua-8115	51	10	=	=	SYM
aiua-8115	51	11	163	163	NUM
aiua-8115	51	12	)	)	PUNCT
aiua-8115	51	13	was	be	AUX
aiua-8115	51	14	histologically	histologically	ADV
aiua-8115	51	15	confirmed	confirm	VERB
aiua-8115	51	16	to	to	PART
aiua-8115	51	17	have	have	VERB
aiua-8115	51	18	benign	benign	ADJ
aiua-8115	51	19	prostatic	prostatic	ADJ
aiua-8115	51	20	hyperplasia	hyperplasia	NOUN
aiua-8115	51	21	(	(	PUNCT
aiua-8115	51	22	bph	bph	NOUN
aiua-8115	51	23	)	)	PUNCT
aiua-8115	51	24	,	,	PUNCT
aiua-8115	51	25	while	while	SCONJ
aiua-8115	51	26	the	the	DET
aiua-8115	51	27	other	other	ADJ
aiua-8115	51	28	18.5	18.5	NUM
aiua-8115	51	29	%	%	NOUN
aiua-8115	51	30	of	of	ADP
aiua-8115	51	31	patients	patient	NOUN
aiua-8115	51	32	(	(	PUNCT
aiua-8115	51	33	n	n	NOUN
aiua-8115	51	34	=	=	SYM
aiua-8115	51	35	37	37	NUM
aiua-8115	51	36	)	)	PUNCT
aiua-8115	51	37	had	have	VERB
aiua-8115	51	38	pca	pca	PROPN
aiua-8115	51	39	.	.	PUNCT
aiua-8115	52	1	histology	histology	NOUN
aiua-8115	52	2	also	also	ADV
aiua-8115	52	3	showed	show	VERB
aiua-8115	52	4	inflammation	inflammation	NOUN
aiua-8115	52	5	in	in	ADP
aiua-8115	52	6	biopsy	biopsy	ADJ
aiua-8115	52	7	specimens	specimen	NOUN
aiua-8115	52	8	of	of	ADP
aiua-8115	52	9	a	a	DET
aiua-8115	52	10	proportion	proportion	NOUN
aiua-8115	52	11	of	of	ADP
aiua-8115	52	12	49.5	49.5	NUM
aiua-8115	52	13	%	%	NOUN
aiua-8115	52	14	of	of	ADP
aiua-8115	52	15	patients	patient	NOUN
aiua-8115	52	16	(	(	PUNCT
aiua-8115	52	17	n	n	NOUN
aiua-8115	52	18	=	=	SYM
aiua-8115	52	19	99	99	NUM
aiua-8115	52	20	)	)	PUNCT
aiua-8115	52	21	.	.	PUNCT
aiua-8115	53	1	a	a	DET
aiua-8115	53	2	comparison	comparison	NOUN
aiua-8115	53	3	of	of	ADP
aiua-8115	53	4	pca	pca	PROPN
aiua-8115	53	5	and	and	CCONJ
aiua-8115	53	6	bph	bph	NOUN
aiua-8115	53	7	patients	patient	NOUN
aiua-8115	53	8	in	in	ADP
aiua-8115	53	9	terms	term	NOUN
aiua-8115	53	10	of	of	ADP
aiua-8115	53	11	clinical	clinical	ADJ
aiua-8115	53	12	variables	variable	NOUN
aiua-8115	53	13	is	be	AUX
aiua-8115	53	14	provided	provide	VERB
aiua-8115	53	15	in	in	ADP
aiua-8115	53	16	table	table	NOUN
aiua-8115	53	17	1	1	NUM
aiua-8115	53	18	.	.	PUNCT
aiua-8115	54	1	pca	pca	NOUN
aiua-8115	54	2	patients	patient	NOUN
aiua-8115	54	3	had	have	VERB
aiua-8115	54	4	a	a	DET
aiua-8115	54	5	mean	mean	ADJ
aiua-8115	54	6	age	age	NOUN
aiua-8115	54	7	of	of	ADP
aiua-8115	54	8	65.47	65.47	NUM
aiua-8115	54	9	±	±	NUM
aiua-8115	54	10	7.84	7.84	NUM
aiua-8115	54	11	years	year	NOUN
aiua-8115	54	12	,	,	PUNCT
aiua-8115	54	13	while	while	SCONJ
aiua-8115	54	14	bph	bph	NOUN
aiua-8115	54	15	patients	patient	NOUN
aiua-8115	54	16	had	have	VERB
aiua-8115	54	17	a	a	DET
aiua-8115	54	18	mean	mean	ADJ
aiua-8115	54	19	age	age	NOUN
aiua-8115	54	20	of	of	ADP
aiua-8115	54	21	63.12	63.12	NUM
aiua-8115	54	22	±	±	NUM
aiua-8115	54	23	7.73	7.73	NUM
aiua-8115	54	24	years	year	NOUN
aiua-8115	54	25	(	(	PUNCT
aiua-8115	54	26	p	p	X
aiua-8115	54	27	=	=	NOUN
aiua-8115	54	28	0.197	0.197	NUM
aiua-8115	54	29	)	)	PUNCT
aiua-8115	54	30	.	.	PUNCT
aiua-8115	55	1	pca	pca	NOUN
aiua-8115	55	2	patients	patient	NOUN
aiua-8115	55	3	had	have	VERB
aiua-8115	55	4	significantly	significantly	ADV
aiua-8115	55	5	higher	high	ADJ
aiua-8115	55	6	total	total	ADJ
aiua-8115	55	7	psa	psa	NOUN
aiua-8115	55	8	compared	compare	VERB
aiua-8115	55	9	to	to	ADP
aiua-8115	55	10	bph	bph	NOUN
aiua-8115	55	11	patients	patient	NOUN
aiua-8115	55	12	(	(	PUNCT
aiua-8115	55	13	p	p	X
aiua-8115	55	14	=	=	NOUN
aiua-8115	55	15	0.001	0.001	NUM
aiua-8115	55	16	)	)	PUNCT
aiua-8115	55	17	,	,	PUNCT
aiua-8115	55	18	but	but	CCONJ
aiua-8115	55	19	the	the	DET
aiua-8115	55	20	two	two	NUM
aiua-8115	55	21	groups	group	NOUN
aiua-8115	55	22	were	be	AUX
aiua-8115	55	23	similar	similar	ADJ
aiua-8115	55	24	in	in	ADP
aiua-8115	55	25	terms	term	NOUN
aiua-8115	55	26	of	of	ADP
aiua-8115	55	27	free	free	ADJ
aiua-8115	55	28	-	-	PUNCT
aiua-8115	55	29	to	to	ADP
aiua-8115	55	30	-	-	PUNCT
aiua-8115	55	31	total	total	ADJ
aiua-8115	55	32	psa	psa	NOUN
aiua-8115	55	33	ratios	ratio	NOUN
aiua-8115	55	34	.	.	PUNCT
aiua-8115	56	1	furthermore	furthermore	ADV
aiua-8115	56	2	,	,	PUNCT
aiua-8115	56	3	pca	pca	NOUN
aiua-8115	56	4	patients	patient	NOUN
aiua-8115	56	5	had	have	VERB
aiua-8115	56	6	significantly	significantly	ADV
aiua-8115	56	7	lower	low	ADJ
aiua-8115	56	8	mean	mean	ADJ
aiua-8115	56	9	prostate	prostate	NOUN
aiua-8115	56	10	volumes	volume	NOUN
aiua-8115	56	11	(	(	PUNCT
aiua-8115	56	12	p	p	X
aiua-8115	56	13	=	=	NOUN
aiua-8115	56	14	0.040	0.040	NUM
aiua-8115	56	15	)	)	PUNCT
aiua-8115	56	16	,	,	PUNCT
aiua-8115	56	17	the	the	DET
aiua-8115	56	18	psad	psad	ADJ
aiua-8115	56	19	values	value	NOUN
aiua-8115	56	20	were	be	AUX
aiua-8115	56	21	significantly	significantly	ADV
aiua-8115	56	22	higher	high	ADJ
aiua-8115	56	23	in	in	ADP
aiua-8115	56	24	the	the	DET
aiua-8115	56	25	pca	pca	NOUN
aiua-8115	56	26	than	than	ADP
aiua-8115	56	27	in	in	ADP
aiua-8115	56	28	the	the	DET
aiua-8115	56	29	bph	bph	NOUN
aiua-8115	56	30	group	group	NOUN
aiua-8115	56	31	(	(	PUNCT
aiua-8115	56	32	p	p	NOUN
aiua-8115	56	33	=	=	NOUN
aiua-8115	56	34	0.001	0.001	NUM
aiua-8115	56	35	)	)	PUNCT
aiua-8115	56	36	.	.	PUNCT
aiua-8115	57	1	however	however	ADV
aiua-8115	57	2	,	,	PUNCT
aiua-8115	57	3	histology	histology	NOUN
aiua-8115	57	4	did	do	AUX
aiua-8115	57	5	not	not	PART
aiua-8115	57	6	show	show	VERB
aiua-8115	57	7	a	a	DET
aiua-8115	57	8	significant	significant	ADJ
aiua-8115	57	9	difference	difference	NOUN
aiua-8115	57	10	between	between	ADP
aiua-8115	57	11	the	the	DET
aiua-8115	57	12	groups	group	NOUN
aiua-8115	57	13	regarding	regard	VERB
aiua-8115	57	14	inflammation	inflammation	NOUN
aiua-8115	57	15	(	(	PUNCT
aiua-8115	57	16	p	p	NOUN
aiua-8115	57	17	=	=	NOUN
aiua-8115	57	18	0.738	0.738	NUM
aiua-8115	57	19	)	)	PUNCT
aiua-8115	57	20	.	.	PUNCT
aiua-8115	58	1	a	a	DET
aiua-8115	58	2	proportion	proportion	NOUN
aiua-8115	58	3	of	of	ADP
aiua-8115	58	4	35	35	NUM
aiua-8115	58	5	%	%	NOUN
aiua-8115	58	6	of	of	ADP
aiua-8115	58	7	patients	patient	NOUN
aiua-8115	58	8	(	(	PUNCT
aiua-8115	58	9	n	n	NOUN
aiua-8115	58	10	=	=	SYM
aiua-8115	58	11	70	70	NUM
aiua-8115	58	12	)	)	PUNCT
aiua-8115	58	13	exhibited	exhibit	VERB
aiua-8115	58	14	pyuria	pyuria	PROPN
aiua-8115	58	15	,	,	PUNCT
aiua-8115	58	16	while	while	SCONJ
aiua-8115	58	17	the	the	DET
aiua-8115	58	18	other	other	ADJ
aiua-8115	58	19	65	65	NUM
aiua-8115	58	20	%	%	NOUN
aiua-8115	58	21	(	(	PUNCT
aiua-8115	58	22	n	n	NOUN
aiua-8115	58	23	=	=	SYM
aiua-8115	58	24	130	130	NUM
aiua-8115	58	25	)	)	PUNCT
aiua-8115	58	26	did	do	VERB
aiua-8115	58	27	not	not	PART
aiua-8115	58	28	,	,	PUNCT
aiua-8115	58	29	as	as	SCONJ
aiua-8115	58	30	revealed	reveal	VERB
aiua-8115	58	31	by	by	ADP
aiua-8115	58	32	the	the	DET
aiua-8115	58	33	distribution	distribution	NOUN
aiua-8115	58	34	of	of	ADP
aiua-8115	58	35	the	the	DET
aiua-8115	58	36	urinary	urinary	ADJ
aiua-8115	58	37	leukocyte	leukocyte	NOUN
aiua-8115	58	38	count	count	NOUN
aiua-8115	58	39	.	.	PUNCT
aiua-8115	59	1	a	a	DET
aiua-8115	59	2	comparison	comparison	NOUN
aiua-8115	59	3	of	of	ADP
aiua-8115	59	4	these	these	DET
aiua-8115	59	5	two	two	NUM
aiua-8115	59	6	groups	group	NOUN
aiua-8115	59	7	in	in	ADP
aiua-8115	59	8	terms	term	NOUN
aiua-8115	59	9	of	of	ADP
aiua-8115	59	10	clinical	clinical	ADJ
aiua-8115	59	11	variables	variable	NOUN
aiua-8115	59	12	,	,	PUNCT
aiua-8115	59	13	cancer	cancer	NOUN
aiua-8115	59	14	detection	detection	NOUN
aiua-8115	59	15	rates	rate	NOUN
aiua-8115	59	16	,	,	PUNCT
aiua-8115	59	17	and	and	CCONJ
aiua-8115	59	18	histologically	histologically	ADV
aiua-8115	59	19	-	-	PUNCT
aiua-8115	59	20	detected	detect	VERB
aiua-8115	59	21	inflammation	inflammation	NOUN
aiua-8115	59	22	is	be	AUX
aiua-8115	59	23	provided	provide	VERB
aiua-8115	59	24	in	in	ADP
aiua-8115	59	25	table	table	NOUN
aiua-8115	59	26	2	2	NUM
aiua-8115	59	27	.	.	PUNCT
aiua-8115	60	1	the	the	DET
aiua-8115	60	2	groups	group	NOUN
aiua-8115	60	3	were	be	AUX
aiua-8115	60	4	similar	similar	ADJ
aiua-8115	60	5	regarding	regard	VERB
aiua-8115	60	6	age	age	NOUN
aiua-8115	60	7	,	,	PUNCT
aiua-8115	60	8	free	free	ADJ
aiua-8115	60	9	-	-	PUNCT
aiua-8115	60	10	to	to	ADP
aiua-8115	60	11	-	-	PUNCT
aiua-8115	60	12	total	total	NOUN
aiua-8115	60	13	psa	psa	NOUN
aiua-8115	60	14	ratio	ratio	NOUN
aiua-8115	60	15	,	,	PUNCT
aiua-8115	60	16	prostate	prostate	NOUN
aiua-8115	60	17	volume	volume	NOUN
aiua-8115	60	18	,	,	PUNCT
aiua-8115	60	19	and	and	CCONJ
aiua-8115	60	20	psad	psad	ADJ
aiua-8115	60	21	value	value	NOUN
aiua-8115	60	22	,	,	PUNCT
aiua-8115	60	23	although	although	SCONJ
aiua-8115	60	24	the	the	DET
aiua-8115	60	25	pyuria	pyuria	PROPN
aiua-8115	60	26	group	group	NOUN
aiua-8115	60	27	exhibited	exhibit	VERB
aiua-8115	60	28	significantly	significantly	ADV
aiua-8115	60	29	higher	high	ADJ
aiua-8115	60	30	total	total	ADJ
aiua-8115	60	31	psa	psa	NOUN
aiua-8115	60	32	compared	compare	VERB
aiua-8115	60	33	to	to	ADP
aiua-8115	60	34	the	the	DET
aiua-8115	60	35	non	non	ADJ
aiua-8115	60	36	-	-	ADJ
aiua-8115	60	37	pyuria	pyuria	ADJ
aiua-8115	60	38	group	group	NOUN
aiua-8115	60	39	(	(	PUNCT
aiua-8115	60	40	p	p	X
aiua-8115	60	41	=	=	NOUN
aiua-8115	60	42	0.044	0.044	NUM
aiua-8115	60	43	)	)	PUNCT
aiua-8115	60	44	,	,	PUNCT
aiua-8115	60	45	as	as	ADV
aiua-8115	60	46	well	well	ADV
aiua-8115	60	47	as	as	ADP
aiua-8115	60	48	significantly	significantly	ADV
aiua-8115	60	49	higher	high	ADJ
aiua-8115	60	50	serum	serum	PROPN
aiua-8115	60	51	crp	crp	PROPN
aiua-8115	60	52	(	(	PUNCT
aiua-8115	60	53	p	p	NOUN
aiua-8115	60	54	=	=	NOUN
aiua-8115	60	55	0.001	0.001	NUM
aiua-8115	60	56	)	)	PUNCT
aiua-8115	60	57	.	.	PUNCT
aiua-8115	61	1	furthermore	furthermore	ADV
aiua-8115	61	2	,	,	PUNCT
aiua-8115	61	3	the	the	DET
aiua-8115	61	4	groups	group	NOUN
aiua-8115	61	5	were	be	AUX
aiua-8115	61	6	similar	similar	ADJ
aiua-8115	61	7	in	in	ADP
aiua-8115	61	8	terms	term	NOUN
aiua-8115	61	9	of	of	ADP
aiua-8115	61	10	histological	histological	ADJ
aiua-8115	61	11	cancer	cancer	NOUN
aiua-8115	61	12	detection	detection	NOUN
aiua-8115	61	13	rate	rate	NOUN
aiua-8115	61	14	(	(	PUNCT
aiua-8115	61	15	p	p	NOUN
aiua-8115	61	16	=	=	NOUN
aiua-8115	61	17	0.752	0.752	NUM
aiua-8115	61	18	)	)	PUNCT
aiua-8115	61	19	,	,	PUNCT
aiua-8115	61	20	but	but	CCONJ
aiua-8115	61	21	the	the	DET
aiua-8115	61	22	pyuria	pyuria	PROPN
aiua-8115	61	23	group	group	NOUN
aiua-8115	61	24	displayed	display	VERB
aiua-8115	61	25	greater	great	ADJ
aiua-8115	61	26	histological	histological	ADJ
aiua-8115	61	27	inflammation	inflammation	NOUN
aiua-8115	61	28	(	(	PUNCT
aiua-8115	61	29	70	70	NUM
aiua-8115	61	30	%	%	NOUN
aiua-8115	61	31	vs	vs	ADP
aiua-8115	61	32	38.5	38.5	NUM
aiua-8115	61	33	%	%	NOUN
aiua-8115	61	34	;	;	PUNCT
aiua-8115	61	35	p	p	X
aiua-8115	61	36	=	=	NOUN
aiua-8115	61	37	0.001	0.001	NUM
aiua-8115	61	38	)	)	PUNCT
aiua-8115	61	39	.	.	PUNCT
aiua-8115	62	1	table	table	NOUN
aiua-8115	62	2	1	1	NUM
aiua-8115	62	3	.	.	PUNCT
aiua-8115	63	1	characteristics	characteristic	NOUN
aiua-8115	63	2	of	of	ADP
aiua-8115	63	3	recruited	recruit	VERB
aiua-8115	63	4	patients	patient	NOUN
aiua-8115	63	5	.	.	PUNCT
aiua-8115	64	1	bph	bph	NOUN
aiua-8115	64	2	(	(	PUNCT
aiua-8115	64	3	n	n	NOUN
aiua-8115	64	4	=	=	SYM
aiua-8115	64	5	163	163	NUM
aiua-8115	64	6	)	)	PUNCT
aiua-8115	64	7	pca	pca	NOUN
aiua-8115	64	8	(	(	PUNCT
aiua-8115	64	9	n	n	NOUN
aiua-8115	64	10	=	=	SYM
aiua-8115	64	11	37	37	NUM
aiua-8115	64	12	)	)	PUNCT
aiua-8115	64	13	p	p	NOUN
aiua-8115	64	14	age	age	NOUN
aiua-8115	64	15	(	(	PUNCT
aiua-8115	64	16	years	year	NOUN
aiua-8115	64	17	)	)	PUNCT
aiua-8115	64	18	63.12	63.12	NUM
aiua-8115	64	19	±	±	NUM
aiua-8115	64	20	7.73	7.73	NUM
aiua-8115	64	21	(	(	PUNCT
aiua-8115	64	22	40	40	NUM
aiua-8115	64	23	-	-	SYM
aiua-8115	64	24	79	79	NUM
aiua-8115	64	25	)	)	PUNCT
aiua-8115	65	1	65.47	65.47	NUM
aiua-8115	65	2	±	±	NUM
aiua-8115	65	3	7.84	7.84	NUM
aiua-8115	65	4	(	(	PUNCT
aiua-8115	65	5	45	45	NUM
aiua-8115	65	6	-	-	SYM
aiua-8115	65	7	80	80	NUM
aiua-8115	65	8	)	)	PUNCT
aiua-8115	65	9	0.637	0.637	NUM
aiua-8115	65	10	urinary	urinary	ADJ
aiua-8115	65	11	leukocyte	leukocyte	NOUN
aiua-8115	65	12	count	count	NOUN
aiua-8115	65	13	(	(	PUNCT
aiua-8115	65	14	n	n	CCONJ
aiua-8115	65	15	°	°	NOUN
aiua-8115	65	16	/h.p.f	/h.p.f	NOUN
aiua-8115	65	17	.	.	PUNCT
aiua-8115	65	18	)	)	PUNCT
aiua-8115	66	1	9.44	9.44	NUM
aiua-8115	66	2	±	±	NUM
aiua-8115	66	3	19.18	19.18	NUM
aiua-8115	66	4	(	(	PUNCT
aiua-8115	66	5	1	1	NUM
aiua-8115	66	6	-	-	NUM
aiua-8115	66	7	80	80	NUM
aiua-8115	66	8	)	)	PUNCT
aiua-8115	66	9	10.71	10.71	NUM
aiua-8115	66	10	±	±	NUM
aiua-8115	66	11	21.25	21.25	NUM
aiua-8115	66	12	(	(	PUNCT
aiua-8115	66	13	1	1	NUM
aiua-8115	66	14	-	-	SYM
aiua-8115	66	15	90	90	NUM
aiua-8115	66	16	)	)	PUNCT
aiua-8115	66	17	0.288	0.288	NUM
aiua-8115	66	18	crp	crp	NOUN
aiua-8115	66	19	(	(	PUNCT
aiua-8115	66	20	mg	mg	PROPN
aiua-8115	66	21	/	/	SYM
aiua-8115	66	22	dl	dl	NOUN
aiua-8115	66	23	)	)	PUNCT
aiua-8115	66	24	1.23	1.23	NUM
aiua-8115	66	25	±	±	NUM
aiua-8115	66	26	1.55	1.55	NUM
aiua-8115	66	27	(	(	PUNCT
aiua-8115	66	28	0.10	0.10	NUM
aiua-8115	66	29	-	-	SYM
aiua-8115	66	30	8.00	8.00	NUM
aiua-8115	66	31	)	)	PUNCT
aiua-8115	66	32	0.85	0.85	NUM
aiua-8115	66	33	±	±	NUM
aiua-8115	66	34	0.63	0.63	NUM
aiua-8115	66	35	(	(	PUNCT
aiua-8115	66	36	0.10	0.10	NUM
aiua-8115	66	37	-	-	SYM
aiua-8115	66	38	3.12	3.12	NUM
aiua-8115	66	39	)	)	PUNCT
aiua-8115	66	40	0.520	0.520	NUM
aiua-8115	66	41	t	t	PROPN
aiua-8115	66	42	-	-	PUNCT
aiua-8115	66	43	psa	psa	NOUN
aiua-8115	66	44	(	(	PUNCT
aiua-8115	66	45	ng	ng	PROPN
aiua-8115	66	46	/	/	SYM
aiua-8115	66	47	ml	ml	NOUN
aiua-8115	66	48	)	)	PUNCT
aiua-8115	66	49	5.84	5.84	NUM
aiua-8115	66	50	±	±	NUM
aiua-8115	66	51	2.54	2.54	NUM
aiua-8115	66	52	(	(	PUNCT
aiua-8115	66	53	3.11	3.11	NUM
aiua-8115	66	54	-	-	SYM
aiua-8115	66	55	14	14	NUM
aiua-8115	66	56	)	)	PUNCT
aiua-8115	66	57	8.72	8.72	NUM
aiua-8115	66	58	±	±	NUM
aiua-8115	66	59	4.48	4.48	NUM
aiua-8115	66	60	(	(	PUNCT
aiua-8115	66	61	3.65	3.65	NUM
aiua-8115	66	62	-	-	SYM
aiua-8115	66	63	20.00	20.00	NUM
aiua-8115	66	64	)	)	PUNCT
aiua-8115	66	65	0.001	0.001	NUM
aiua-8115	66	66	*	*	PUNCT
aiua-8115	66	67	prostate	prostate	NOUN
aiua-8115	66	68	volume	volume	NOUN
aiua-8115	66	69	(	(	PUNCT
aiua-8115	66	70	ml	ml	NOUN
aiua-8115	66	71	)	)	PUNCT
aiua-8115	66	72	57.77	57.77	NUM
aiua-8115	66	73	±	±	NUM
aiua-8115	66	74	34.65	34.65	NUM
aiua-8115	66	75	(	(	PUNCT
aiua-8115	66	76	17	17	NUM
aiua-8115	66	77	-	-	SYM
aiua-8115	66	78	260	260	NUM
aiua-8115	66	79	)	)	PUNCT
aiua-8115	66	80	41.2	41.2	NUM
aiua-8115	66	81	±	±	NUM
aiua-8115	66	82	20.36	20.36	NUM
aiua-8115	66	83	(	(	PUNCT
aiua-8115	66	84	20	20	NUM
aiua-8115	66	85	-	-	SYM
aiua-8115	66	86	120	120	NUM
aiua-8115	66	87	)	)	PUNCT
aiua-8115	66	88	0.040	0.040	NUM
aiua-8115	66	89	*	*	PUNCT
aiua-8115	66	90	free	free	ADJ
aiua-8115	66	91	to	to	PART
aiua-8115	66	92	total	total	VERB
aiua-8115	66	93	psa	psa	NOUN
aiua-8115	66	94	ratio	ratio	NOUN
aiua-8115	66	95	(	(	PUNCT
aiua-8115	66	96	%	%	NOUN
aiua-8115	66	97	)	)	PUNCT
aiua-8115	66	98	19	19	NUM
aiua-8115	66	99	±	±	NUM
aiua-8115	66	100	7	7	NUM
aiua-8115	66	101	(	(	PUNCT
aiua-8115	66	102	5	5	NUM
aiua-8115	66	103	-	-	SYM
aiua-8115	66	104	38	38	NUM
aiua-8115	66	105	)	)	PUNCT
aiua-8115	66	106	22	22	NUM
aiua-8115	66	107	±	±	NUM
aiua-8115	66	108	23	23	NUM
aiua-8115	66	109	(	(	PUNCT
aiua-8115	66	110	3	3	NUM
aiua-8115	66	111	-	-	SYM
aiua-8115	66	112	58	58	NUM
aiua-8115	66	113	)	)	PUNCT
aiua-8115	66	114	0.752	0.752	NUM
aiua-8115	66	115	psad	psad	ADJ
aiua-8115	66	116	0.12	0.12	NUM
aiua-8115	66	117	±	±	NUM
aiua-8115	66	118	0.07	0.07	NUM
aiua-8115	66	119	(	(	PUNCT
aiua-8115	66	120	0.03	0.03	NUM
aiua-8115	66	121	-	-	SYM
aiua-8115	66	122	0.34	0.34	NUM
aiua-8115	66	123	)	)	PUNCT
aiua-8115	66	124	0.25	0.25	NUM
aiua-8115	66	125	±	±	NUM
aiua-8115	66	126	0.21	0.21	NUM
aiua-8115	66	127	(	(	PUNCT
aiua-8115	66	128	0.07	0.07	NUM
aiua-8115	66	129	-	-	SYM
aiua-8115	66	130	0.85	0.85	NUM
aiua-8115	66	131	)	)	PUNCT
aiua-8115	66	132	0.001	0.001	NUM
aiua-8115	66	133	*	*	VERB
aiua-8115	66	134	histologically	histologically	ADV
aiua-8115	66	135	-	-	PUNCT
aiua-8115	66	136	detected	detect	VERB
aiua-8115	66	137	inflammation	inflammation	NOUN
aiua-8115	66	138	rate	rate	NOUN
aiua-8115	66	139	49.7	49.7	NUM
aiua-8115	66	140	%	%	NOUN
aiua-8115	66	141	(	(	PUNCT
aiua-8115	66	142	81/163	81/163	NUM
aiua-8115	66	143	)	)	PUNCT
aiua-8115	66	144	48.6	48.6	NUM
aiua-8115	66	145	%	%	NOUN
aiua-8115	66	146	(	(	PUNCT
aiua-8115	66	147	18/37	18/37	NUM
aiua-8115	66	148	)	)	PUNCT
aiua-8115	66	149	0.738	0.738	NUM
aiua-8115	66	150	†mean	†mean	NUM
aiua-8115	66	151	±	±	NUM
aiua-8115	66	152	sd	sd	ADP
aiua-8115	66	153	range	range	NOUN
aiua-8115	66	154	;	;	PUNCT
aiua-8115	66	155	‡bph	‡bph	X
aiua-8115	66	156	versus	versus	ADP
aiua-8115	66	157	pca	pca	PROPN
aiua-8115	66	158	.	.	PROPN
aiua-8115	66	159	bph	bph	PROPN
aiua-8115	66	160	:	:	PUNCT
aiua-8115	66	161	benign	benign	ADJ
aiua-8115	66	162	prostatic	prostatic	ADJ
aiua-8115	66	163	hyperplasia	hyperplasia	NOUN
aiua-8115	66	164	;	;	PUNCT
aiua-8115	66	165	crp	crp	PROPN
aiua-8115	66	166	:	:	PUNCT
aiua-8115	66	167	c	c	X
aiua-8115	66	168	-	-	PUNCT
aiua-8115	66	169	reactive	reactive	ADJ
aiua-8115	66	170	protein	protein	NOUN
aiua-8115	66	171	;	;	PUNCT
aiua-8115	66	172	pca	pca	NOUN
aiua-8115	66	173	:	:	PUNCT
aiua-8115	66	174	prostate	prostate	NOUN
aiua-8115	66	175	cancer	cancer	NOUN
aiua-8115	66	176	;	;	PUNCT
aiua-8115	66	177	t	t	PROPN
aiua-8115	66	178	-	-	PUNCT
aiua-8115	66	179	psa	psa	NOUN
aiua-8115	66	180	:	:	PUNCT
aiua-8115	66	181	total	total	ADJ
aiua-8115	66	182	prostate	prostate	NOUN
aiua-8115	66	183	-	-	PUNCT
aiua-8115	66	184	specific	specific	ADJ
aiua-8115	66	185	antigen	antigen	NOUN
aiua-8115	66	186	;	;	PUNCT
aiua-8115	66	187	psad	psad	ADJ
aiua-8115	66	188	:	:	PUNCT
aiua-8115	66	189	psa	psa	VERB
aiua-8115	66	190	density	density	NOUN
aiua-8115	66	191	.	.	PUNCT
aiua-8115	67	1	table	table	NOUN
aiua-8115	67	2	2	2	NUM
aiua-8115	67	3	.	.	PUNCT
aiua-8115	68	1	clinical	clinical	ADJ
aiua-8115	68	2	variables	variable	NOUN
aiua-8115	68	3	,	,	PUNCT
aiua-8115	68	4	cancer	cancer	NOUN
aiua-8115	68	5	detection	detection	NOUN
aiua-8115	68	6	rates	rate	NOUN
aiua-8115	68	7	and	and	CCONJ
aiua-8115	68	8	histologically	histologically	ADV
aiua-8115	68	9	-	-	PUNCT
aiua-8115	68	10	detected	detect	VERB
aiua-8115	68	11	inflammation	inflammation	NOUN
aiua-8115	68	12	rates	rate	NOUN
aiua-8115	68	13	in	in	ADP
aiua-8115	68	14	pyuria	pyuria	PROPN
aiua-8115	68	15	and	and	CCONJ
aiua-8115	68	16	non	non	ADJ
aiua-8115	68	17	-	-	ADJ
aiua-8115	68	18	pyuria	pyuria	ADJ
aiua-8115	68	19	groups	group	NOUN
aiua-8115	68	20	.	.	PUNCT
aiua-8115	69	1	non	non	ADJ
aiua-8115	69	2	-	-	ADJ
aiua-8115	69	3	pyuria	pyuria	ADJ
aiua-8115	69	4	group	group	NOUN
aiua-8115	69	5	(	(	PUNCT
aiua-8115	69	6	n	n	CCONJ
aiua-8115	69	7	:	:	SYM
aiua-8115	69	8	130	130	NUM
aiua-8115	69	9	)	)	PUNCT
aiua-8115	69	10	pyuria	pyuria	PROPN
aiua-8115	69	11	group	group	NOUN
aiua-8115	69	12	(	(	PUNCT
aiua-8115	69	13	n	n	CCONJ
aiua-8115	69	14	:	:	PUNCT
aiua-8115	69	15	70	70	NUM
aiua-8115	69	16	)	)	PUNCT
aiua-8115	69	17	p	p	NOUN
aiua-8115	69	18	age	age	NOUN
aiua-8115	69	19	(	(	PUNCT
aiua-8115	69	20	years	year	NOUN
aiua-8115	69	21	)	)	PUNCT
aiua-8115	69	22	60.45	60.45	NUM
aiua-8115	69	23	±	±	NUM
aiua-8115	69	24	7.51	7.51	NUM
aiua-8115	69	25	(	(	PUNCT
aiua-8115	69	26	40	40	NUM
aiua-8115	69	27	-	-	SYM
aiua-8115	69	28	80	80	NUM
aiua-8115	69	29	)	)	PUNCT
aiua-8115	69	30	64	64	NUM
aiua-8115	69	31	±	±	NUM
aiua-8115	69	32	6.07	6.07	NUM
aiua-8115	69	33	(	(	PUNCT
aiua-8115	69	34	50	50	NUM
aiua-8115	69	35	-	-	SYM
aiua-8115	69	36	78	78	NUM
aiua-8115	69	37	)	)	PUNCT
aiua-8115	69	38	0.637	0.637	NUM
aiua-8115	69	39	crp	crp	NOUN
aiua-8115	69	40	(	(	PUNCT
aiua-8115	69	41	mg	mg	PROPN
aiua-8115	69	42	/	/	SYM
aiua-8115	69	43	dl	dl	NOUN
aiua-8115	69	44	)	)	PUNCT
aiua-8115	69	45	0.75	0.75	NUM
aiua-8115	69	46	±	±	NUM
aiua-8115	69	47	0.78	0.78	NUM
aiua-8115	69	48	(	(	PUNCT
aiua-8115	69	49	0.10	0.10	NUM
aiua-8115	69	50	-	-	SYM
aiua-8115	69	51	3.22	3.22	NUM
aiua-8115	69	52	)	)	PUNCT
aiua-8115	69	53	2.39	2.39	NUM
aiua-8115	69	54	±	±	NUM
aiua-8115	69	55	2.09	2.09	NUM
aiua-8115	69	56	(	(	PUNCT
aiua-8115	69	57	0.28	0.28	NUM
aiua-8115	69	58	-	-	NUM
aiua-8115	69	59	8.00	8.00	NUM
aiua-8115	69	60	)	)	PUNCT
aiua-8115	69	61	0.001	0.001	NUM
aiua-8115	69	62	*	*	SYM
aiua-8115	69	63	t.psa	t.psa	PROPN
aiua-8115	69	64	(	(	PUNCT
aiua-8115	69	65	ng	ng	PROPN
aiua-8115	69	66	/	/	SYM
aiua-8115	69	67	ml	ml	PROPN
aiua-8115	69	68	)	)	PUNCT
aiua-8115	69	69	6.42	6.42	NUM
aiua-8115	69	70	±	±	NUM
aiua-8115	69	71	2.41	2.41	NUM
aiua-8115	69	72	(	(	PUNCT
aiua-8115	69	73	3.29	3.29	NUM
aiua-8115	69	74	-	-	SYM
aiua-8115	69	75	15.07	15.07	NUM
aiua-8115	69	76	)	)	PUNCT
aiua-8115	69	77	7.85	7.85	NUM
aiua-8115	69	78	±	±	NUM
aiua-8115	69	79	3.88	3.88	NUM
aiua-8115	69	80	(	(	PUNCT
aiua-8115	69	81	3.11	3.11	NUM
aiua-8115	69	82	-	-	SYM
aiua-8115	69	83	20.00	20.00	NUM
aiua-8115	69	84	)	)	PUNCT
aiua-8115	69	85	0.044	0.044	NUM
aiua-8115	69	86	*	*	PUNCT
aiua-8115	69	87	prostate	prostate	NOUN
aiua-8115	69	88	volume(ml	volume(ml	NOUN
aiua-8115	69	89	)	)	PUNCT
aiua-8115	69	90	50.3	50.3	NUM
aiua-8115	69	91	±	±	NUM
aiua-8115	69	92	34.4	34.4	NUM
aiua-8115	69	93	(	(	PUNCT
aiua-8115	69	94	17	17	NUM
aiua-8115	69	95	-	-	SYM
aiua-8115	69	96	260	260	NUM
aiua-8115	69	97	)	)	PUNCT
aiua-8115	69	98	55.4	55.4	NUM
aiua-8115	69	99	±	±	NUM
aiua-8115	69	100	26.5	26.5	NUM
aiua-8115	69	101	(	(	PUNCT
aiua-8115	69	102	30	30	NUM
aiua-8115	69	103	-	-	SYM
aiua-8115	69	104	130	130	NUM
aiua-8115	69	105	)	)	PUNCT
aiua-8115	69	106	0.208	0.208	NUM
aiua-8115	69	107	free	free	ADJ
aiua-8115	69	108	to	to	PART
aiua-8115	69	109	total	total	VERB
aiua-8115	69	110	psa	psa	NOUN
aiua-8115	69	111	ratio	ratio	NOUN
aiua-8115	69	112	(	(	PUNCT
aiua-8115	69	113	%	%	NOUN
aiua-8115	69	114	)	)	PUNCT
aiua-8115	69	115	17	17	NUM
aiua-8115	69	116	±	±	NUM
aiua-8115	69	117	9	9	NUM
aiua-8115	69	118	(	(	PUNCT
aiua-8115	69	119	3	3	NUM
aiua-8115	69	120	-	-	SYM
aiua-8115	69	121	35	35	NUM
aiua-8115	69	122	)	)	PUNCT
aiua-8115	69	123	20	20	NUM
aiua-8115	69	124	±	±	NUM
aiua-8115	69	125	11	11	NUM
aiua-8115	69	126	(	(	PUNCT
aiua-8115	69	127	11	11	NUM
aiua-8115	69	128	-	-	SYM
aiua-8115	69	129	58	58	NUM
aiua-8115	69	130	)	)	PUNCT
aiua-8115	69	131	0.814	0.814	NUM
aiua-8115	69	132	psad	psad	ADJ
aiua-8115	69	133	0.14	0.14	NUM
aiua-8115	69	134	±	±	NUM
aiua-8115	69	135	0.07	0.07	NUM
aiua-8115	69	136	(	(	PUNCT
aiua-8115	69	137	0.04	0.04	NUM
aiua-8115	69	138	-	-	SYM
aiua-8115	69	139	0.61	0.61	NUM
aiua-8115	69	140	)	)	PUNCT
aiua-8115	69	141	0.15	0.15	NUM
aiua-8115	69	142	±	±	NUM
aiua-8115	69	143	0.12	0.12	NUM
aiua-8115	69	144	(	(	PUNCT
aiua-8115	69	145	0.03	0.03	NUM
aiua-8115	69	146	-	-	SYM
aiua-8115	69	147	0.85	0.85	NUM
aiua-8115	69	148	)	)	PUNCT
aiua-8115	69	149	0.288	0.288	NUM
aiua-8115	69	150	histologically	histologically	ADV
aiua-8115	69	151	-	-	PUNCT
aiua-8115	69	152	detected	detect	VERB
aiua-8115	69	153	inflammation	inflammation	NOUN
aiua-8115	69	154	rate	rate	NOUN
aiua-8115	69	155	38.5	38.5	NUM
aiua-8115	69	156	%	%	NOUN
aiua-8115	69	157	(	(	PUNCT
aiua-8115	69	158	50/130	50/130	NUM
aiua-8115	69	159	)	)	PUNCT
aiua-8115	69	160	70	70	NUM
aiua-8115	69	161	%	%	NOUN
aiua-8115	69	162	(	(	PUNCT
aiua-8115	69	163	49/70	49/70	NUM
aiua-8115	69	164	)	)	PUNCT
aiua-8115	69	165	0.001	0.001	NUM
aiua-8115	69	166	*	*	PUNCT
aiua-8115	69	167	cancer	cancer	NOUN
aiua-8115	69	168	detection	detection	NOUN
aiua-8115	69	169	rate	rate	NOUN
aiua-8115	69	170	17.6	17.6	NUM
aiua-8115	69	171	%	%	NOUN
aiua-8115	69	172	(	(	PUNCT
aiua-8115	69	173	23/130	23/130	NUM
aiua-8115	69	174	)	)	PUNCT
aiua-8115	69	175	20	20	NUM
aiua-8115	69	176	%	%	NOUN
aiua-8115	69	177	(	(	PUNCT
aiua-8115	69	178	14/70	14/70	NUM
aiua-8115	69	179	)	)	PUNCT
aiua-8115	69	180	0.752	0.752	NUM
aiua-8115	69	181	mean	mean	NOUN
aiua-8115	69	182	±	±	NUM
aiua-8115	69	183	sd	sd	ADP
aiua-8115	69	184	range	range	NOUN
aiua-8115	69	185	;	;	PUNCT
aiua-8115	69	186	‡non	‡non	NOUN
aiua-8115	69	187	-	-	ADJ
aiua-8115	69	188	pyuria	pyuria	ADJ
aiua-8115	69	189	,	,	PUNCT
aiua-8115	69	190	urinary	urinary	ADJ
aiua-8115	69	191	leukocyte	leukocyte	NOUN
aiua-8115	69	192	count	count	NOUN
aiua-8115	69	193	≤	≤	ADJ
aiua-8115	69	194	3	3	NUM
aiua-8115	69	195	/	/	SYM
aiua-8115	69	196	h.p.f	h.p.f	NOUN
aiua-8115	69	197	.	.	PUNCT
aiua-8115	69	198	;	;	PUNCT
aiua-8115	69	199	pyuria	pyuria	INTJ
aiua-8115	69	200	,	,	PUNCT
aiua-8115	69	201	urinary	urinary	ADJ
aiua-8115	69	202	leukocyte	leukocyte	NOUN
aiua-8115	69	203	count	count	NOUN
aiua-8115	69	204	>	>	X
aiua-8115	69	205	3	3	NUM
aiua-8115	69	206	/	/	SYM
aiua-8115	69	207	h.p.f	h.p.f	NOUN
aiua-8115	69	208	.	.	PUNCT
aiua-8115	69	209	;	;	PUNCT
aiua-8115	69	210	crp	crp	PROPN
aiua-8115	69	211	:	:	PUNCT
aiua-8115	69	212	c	c	X
aiua-8115	69	213	-	-	PUNCT
aiua-8115	69	214	reactive	reactive	ADJ
aiua-8115	69	215	protein	protein	NOUN
aiua-8115	69	216	;	;	PUNCT
aiua-8115	69	217	h.p.f	h.p.f	ADJ
aiua-8115	69	218	.	.	PUNCT
aiua-8115	69	219	:	:	PUNCT
aiua-8115	70	1	high	high	ADJ
aiua-8115	70	2	power	power	NOUN
aiua-8115	70	3	field	field	NOUN
aiua-8115	70	4	;	;	PUNCT
aiua-8115	70	5	t	t	X
aiua-8115	70	6	-	-	PUNCT
aiua-8115	70	7	psa	psa	NOUN
aiua-8115	70	8	:	:	PUNCT
aiua-8115	70	9	total	total	ADJ
aiua-8115	70	10	prostate	prostate	NOUN
aiua-8115	70	11	specific	specific	ADJ
aiua-8115	70	12	antigen	antigen	NOUN
aiua-8115	70	13	;	;	PUNCT
aiua-8115	70	14	psad	psad	ADJ
aiua-8115	70	15	:	:	PUNCT
aiua-8115	70	16	psa	psa	VERB
aiua-8115	70	17	density	density	NOUN
aiua-8115	70	18	.	.	PUNCT
aiua-8115	71	1	demir_stesura	demir_stesura	NOUN
aiua-8115	71	2	seveso	seveso	VERB
aiua-8115	71	3	30/09/19	30/09/19	PROPN
aiua-8115	71	4	18:21	18:21	NUM
aiua-8115	71	5	pagina	pagina	NOUN
aiua-8115	71	6	168	168	NUM
aiua-8115	71	7	two	two	NUM
aiua-8115	71	8	groups	group	NOUN
aiua-8115	71	9	of	of	ADP
aiua-8115	71	10	positive	positive	ADJ
aiua-8115	71	11	crp	crp	NOUN
aiua-8115	71	12	(	(	PUNCT
aiua-8115	71	13	71.5	71.5	NUM
aiua-8115	71	14	%	%	NOUN
aiua-8115	71	15	,	,	PUNCT
aiua-8115	71	16	n	n	PROPN
aiua-8115	71	17	=	=	SYM
aiua-8115	71	18	143	143	NUM
aiua-8115	71	19	)	)	PUNCT
aiua-8115	71	20	and	and	CCONJ
aiua-8115	71	21	negative	negative	ADJ
aiua-8115	71	22	crp	crp	NOUN
aiua-8115	71	23	(	(	PUNCT
aiua-8115	71	24	28.5	28.5	NUM
aiua-8115	71	25	%	%	NOUN
aiua-8115	71	26	,	,	PUNCT
aiua-8115	71	27	n	n	NOUN
aiua-8115	71	28	=	=	SYM
aiua-8115	71	29	57	57	NUM
aiua-8115	71	30	)	)	PUNCT
aiua-8115	71	31	were	be	AUX
aiua-8115	71	32	also	also	ADV
aiua-8115	71	33	distinguished	distinguish	VERB
aiua-8115	71	34	based	base	VERB
aiua-8115	71	35	on	on	ADP
aiua-8115	71	36	the	the	DET
aiua-8115	71	37	manner	manner	NOUN
aiua-8115	71	38	in	in	ADP
aiua-8115	71	39	which	which	PRON
aiua-8115	71	40	pre	pre	ADJ
aiua-8115	71	41	-	-	NOUN
aiua-8115	71	42	treatment	treatment	ADJ
aiua-8115	71	43	serum	serum	NOUN
aiua-8115	71	44	crp	crp	PROPN
aiua-8115	71	45	levels	level	NOUN
aiua-8115	71	46	were	be	AUX
aiua-8115	71	47	distributed	distribute	VERB
aiua-8115	71	48	.	.	PUNCT
aiua-8115	72	1	a	a	DET
aiua-8115	72	2	comparison	comparison	NOUN
aiua-8115	72	3	of	of	ADP
aiua-8115	72	4	these	these	DET
aiua-8115	72	5	two	two	NUM
aiua-8115	72	6	groups	group	NOUN
aiua-8115	72	7	in	in	ADP
aiua-8115	72	8	terms	term	NOUN
aiua-8115	72	9	of	of	ADP
aiua-8115	72	10	clinical	clinical	ADJ
aiua-8115	72	11	parameters	parameter	NOUN
aiua-8115	72	12	,	,	PUNCT
aiua-8115	72	13	cancer	cancer	NOUN
aiua-8115	72	14	detection	detection	NOUN
aiua-8115	72	15	rates	rate	NOUN
aiua-8115	72	16	,	,	PUNCT
aiua-8115	72	17	and	and	CCONJ
aiua-8115	72	18	histologically	histologically	ADV
aiua-8115	72	19	-	-	PUNCT
aiua-8115	72	20	detected	detect	VERB
aiua-8115	72	21	inflammation	inflammation	NOUN
aiua-8115	72	22	is	be	AUX
aiua-8115	72	23	provided	provide	VERB
aiua-8115	72	24	in	in	ADP
aiua-8115	72	25	table	table	NOUN
aiua-8115	72	26	3	3	NUM
aiua-8115	72	27	.	.	PUNCT
aiua-8115	73	1	it	it	PRON
aiua-8115	73	2	was	be	AUX
aiua-8115	73	3	observed	observe	VERB
aiua-8115	73	4	that	that	SCONJ
aiua-8115	73	5	the	the	DET
aiua-8115	73	6	groups	group	NOUN
aiua-8115	73	7	were	be	AUX
aiua-8115	73	8	similar	similar	ADJ
aiua-8115	73	9	regarding	regard	VERB
aiua-8115	73	10	age	age	NOUN
aiua-8115	73	11	,	,	PUNCT
aiua-8115	73	12	free	free	ADJ
aiua-8115	73	13	-	-	PUNCT
aiua-8115	73	14	to	to	ADP
aiua-8115	73	15	-	-	PUNCT
aiua-8115	73	16	total	total	NOUN
aiua-8115	73	17	psa	psa	NOUN
aiua-8115	73	18	ratio	ratio	NOUN
aiua-8115	73	19	,	,	PUNCT
aiua-8115	73	20	prostate	prostate	NOUN
aiua-8115	73	21	volume	volume	NOUN
aiua-8115	73	22	,	,	PUNCT
aiua-8115	73	23	cancer	cancer	NOUN
aiua-8115	73	24	detection	detection	NOUN
aiua-8115	73	25	rates	rate	NOUN
aiua-8115	73	26	,	,	PUNCT
aiua-8115	73	27	and	and	CCONJ
aiua-8115	73	28	histologically	histologically	ADV
aiua-8115	73	29	-	-	PUNCT
aiua-8115	73	30	detected	detect	VERB
aiua-8115	73	31	inflammation	inflammation	NOUN
aiua-8115	73	32	and	and	CCONJ
aiua-8115	73	33	psad	psad	ADJ
aiua-8115	73	34	values	value	NOUN
aiua-8115	73	35	.	.	PUNCT
aiua-8115	74	1	discussion	discussion	NOUN
aiua-8115	74	2	since	since	SCONJ
aiua-8115	74	3	the	the	DET
aiua-8115	74	4	first	first	ADJ
aiua-8115	74	5	isolation	isolation	NOUN
aiua-8115	74	6	of	of	ADP
aiua-8115	74	7	serine	serine	ADJ
aiua-8115	74	8	protease	protease	NOUN
aiua-8115	74	9	psa	psa	NOUN
aiua-8115	74	10	from	from	ADP
aiua-8115	74	11	prostate	prostate	NOUN
aiua-8115	74	12	epithelial	epithelial	ADJ
aiua-8115	74	13	cells	cell	NOUN
aiua-8115	74	14	that	that	PRON
aiua-8115	74	15	was	be	AUX
aiua-8115	74	16	accomplished	accomplish	VERB
aiua-8115	74	17	by	by	ADP
aiua-8115	74	18	wang	wang	PROPN
aiua-8115	74	19	et	et	PROPN
aiua-8115	74	20	al	al	PROPN
aiua-8115	74	21	.	.	PROPN
aiua-8115	75	1	in	in	ADP
aiua-8115	75	2	1979	1979	NUM
aiua-8115	75	3	,	,	PUNCT
aiua-8115	75	4	pca	pca	PROPN
aiua-8115	75	5	began	begin	VERB
aiua-8115	75	6	to	to	PART
aiua-8115	75	7	be	be	AUX
aiua-8115	75	8	diagnosed	diagnose	VERB
aiua-8115	75	9	and	and	CCONJ
aiua-8115	75	10	treated	treat	VERB
aiua-8115	75	11	based	base	VERB
aiua-8115	75	12	primarily	primarily	ADV
aiua-8115	75	13	on	on	ADP
aiua-8115	75	14	psa	psa	NOUN
aiua-8115	75	15	measurement	measurement	NOUN
aiua-8115	75	16	(	(	PUNCT
aiua-8115	75	17	15	15	NUM
aiua-8115	75	18	)	)	PUNCT
aiua-8115	75	19	.	.	PUNCT
aiua-8115	76	1	there	there	PRON
aiua-8115	76	2	are	be	VERB
aiua-8115	76	3	significant	significant	ADJ
aiua-8115	76	4	challenges	challenge	NOUN
aiua-8115	76	5	involved	involve	VERB
aiua-8115	76	6	in	in	ADP
aiua-8115	76	7	differentiating	differentiate	VERB
aiua-8115	76	8	pca	pca	PROPN
aiua-8115	76	9	from	from	ADP
aiua-8115	76	10	bph	bph	NOUN
aiua-8115	76	11	,	,	PUNCT
aiua-8115	76	12	especially	especially	ADV
aiua-8115	76	13	in	in	ADP
aiua-8115	76	14	cases	case	NOUN
aiua-8115	76	15	with	with	ADP
aiua-8115	76	16	intermediate	intermediate	ADJ
aiua-8115	76	17	levels	level	NOUN
aiua-8115	76	18	of	of	ADP
aiua-8115	76	19	psa	psa	NOUN
aiua-8115	76	20	.	.	PUNCT
aiua-8115	77	1	furthermore	furthermore	ADV
aiua-8115	77	2	,	,	PUNCT
aiua-8115	77	3	psa	psa	VERB
aiua-8115	77	4	is	be	AUX
aiua-8115	77	5	not	not	PART
aiua-8115	77	6	associated	associate	VERB
aiua-8115	77	7	exclusively	exclusively	ADV
aiua-8115	77	8	with	with	ADP
aiua-8115	77	9	pca	pca	NOUN
aiua-8115	77	10	but	but	CCONJ
aiua-8115	77	11	is	be	AUX
aiua-8115	77	12	expressed	express	VERB
aiua-8115	77	13	by	by	ADP
aiua-8115	77	14	malignant	malignant	NOUN
aiua-8115	77	15	as	as	ADV
aiua-8115	77	16	well	well	ADV
aiua-8115	77	17	as	as	ADP
aiua-8115	77	18	normal	normal	ADJ
aiua-8115	77	19	prostate	prostate	NOUN
aiua-8115	77	20	glands	gland	NOUN
aiua-8115	77	21	.	.	PUNCT
aiua-8115	78	1	efforts	effort	NOUN
aiua-8115	78	2	to	to	PART
aiua-8115	78	3	make	make	VERB
aiua-8115	78	4	prostate	prostate	NOUN
aiua-8115	78	5	biopsy	biopsy	NOUN
aiua-8115	78	6	more	more	ADV
aiua-8115	78	7	efficient	efficient	ADJ
aiua-8115	78	8	directed	direct	VERB
aiua-8115	78	9	attention	attention	NOUN
aiua-8115	78	10	to	to	ADP
aiua-8115	78	11	a	a	DET
aiua-8115	78	12	number	number	NOUN
aiua-8115	78	13	of	of	ADP
aiua-8115	78	14	factors	factor	NOUN
aiua-8115	78	15	associated	associate	VERB
aiua-8115	78	16	with	with	ADP
aiua-8115	78	17	psa	psa	NOUN
aiua-8115	78	18	,	,	PUNCT
aiua-8115	78	19	including	include	VERB
aiua-8115	78	20	the	the	DET
aiua-8115	78	21	free	free	ADJ
aiua-8115	78	22	-	-	PUNCT
aiua-8115	78	23	to	to	ADP
aiua-8115	78	24	-	-	PUNCT
aiua-8115	78	25	total	total	NOUN
aiua-8115	78	26	psa	psa	NOUN
aiua-8115	78	27	ratio	ratio	NOUN
aiua-8115	78	28	,	,	PUNCT
aiua-8115	78	29	psad	psad	ADJ
aiua-8115	78	30	and	and	CCONJ
aiua-8115	78	31	psa	psa	VERB
aiua-8115	78	32	velocity	velocity	NOUN
aiua-8115	78	33	(	(	PUNCT
aiua-8115	78	34	12	12	NUM
aiua-8115	78	35	,	,	PUNCT
aiua-8115	78	36	13	13	NUM
aiua-8115	78	37	)	)	PUNCT
aiua-8115	78	38	.	.	PUNCT
aiua-8115	79	1	particular	particular	ADJ
aiua-8115	79	2	focus	focus	NOUN
aiua-8115	79	3	was	be	AUX
aiua-8115	79	4	put	put	VERB
aiua-8115	79	5	on	on	ADP
aiua-8115	79	6	serum	serum	NOUN
aiua-8115	79	7	markers	marker	NOUN
aiua-8115	79	8	like	like	ADP
aiua-8115	79	9	p53	p53	NOUN
aiua-8115	79	10	antibody	antibody	NOUN
aiua-8115	79	11	and	and	CCONJ
aiua-8115	79	12	insulin	insulin	NOUN
aiua-8115	79	13	-	-	PUNCT
aiua-8115	79	14	like	like	ADJ
aiua-8115	79	15	growth	growth	NOUN
aiua-8115	79	16	factor	factor	NOUN
aiua-8115	79	17	1	1	NUM
aiua-8115	79	18	(	(	PUNCT
aiua-8115	79	19	igf-1	igf-1	NOUN
aiua-8115	79	20	)	)	PUNCT
aiua-8115	79	21	with	with	ADP
aiua-8115	79	22	the	the	DET
aiua-8115	79	23	purpose	purpose	NOUN
aiua-8115	79	24	of	of	ADP
aiua-8115	79	25	enhancing	enhance	VERB
aiua-8115	79	26	positive	positive	ADJ
aiua-8115	79	27	predictive	predictive	ADJ
aiua-8115	79	28	value	value	NOUN
aiua-8115	79	29	(	(	PUNCT
aiua-8115	79	30	16	16	NUM
aiua-8115	79	31	,	,	PUNCT
aiua-8115	79	32	17	17	NUM
aiua-8115	79	33	)	)	PUNCT
aiua-8115	79	34	,	,	PUNCT
aiua-8115	79	35	which	which	PRON
aiua-8115	79	36	has	have	AUX
aiua-8115	79	37	also	also	ADV
aiua-8115	79	38	benefitted	benefit	VERB
aiua-8115	79	39	from	from	ADP
aiua-8115	79	40	pca	pca	NOUN
aiua-8115	79	41	visualisation	visualisation	NOUN
aiua-8115	79	42	innovations	innovation	NOUN
aiua-8115	79	43	,	,	PUNCT
aiua-8115	79	44	including	include	VERB
aiua-8115	79	45	magnetic	magnetic	ADJ
aiua-8115	79	46	resonance	resonance	NOUN
aiua-8115	79	47	spectroscopic	spectroscopic	NOUN
aiua-8115	79	48	imaging	imaging	NOUN
aiua-8115	79	49	,	,	PUNCT
aiua-8115	79	50	dynamic	dynamic	ADJ
aiua-8115	79	51	contrastenhanced	contrastenhance	VERB
aiua-8115	79	52	magnetic	magnetic	ADJ
aiua-8115	79	53	resonance	resonance	NOUN
aiua-8115	79	54	imaging	imaging	NOUN
aiua-8115	79	55	,	,	PUNCT
aiua-8115	79	56	positron	positron	NOUN
aiua-8115	79	57	emission	emission	NOUN
aiua-8115	79	58	tomography	tomography	NOUN
aiua-8115	79	59	and	and	CCONJ
aiua-8115	79	60	transrectal	transrectal	ADJ
aiua-8115	79	61	power	power	NOUN
aiua-8115	79	62	doppler	doppler	NOUN
aiua-8115	79	63	imaging	imaging	NOUN
aiua-8115	79	64	(	(	PUNCT
aiua-8115	79	65	18	18	NUM
aiua-8115	79	66	,	,	PUNCT
aiua-8115	79	67	19	19	NUM
aiua-8115	79	68	)	)	PUNCT
aiua-8115	79	69	.	.	PUNCT
aiua-8115	80	1	reduction	reduction	NOUN
aiua-8115	80	2	of	of	ADP
aiua-8115	80	3	negative	negative	ADJ
aiua-8115	80	4	biopsy	biopsy	NOUN
aiua-8115	80	5	rate	rate	NOUN
aiua-8115	80	6	as	as	ADV
aiua-8115	80	7	much	much	ADV
aiua-8115	80	8	as	as	ADP
aiua-8115	80	9	possible	possible	ADJ
aiua-8115	80	10	should	should	AUX
aiua-8115	80	11	be	be	AUX
aiua-8115	80	12	a	a	DET
aiua-8115	80	13	key	key	ADJ
aiua-8115	80	14	priority	priority	NOUN
aiua-8115	80	15	of	of	ADP
aiua-8115	80	16	management	management	NOUN
aiua-8115	80	17	since	since	SCONJ
aiua-8115	80	18	prostate	prostate	NOUN
aiua-8115	80	19	biopsy	biopsy	NOUN
aiua-8115	80	20	can	can	AUX
aiua-8115	80	21	entail	entail	VERB
aiua-8115	80	22	a	a	DET
aiua-8115	80	23	great	great	ADJ
aiua-8115	80	24	deal	deal	NOUN
aiua-8115	80	25	of	of	ADP
aiua-8115	80	26	pain	pain	NOUN
aiua-8115	80	27	and	and	CCONJ
aiua-8115	80	28	could	could	AUX
aiua-8115	80	29	result	result	VERB
aiua-8115	80	30	in	in	ADP
aiua-8115	80	31	considerable	considerable	ADJ
aiua-8115	80	32	morbidity	morbidity	NOUN
aiua-8115	80	33	.	.	PUNCT
aiua-8115	81	1	besides	besides	SCONJ
aiua-8115	81	2	pca	pca	PROPN
aiua-8115	81	3	,	,	PUNCT
aiua-8115	81	4	benign	benign	ADJ
aiua-8115	81	5	conditions	condition	NOUN
aiua-8115	81	6	like	like	ADP
aiua-8115	81	7	benign	benign	ADJ
aiua-8115	81	8	prostatic	prostatic	ADJ
aiua-8115	81	9	hyperplasia	hyperplasia	NOUN
aiua-8115	81	10	,	,	PUNCT
aiua-8115	81	11	prostatic	prostatic	ADJ
aiua-8115	81	12	manipulation	manipulation	NOUN
aiua-8115	81	13	,	,	PUNCT
aiua-8115	81	14	and	and	CCONJ
aiua-8115	81	15	even	even	ADV
aiua-8115	81	16	asymptomatic	asymptomatic	ADJ
aiua-8115	81	17	and	and	CCONJ
aiua-8115	81	18	chronic	chronic	ADJ
aiua-8115	81	19	prostatitis	prostatitis	NOUN
aiua-8115	81	20	are	be	AUX
aiua-8115	81	21	associated	associate	VERB
aiua-8115	81	22	with	with	ADP
aiua-8115	81	23	elevated	elevated	ADJ
aiua-8115	81	24	levels	level	NOUN
aiua-8115	81	25	of	of	ADP
aiua-8115	81	26	serum	serum	NOUN
aiua-8115	81	27	psa	psa	NOUN
aiua-8115	81	28	(	(	PUNCT
aiua-8115	81	29	6	6	NUM
aiua-8115	81	30	,	,	PUNCT
aiua-8115	81	31	7	7	NUM
aiua-8115	81	32	)	)	PUNCT
aiua-8115	81	33	.	.	PUNCT
aiua-8115	82	1	it	it	PRON
aiua-8115	82	2	is	be	AUX
aiua-8115	82	3	well	well	ADV
aiua-8115	82	4	-	-	PUNCT
aiua-8115	82	5	known	know	VERB
aiua-8115	82	6	that	that	SCONJ
aiua-8115	82	7	the	the	DET
aiua-8115	82	8	development	development	NOUN
aiua-8115	82	9	and	and	CCONJ
aiua-8115	82	10	progression	progression	NOUN
aiua-8115	82	11	of	of	ADP
aiua-8115	82	12	numerous	numerous	ADJ
aiua-8115	82	13	cancers	cancer	NOUN
aiua-8115	82	14	are	be	AUX
aiua-8115	82	15	associated	associate	VERB
aiua-8115	82	16	with	with	ADP
aiua-8115	82	17	the	the	DET
aiua-8115	82	18	risk	risk	NOUN
aiua-8115	82	19	factor	factor	NOUN
aiua-8115	82	20	of	of	ADP
aiua-8115	82	21	inflammation	inflammation	NOUN
aiua-8115	82	22	(	(	PUNCT
aiua-8115	82	23	20	20	NUM
aiua-8115	82	24	)	)	PUNCT
aiua-8115	82	25	,	,	PUNCT
aiua-8115	82	26	with	with	ADP
aiua-8115	82	27	pre	pre	ADJ
aiua-8115	82	28	-	-	ADJ
aiua-8115	82	29	malignant	malignant	ADJ
aiua-8115	82	30	modifications	modification	NOUN
aiua-8115	82	31	and	and	CCONJ
aiua-8115	82	32	adenocarcinoma	adenocarcinoma	NOUN
aiua-8115	82	33	of	of	ADP
aiua-8115	82	34	the	the	DET
aiua-8115	82	35	prostate	prostate	NOUN
aiua-8115	82	36	having	having	AUX
aiua-8115	82	37	been	be	AUX
aiua-8115	82	38	found	find	VERB
aiua-8115	82	39	to	to	PART
aiua-8115	82	40	be	be	AUX
aiua-8115	82	41	underpinned	underpin	VERB
aiua-8115	82	42	by	by	ADP
aiua-8115	82	43	inflammatory	inflammatory	ADJ
aiua-8115	82	44	processes	process	NOUN
aiua-8115	82	45	(	(	PUNCT
aiua-8115	82	46	21	21	NUM
aiua-8115	82	47	)	)	PUNCT
aiua-8115	82	48	.	.	PUNCT
aiua-8115	83	1	cytokines	cytokine	NOUN
aiua-8115	83	2	stimulating	stimulate	VERB
aiua-8115	83	3	inflammation	inflammation	NOUN
aiua-8115	83	4	,	,	PUNCT
aiua-8115	83	5	especially	especially	ADV
aiua-8115	83	6	interleukin	interleukin	NOUN
aiua-8115	83	7	6	6	NUM
aiua-8115	83	8	(	(	PUNCT
aiua-8115	83	9	il-6	il-6	NUM
aiua-8115	83	10	)	)	PUNCT
aiua-8115	83	11	(	(	PUNCT
aiua-8115	83	12	22	22	NUM
aiua-8115	83	13	)	)	PUNCT
aiua-8115	83	14	,	,	PUNCT
aiua-8115	83	15	have	have	VERB
aiua-8115	83	16	a	a	DET
aiua-8115	83	17	significant	significant	ADJ
aiua-8115	83	18	influence	influence	NOUN
aiua-8115	83	19	on	on	ADP
aiua-8115	83	20	systemic	systemic	ADJ
aiua-8115	83	21	inflammation	inflammation	ADJ
aiua-8115	83	22	markers	marker	NOUN
aiua-8115	83	23	like	like	ADP
aiua-8115	83	24	crp	crp	PROPN
aiua-8115	83	25	(	(	PUNCT
aiua-8115	83	26	23	23	NUM
aiua-8115	83	27	)	)	PUNCT
aiua-8115	83	28	.	.	PUNCT
aiua-8115	84	1	however	however	ADV
aiua-8115	84	2	,	,	PUNCT
aiua-8115	84	3	il-6	il-6	PRON
aiua-8115	84	4	is	be	AUX
aiua-8115	84	5	not	not	PART
aiua-8115	84	6	only	only	ADV
aiua-8115	84	7	involved	involve	VERB
aiua-8115	84	8	in	in	ADP
aiua-8115	84	9	the	the	DET
aiua-8115	84	10	mobilization	mobilization	NOUN
aiua-8115	84	11	of	of	ADP
aiua-8115	84	12	inflammatory	inflammatory	ADJ
aiua-8115	84	13	cells	cell	NOUN
aiua-8115	84	14	but	but	CCONJ
aiua-8115	84	15	is	be	AUX
aiua-8115	84	16	also	also	ADV
aiua-8115	84	17	believed	believe	VERB
aiua-8115	84	18	to	to	PART
aiua-8115	84	19	be	be	AUX
aiua-8115	84	20	mitogenic	mitogenic	ADJ
aiua-8115	84	21	in	in	ADP
aiua-8115	84	22	the	the	DET
aiua-8115	84	23	case	case	NOUN
aiua-8115	84	24	of	of	ADP
aiua-8115	84	25	prostate	prostate	NOUN
aiua-8115	84	26	cells	cell	NOUN
aiua-8115	84	27	(	(	PUNCT
aiua-8115	84	28	24	24	NUM
aiua-8115	84	29	)	)	PUNCT
aiua-8115	84	30	.	.	PUNCT
aiua-8115	85	1	in	in	ADP
aiua-8115	85	2	a	a	DET
aiua-8115	85	3	retrospective	retrospective	ADJ
aiua-8115	85	4	study	study	NOUN
aiua-8115	85	5	on	on	ADP
aiua-8115	85	6	284	284	NUM
aiua-8115	85	7	patients	patient	NOUN
aiua-8115	85	8	showing	show	VERB
aiua-8115	85	9	no	no	DET
aiua-8115	85	10	cancer	cancer	NOUN
aiua-8115	85	11	signs	sign	NOUN
aiua-8115	85	12	in	in	ADP
aiua-8115	85	13	sextant	sextant	ADJ
aiua-8115	85	14	ultrasound	ultrasound	NOUN
aiua-8115	85	15	-	-	PUNCT
aiua-8115	85	16	guided	guide	VERB
aiua-8115	85	17	biopsies	biopsy	NOUN
aiua-8115	85	18	,	,	PUNCT
aiua-8115	85	19	morote	morote	VERB
aiua-8115	85	20	et	et	PROPN
aiua-8115	85	21	al	al	PROPN
aiua-8115	85	22	.	.	PROPN
aiua-8115	85	23	reported	report	VERB
aiua-8115	85	24	that	that	SCONJ
aiua-8115	85	25	23.2	23.2	NUM
aiua-8115	85	26	%	%	NOUN
aiua-8115	85	27	of	of	ADP
aiua-8115	85	28	patients	patient	NOUN
aiua-8115	85	29	had	have	VERB
aiua-8115	85	30	non	non	ADJ
aiua-8115	85	31	-	-	ADJ
aiua-8115	85	32	malignant	malignant	ADJ
aiua-8115	85	33	tissue	tissue	NOUN
aiua-8115	85	34	without	without	ADP
aiua-8115	85	35	inflammation	inflammation	NOUN
aiua-8115	85	36	,	,	PUNCT
aiua-8115	85	37	68.3	68.3	NUM
aiua-8115	85	38	%	%	NOUN
aiua-8115	85	39	displayed	display	VERB
aiua-8115	85	40	chronic	chronic	ADJ
aiua-8115	85	41	prostatitis	prostatitis	NOUN
aiua-8115	85	42	,	,	PUNCT
aiua-8115	85	43	and	and	CCONJ
aiua-8115	85	44	8.4	8.4	NUM
aiua-8115	85	45	%	%	NOUN
aiua-8115	85	46	displayed	display	VERB
aiua-8115	85	47	acute	acute	ADJ
aiua-8115	85	48	prostatitis	prostatitis	NOUN
aiua-8115	85	49	,	,	PUNCT
aiua-8115	85	50	which	which	PRON
aiua-8115	85	51	implied	imply	VERB
aiua-8115	85	52	that	that	SCONJ
aiua-8115	85	53	bph	bph	NOUN
aiua-8115	85	54	specimens	specimen	NOUN
aiua-8115	85	55	had	have	VERB
aiua-8115	85	56	a	a	DET
aiua-8115	85	57	high	high	ADJ
aiua-8115	85	58	rate	rate	NOUN
aiua-8115	85	59	of	of	ADP
aiua-8115	85	60	prostatic	prostatic	ADJ
aiua-8115	85	61	inflammation	inflammation	NOUN
aiua-8115	85	62	(	(	PUNCT
aiua-8115	85	63	11	11	NUM
aiua-8115	85	64	)	)	PUNCT
aiua-8115	85	65	.	.	PUNCT
aiua-8115	86	1	in	in	ADP
aiua-8115	86	2	a	a	DET
aiua-8115	86	3	different	different	ADJ
aiua-8115	86	4	retrospective	retrospective	ADJ
aiua-8115	86	5	study	study	NOUN
aiua-8115	86	6	,	,	PUNCT
aiua-8115	86	7	tomonori	tomonori	PROPN
aiua-8115	86	8	et	et	PROPN
aiua-8115	86	9	al	al	PROPN
aiua-8115	86	10	.	.	PROPN
aiua-8115	86	11	found	find	VERB
aiua-8115	86	12	that	that	SCONJ
aiua-8115	86	13	53.5	53.5	NUM
aiua-8115	86	14	%	%	NOUN
aiua-8115	86	15	of	of	ADP
aiua-8115	86	16	bph	bph	NOUN
aiua-8115	86	17	patients	patient	NOUN
aiua-8115	86	18	and	and	CCONJ
aiua-8115	86	19	14.1	14.1	NUM
aiua-8115	86	20	%	%	NOUN
aiua-8115	86	21	of	of	ADP
aiua-8115	86	22	pca	pca	NOUN
aiua-8115	86	23	patients	patient	NOUN
aiua-8115	86	24	had	have	VERB
aiua-8115	86	25	inflammation	inflammation	NOUN
aiua-8115	86	26	(	(	PUNCT
aiua-8115	86	27	25	25	NUM
aiua-8115	86	28	)	)	PUNCT
aiua-8115	86	29	.	.	PUNCT
aiua-8115	87	1	in	in	ADP
aiua-8115	87	2	the	the	DET
aiua-8115	87	3	present	present	ADJ
aiua-8115	87	4	study	study	NOUN
aiua-8115	87	5	,	,	PUNCT
aiua-8115	87	6	histology	histology	NOUN
aiua-8115	87	7	revealed	reveal	VERB
aiua-8115	87	8	that	that	SCONJ
aiua-8115	87	9	49.7	49.7	NUM
aiua-8115	87	10	%	%	NOUN
aiua-8115	87	11	of	of	ADP
aiua-8115	87	12	bph	bph	NOUN
aiua-8115	87	13	patients	patient	NOUN
aiua-8115	87	14	and	and	CCONJ
aiua-8115	87	15	48.6	48.6	NUM
aiua-8115	87	16	%	%	NOUN
aiua-8115	87	17	of	of	ADP
aiua-8115	87	18	pca	pca	NOUN
aiua-8115	87	19	patients	patient	NOUN
aiua-8115	87	20	had	have	VERB
aiua-8115	87	21	inflammation	inflammation	NOUN
aiua-8115	87	22	.	.	PUNCT
aiua-8115	88	1	asymptomatic	asymptomatic	ADJ
aiua-8115	88	2	prostatitis	prostatitis	NOUN
aiua-8115	88	3	are	be	AUX
aiua-8115	88	4	diagnosed	diagnose	VERB
aiua-8115	88	5	when	when	SCONJ
aiua-8115	88	6	inflammatory	inflammatory	ADJ
aiua-8115	88	7	cells	cell	NOUN
aiua-8115	88	8	are	be	AUX
aiua-8115	88	9	present	present	ADJ
aiua-8115	88	10	in	in	ADP
aiua-8115	88	11	histological	histological	ADJ
aiua-8115	88	12	prostate	prostate	NOUN
aiua-8115	88	13	biopsy	biopsy	NOUN
aiua-8115	88	14	specimens	specimen	NOUN
aiua-8115	88	15	according	accord	VERB
aiua-8115	88	16	to	to	ADP
aiua-8115	88	17	the	the	DET
aiua-8115	88	18	national	national	PROPN
aiua-8115	88	19	institute	institute	PROPN
aiua-8115	88	20	of	of	ADP
aiua-8115	88	21	health	health	PROPN
aiua-8115	88	22	(	(	PUNCT
aiua-8115	88	23	nih	nih	PROPN
aiua-8115	88	24	)	)	PUNCT
aiua-8115	88	25	(	(	PUNCT
aiua-8115	88	26	14	14	NUM
aiua-8115	88	27	)	)	PUNCT
aiua-8115	88	28	.	.	PUNCT
aiua-8115	89	1	it	it	PRON
aiua-8115	89	2	was	be	AUX
aiua-8115	89	3	noted	note	VERB
aiua-8115	89	4	that	that	SCONJ
aiua-8115	89	5	serum	serum	PROPN
aiua-8115	89	6	psa	psa	NOUN
aiua-8115	89	7	was	be	AUX
aiua-8115	89	8	significantly	significantly	ADV
aiua-8115	89	9	higher	high	ADJ
aiua-8115	89	10	in	in	ADP
aiua-8115	89	11	pyuria	pyuria	PROPN
aiua-8115	89	12	patients	patient	NOUN
aiua-8115	89	13	with	with	ADP
aiua-8115	89	14	a	a	DET
aiua-8115	89	15	urinary	urinary	ADJ
aiua-8115	89	16	leukocyte	leukocyte	NOUN
aiua-8115	89	17	count	count	NOUN
aiua-8115	89	18	exceeding	exceed	VERB
aiua-8115	89	19	3	3	NUM
aiua-8115	89	20	/	/	SYM
aiua-8115	89	21	h.p.f	h.p.f	NOUN
aiua-8115	89	22	.	.	PUNCT
aiua-8115	90	1	(	(	PUNCT
aiua-8115	90	2	p	p	X
aiua-8115	90	3	=	=	NOUN
aiua-8115	90	4	0.044	0.044	NUM
aiua-8115	90	5	)	)	PUNCT
aiua-8115	90	6	,	,	PUNCT
aiua-8115	90	7	but	but	CCONJ
aiua-8115	90	8	the	the	DET
aiua-8115	90	9	two	two	NUM
aiua-8115	90	10	groups	group	NOUN
aiua-8115	90	11	were	be	AUX
aiua-8115	90	12	similar	similar	ADJ
aiua-8115	90	13	regarding	regard	VERB
aiua-8115	90	14	the	the	DET
aiua-8115	90	15	cancer	cancer	NOUN
aiua-8115	90	16	detection	detection	NOUN
aiua-8115	90	17	rate	rate	NOUN
aiua-8115	90	18	(	(	PUNCT
aiua-8115	90	19	p	p	NOUN
aiua-8115	90	20	=	=	NOUN
aiua-8115	90	21	0.752	0.752	NUM
aiua-8115	90	22	)	)	PUNCT
aiua-8115	90	23	.	.	PUNCT
aiua-8115	91	1	histology	histology	NOUN
aiua-8115	91	2	revealed	reveal	VERB
aiua-8115	91	3	that	that	SCONJ
aiua-8115	91	4	pyuria	pyuria	PROPN
aiua-8115	91	5	patients	patient	NOUN
aiua-8115	91	6	had	have	VERB
aiua-8115	91	7	a	a	DET
aiua-8115	91	8	high	high	ADJ
aiua-8115	91	9	inflammation	inflammation	NOUN
aiua-8115	91	10	rate	rate	NOUN
aiua-8115	91	11	,	,	PUNCT
aiua-8115	91	12	even	even	ADV
aiua-8115	91	13	though	though	SCONJ
aiua-8115	91	14	clinical	clinical	ADJ
aiua-8115	91	15	symptoms	symptom	NOUN
aiua-8115	91	16	of	of	ADP
aiua-8115	91	17	prostatitis	prostatitis	NOUN
aiua-8115	91	18	were	be	AUX
aiua-8115	91	19	absent	absent	ADJ
aiua-8115	91	20	(	(	PUNCT
aiua-8115	91	21	p	p	X
aiua-8115	91	22	=	=	NOUN
aiua-8115	91	23	0.001	0.001	NUM
aiua-8115	91	24	)	)	PUNCT
aiua-8115	91	25	(	(	PUNCT
aiua-8115	91	26	table	table	NOUN
aiua-8115	91	27	2	2	NUM
aiua-8115	91	28	)	)	PUNCT
aiua-8115	91	29	.	.	PUNCT
aiua-8115	92	1	furthermore	furthermore	ADV
aiua-8115	92	2	,	,	PUNCT
aiua-8115	92	3	nih	nih	PROPN
aiua-8115	92	4	-	-	PUNCT
aiua-8115	92	5	iv	iv	PROPN
aiua-8115	92	6	prostatitis	prostatitis	NOUN
aiua-8115	92	7	is	be	AUX
aiua-8115	92	8	often	often	ADV
aiua-8115	92	9	accompanied	accompany	VERB
aiua-8115	92	10	by	by	ADP
aiua-8115	92	11	prostate	prostate	NOUN
aiua-8115	92	12	hyperplasia	hyperplasia	NOUN
aiua-8115	92	13	(	(	PUNCT
aiua-8115	92	14	11	11	NUM
aiua-8115	92	15	,	,	PUNCT
aiua-8115	92	16	25	25	NUM
aiua-8115	92	17	-	-	SYM
aiua-8115	92	18	27	27	NUM
aiua-8115	92	19	)	)	PUNCT
aiua-8115	92	20	.	.	PUNCT
aiua-8115	93	1	however	however	ADV
aiua-8115	93	2	,	,	PUNCT
aiua-8115	93	3	the	the	DET
aiua-8115	93	4	results	result	NOUN
aiua-8115	93	5	obtained	obtain	VERB
aiua-8115	93	6	in	in	ADP
aiua-8115	93	7	this	this	DET
aiua-8115	93	8	study	study	NOUN
aiua-8115	93	9	did	do	AUX
aiua-8115	93	10	not	not	PART
aiua-8115	93	11	determine	determine	VERB
aiua-8115	93	12	that	that	PRON
aiua-8115	93	13	serum	serum	PROPN
aiua-8115	93	14	crp	crp	PROPN
aiua-8115	93	15	was	be	AUX
aiua-8115	93	16	clinically	clinically	ADV
aiua-8115	93	17	useful	useful	ADJ
aiua-8115	93	18	in	in	ADP
aiua-8115	93	19	pca	pca	PROPN
aiua-8115	93	20	screening	screening	NOUN
aiua-8115	93	21	.	.	PUNCT
aiua-8115	94	1	pyuria	pyuria	PROPN
aiua-8115	94	2	patients	patient	NOUN
aiua-8115	94	3	had	have	VERB
aiua-8115	94	4	higher	high	ADJ
aiua-8115	94	5	levels	level	NOUN
aiua-8115	94	6	of	of	ADP
aiua-8115	94	7	serum	serum	PROPN
aiua-8115	94	8	crp	crp	PROPN
aiua-8115	94	9	compared	compare	VERB
aiua-8115	94	10	with	with	ADP
aiua-8115	94	11	nonpyuria	nonpyuria	NOUN
aiua-8115	94	12	patients	patient	NOUN
aiua-8115	94	13	(	(	PUNCT
aiua-8115	94	14	table	table	NOUN
aiua-8115	94	15	3	3	NUM
aiua-8115	94	16	)	)	PUNCT
aiua-8115	94	17	.	.	PUNCT
aiua-8115	95	1	high	high	ADJ
aiua-8115	95	2	levels	level	NOUN
aiua-8115	95	3	of	of	ADP
aiua-8115	95	4	both	both	DET
aiua-8115	95	5	psa	psa	NOUN
aiua-8115	95	6	and	and	CCONJ
aiua-8115	95	7	crp	crp	PROPN
aiua-8115	95	8	may	may	AUX
aiua-8115	95	9	be	be	AUX
aiua-8115	95	10	due	due	ADJ
aiua-8115	95	11	to	to	ADP
aiua-8115	95	12	inflammation	inflammation	NOUN
aiua-8115	95	13	.	.	PUNCT
aiua-8115	96	1	meanwhile	meanwhile	ADV
aiua-8115	96	2	,	,	PUNCT
aiua-8115	96	3	crp	crp	PROPN
aiua-8115	96	4	positive	positive	ADJ
aiua-8115	96	5	and	and	CCONJ
aiua-8115	96	6	negative	negative	ADJ
aiua-8115	96	7	groups	group	NOUN
aiua-8115	96	8	did	do	AUX
aiua-8115	96	9	not	not	PART
aiua-8115	96	10	differ	differ	VERB
aiua-8115	96	11	in	in	ADP
aiua-8115	96	12	terms	term	NOUN
aiua-8115	96	13	of	of	ADP
aiua-8115	96	14	inflammation	inflammation	ADJ
aiua-8115	96	15	rate	rate	NOUN
aiua-8115	96	16	and	and	CCONJ
aiua-8115	96	17	cancer	cancer	NOUN
aiua-8115	96	18	detection	detection	NOUN
aiua-8115	96	19	rate	rate	NOUN
aiua-8115	96	20	.	.	PUNCT
aiua-8115	97	1	it	it	PRON
aiua-8115	97	2	was	be	AUX
aiua-8115	97	3	deduced	deduce	VERB
aiua-8115	97	4	that	that	SCONJ
aiua-8115	97	5	prostatic	prostatic	ADJ
aiua-8115	97	6	inflammation	inflammation	NOUN
aiua-8115	97	7	was	be	AUX
aiua-8115	97	8	more	more	ADV
aiua-8115	97	9	reliably	reliably	ADV
aiua-8115	97	10	signaled	signal	VERB
aiua-8115	97	11	by	by	ADP
aiua-8115	97	12	urinary	urinary	ADJ
aiua-8115	97	13	leukocyte	leukocyte	NOUN
aiua-8115	97	14	count	count	NOUN
aiua-8115	97	15	than	than	ADP
aiua-8115	97	16	serum	serum	PROPN
aiua-8115	97	17	crp	crp	PROPN
aiua-8115	97	18	and	and	CCONJ
aiua-8115	97	19	that	that	SCONJ
aiua-8115	97	20	serum	serum	NOUN
aiua-8115	97	21	crp	crp	PROPN
aiua-8115	97	22	and	and	CCONJ
aiua-8115	97	23	elevated	elevated	ADJ
aiua-8115	97	24	psa	psa	NOUN
aiua-8115	97	25	were	be	AUX
aiua-8115	97	26	not	not	PART
aiua-8115	97	27	closely	closely	ADV
aiua-8115	97	28	correlated	correlate	VERB
aiua-8115	97	29	.	.	PUNCT
aiua-8115	98	1	according	accord	VERB
aiua-8115	98	2	to	to	ADP
aiua-8115	98	3	tomonori	tomonori	PROPN
aiua-8115	98	4	et	et	PROPN
aiua-8115	98	5	al	al	PROPN
aiua-8115	98	6	.	.	PROPN
aiua-8115	98	7	,	,	PUNCT
aiua-8115	98	8	non	non	ADJ
aiua-8115	98	9	-	-	ADJ
aiua-8115	98	10	palpable	palpable	ADJ
aiua-8115	98	11	pca	pca	NOUN
aiua-8115	98	12	and	and	CCONJ
aiua-8115	98	13	bph	bph	NOUN
aiua-8115	98	14	might	might	AUX
aiua-8115	98	15	be	be	AUX
aiua-8115	98	16	differentiated	differentiate	VERB
aiua-8115	98	17	based	base	VERB
aiua-8115	98	18	on	on	ADP
aiua-8115	98	19	an	an	DET
aiua-8115	98	20	inflammatory	inflammatory	ADJ
aiua-8115	98	21	index	index	NOUN
aiua-8115	98	22	like	like	ADP
aiua-8115	98	23	urinary	urinary	ADJ
aiua-8115	98	24	leukocyte	leukocyte	NOUN
aiua-8115	98	25	count	count	NOUN
aiua-8115	98	26	applied	apply	VERB
aiua-8115	98	27	in	in	ADP
aiua-8115	98	28	a	a	DET
aiua-8115	98	29	clinical	clinical	ADJ
aiua-8115	98	30	setting	setting	NOUN
aiua-8115	98	31	(	(	PUNCT
aiua-8115	98	32	25	25	NUM
aiua-8115	98	33	)	)	PUNCT
aiua-8115	98	34	.	.	PUNCT
aiua-8115	99	1	however	however	ADV
aiua-8115	99	2	,	,	PUNCT
aiua-8115	99	3	the	the	DET
aiua-8115	99	4	present	present	ADJ
aiua-8115	99	5	study	study	NOUN
aiua-8115	99	6	did	do	AUX
aiua-8115	99	7	not	not	PART
aiua-8115	99	8	support	support	VERB
aiua-8115	99	9	this	this	DET
aiua-8115	99	10	claim	claim	NOUN
aiua-8115	99	11	,	,	PUNCT
aiua-8115	99	12	despite	despite	SCONJ
aiua-8115	99	13	observing	observe	VERB
aiua-8115	99	14	that	that	PRON
aiua-8115	99	15	minute	minute	VERB
aiua-8115	99	16	prostatic	prostatic	ADJ
aiua-8115	99	17	inflammation	inflammation	NOUN
aiua-8115	99	18	could	could	AUX
aiua-8115	99	19	be	be	AUX
aiua-8115	99	20	reliably	reliably	ADV
aiua-8115	99	21	identified	identify	VERB
aiua-8115	99	22	based	base	VERB
aiua-8115	99	23	on	on	ADP
aiua-8115	99	24	the	the	DET
aiua-8115	99	25	urinary	urinary	ADJ
aiua-8115	99	26	leukocyte	leukocyte	NOUN
aiua-8115	99	27	count	count	NOUN
aiua-8115	99	28	.	.	PUNCT
aiua-8115	100	1	meanwhile	meanwhile	ADV
aiua-8115	100	2	,	,	PUNCT
aiua-8115	100	3	in	in	ADP
aiua-8115	100	4	a	a	DET
aiua-8115	100	5	different	different	ADJ
aiua-8115	100	6	study	study	NOUN
aiua-8115	100	7	conducted	conduct	VERB
aiua-8115	100	8	on	on	ADP
aiua-8115	100	9	61	61	NUM
aiua-8115	100	10	patients	patient	NOUN
aiua-8115	100	11	displaying	display	VERB
aiua-8115	100	12	psa	psa	NOUN
aiua-8115	100	13	in	in	ADP
aiua-8115	100	14	the	the	DET
aiua-8115	100	15	range	range	NOUN
aiua-8115	100	16	4	4	NUM
aiua-8115	100	17	-	-	SYM
aiua-8115	100	18	10	10	NUM
aiua-8115	100	19	ng	ng	PROPN
aiua-8115	100	20	/	/	SYM
aiua-8115	100	21	ml	ml	PROPN
aiua-8115	100	22	,	,	PUNCT
aiua-8115	100	23	normal	normal	ADJ
aiua-8115	100	24	dre	dre	NOUN
aiua-8115	100	25	outcomes	outcome	NOUN
aiua-8115	100	26	and	and	CCONJ
aiua-8115	100	27	inflammation	inflammation	NOUN
aiua-8115	100	28	in	in	ADP
aiua-8115	100	29	expressed	express	VERB
aiua-8115	100	30	prostate	prostate	NOUN
aiua-8115	100	31	secretion	secretion	NOUN
aiua-8115	100	32	,	,	PUNCT
aiua-8115	100	33	karazanashvili	karazanashvili	PROPN
aiua-8115	100	34	et	et	PROPN
aiua-8115	100	35	al	al	PROPN
aiua-8115	100	36	aimed	aim	VERB
aiua-8115	100	37	to	to	PART
aiua-8115	100	38	come	come	VERB
aiua-8115	100	39	up	up	ADP
aiua-8115	100	40	with	with	ADP
aiua-8115	100	41	solutions	solution	NOUN
aiua-8115	100	42	for	for	ADP
aiua-8115	100	43	making	make	VERB
aiua-8115	100	44	pca	pca	NOUN
aiua-8115	100	45	screening	screen	VERB
aiua-8115	100	46	more	more	ADV
aiua-8115	100	47	accurate	accurate	ADJ
aiua-8115	100	48	(	(	PUNCT
aiua-8115	100	49	28	28	NUM
aiua-8115	100	50	)	)	PUNCT
aiua-8115	100	51	.	.	PUNCT
aiua-8115	101	1	to	to	ADP
aiua-8115	101	2	that	that	DET
aiua-8115	101	3	end	end	NOUN
aiua-8115	101	4	,	,	PUNCT
aiua-8115	101	5	they	they	PRON
aiua-8115	101	6	used	use	VERB
aiua-8115	101	7	psa	psa	NOUN
aiua-8115	101	8	value	value	NOUN
aiua-8115	101	9	modification	modification	NOUN
aiua-8115	101	10	following	follow	VERB
aiua-8115	101	11	treatment	treatment	NOUN
aiua-8115	101	12	with	with	ADP
aiua-8115	101	13	antibiotics	antibiotic	NOUN
aiua-8115	101	14	as	as	ADP
aiua-8115	101	15	a	a	DET
aiua-8115	101	16	diagnostic	diagnostic	ADJ
aiua-8115	101	17	approach	approach	NOUN
aiua-8115	101	18	.	.	PUNCT
aiua-8115	102	1	pca	pca	PROPN
aiua-8115	102	2	was	be	AUX
aiua-8115	102	3	detected	detect	VERB
aiua-8115	102	4	in	in	ADP
aiua-8115	102	5	only	only	ADV
aiua-8115	102	6	6	6	NUM
aiua-8115	102	7	%	%	NOUN
aiua-8115	102	8	of	of	ADP
aiua-8115	102	9	patients	patient	NOUN
aiua-8115	102	10	with	with	ADP
aiua-8115	102	11	reduced	reduced	ADJ
aiua-8115	102	12	psa	psa	NOUN
aiua-8115	102	13	values	value	NOUN
aiua-8115	102	14	,	,	PUNCT
aiua-8115	102	15	whereas	whereas	SCONJ
aiua-8115	102	16	all	all	DET
aiua-8115	102	17	patients	patient	NOUN
aiua-8115	102	18	exhibited	exhibit	VERB
aiua-8115	102	19	prostate	prostate	NOUN
aiua-8115	102	20	inflammation	inflammation	NOUN
aiua-8115	102	21	.	.	PUNCT
aiua-8115	103	1	on	on	ADP
aiua-8115	103	2	the	the	DET
aiua-8115	103	3	other	other	ADJ
aiua-8115	103	4	hand	hand	NOUN
aiua-8115	103	5	,	,	PUNCT
aiua-8115	103	6	pca	pca	PROPN
aiua-8115	103	7	was	be	AUX
aiua-8115	103	8	detected	detect	VERB
aiua-8115	103	9	in	in	ADP
aiua-8115	103	10	83	83	NUM
aiua-8115	103	11	%	%	NOUN
aiua-8115	103	12	of	of	ADP
aiua-8115	103	13	patients	patient	NOUN
aiua-8115	103	14	with	with	ADP
aiua-8115	103	15	unaltered	unaltered	ADJ
aiua-8115	103	16	or	or	CCONJ
aiua-8115	103	17	ele169archivio	ele169archivio	NOUN
aiua-8115	103	18	italiano	italiano	NOUN
aiua-8115	103	19	di	di	X
aiua-8115	103	20	urologia	urologia	PROPN
aiua-8115	103	21	e	e	PROPN
aiua-8115	103	22	andrologia	andrologia	NOUN
aiua-8115	103	23	2019	2019	NUM
aiua-8115	103	24	;	;	PUNCT
aiua-8115	103	25	91	91	NUM
aiua-8115	103	26	,	,	PUNCT
aiua-8115	103	27	3	3	NUM
aiua-8115	103	28	urinary	urinary	ADJ
aiua-8115	103	29	inflammation	inflammation	NOUN
aiua-8115	103	30	and	and	CCONJ
aiua-8115	103	31	prostate	prostate	NOUN
aiua-8115	103	32	cancer	cancer	NOUN
aiua-8115	103	33	table	table	NOUN
aiua-8115	103	34	3	3	NUM
aiua-8115	103	35	.	.	PUNCT
aiua-8115	104	1	clinical	clinical	ADJ
aiua-8115	104	2	variables	variable	NOUN
aiua-8115	104	3	,	,	PUNCT
aiua-8115	104	4	cancer	cancer	NOUN
aiua-8115	104	5	detection	detection	NOUN
aiua-8115	104	6	rates	rate	NOUN
aiua-8115	104	7	and	and	CCONJ
aiua-8115	104	8	histologically	histologically	ADV
aiua-8115	104	9	-	-	PUNCT
aiua-8115	104	10	detected	detect	VERB
aiua-8115	104	11	inflammation	inflammation	NOUN
aiua-8115	104	12	rates	rate	NOUN
aiua-8115	104	13	in	in	ADP
aiua-8115	104	14	positiveand	positiveand	PROPN
aiua-8115	104	15	negativec	negativec	X
aiua-8115	104	16	-	-	PUNCT
aiua-8115	104	17	reactive	reactive	ADJ
aiua-8115	104	18	protein	protein	NOUN
aiua-8115	104	19	groups	group	NOUN
aiua-8115	104	20	.	.	PUNCT
aiua-8115	105	1	crp	crp	PROPN
aiua-8115	105	2	negative	negative	ADJ
aiua-8115	105	3	(	(	PUNCT
aiua-8115	105	4	n	n	CCONJ
aiua-8115	105	5	:	:	SYM
aiua-8115	105	6	57	57	NUM
aiua-8115	105	7	)	)	PUNCT
aiua-8115	105	8	crp	crp	NOUN
aiua-8115	105	9	positive	positive	ADJ
aiua-8115	105	10	(	(	PUNCT
aiua-8115	105	11	n	n	NUM
aiua-8115	105	12	:	:	PUNCT
aiua-8115	105	13	143	143	NUM
aiua-8115	105	14	)	)	PUNCT
aiua-8115	105	15	p	p	NOUN
aiua-8115	105	16	age	age	NOUN
aiua-8115	105	17	(	(	PUNCT
aiua-8115	105	18	years	year	NOUN
aiua-8115	105	19	)	)	PUNCT
aiua-8115	105	20	63.15	63.15	NUM
aiua-8115	105	21	±	±	NUM
aiua-8115	105	22	7.20	7.20	NUM
aiua-8115	105	23	(	(	PUNCT
aiua-8115	105	24	40	40	NUM
aiua-8115	105	25	-	-	SYM
aiua-8115	105	26	77	77	NUM
aiua-8115	105	27	)	)	PUNCT
aiua-8115	105	28	60±	60±	NOUN
aiua-8115	105	29	6.37	6.37	NUM
aiua-8115	105	30	(	(	PUNCT
aiua-8115	105	31	43	43	NUM
aiua-8115	105	32	-	-	SYM
aiua-8115	105	33	80	80	NUM
aiua-8115	105	34	)	)	PUNCT
aiua-8115	105	35	0.245	0.245	NUM
aiua-8115	105	36	t	t	PROPN
aiua-8115	105	37	-	-	PUNCT
aiua-8115	105	38	psa	psa	NOUN
aiua-8115	105	39	(	(	PUNCT
aiua-8115	105	40	ng	ng	PROPN
aiua-8115	105	41	/	/	SYM
aiua-8115	105	42	ml	ml	PROPN
aiua-8115	105	43	)	)	PUNCT
aiua-8115	105	44	6.80	6.80	NUM
aiua-8115	105	45	±	±	NUM
aiua-8115	105	46	2.45	2.45	NUM
aiua-8115	105	47	(	(	PUNCT
aiua-8115	105	48	3.23	3.23	NUM
aiua-8115	105	49	-	-	SYM
aiua-8115	105	50	14.58	14.58	NUM
aiua-8115	105	51	)	)	PUNCT
aiua-8115	105	52	7.15	7.15	NUM
aiua-8115	105	53	±	±	NUM
aiua-8115	105	54	3.63	3.63	NUM
aiua-8115	105	55	(	(	PUNCT
aiua-8115	105	56	3.11	3.11	NUM
aiua-8115	105	57	-	-	SYM
aiua-8115	105	58	20.00	20.00	NUM
aiua-8115	105	59	)	)	PUNCT
aiua-8115	105	60	0.991	0.991	NUM
aiua-8115	105	61	prostate	prostate	NOUN
aiua-8115	105	62	volume(ml	volume(ml	NOUN
aiua-8115	105	63	)	)	PUNCT
aiua-8115	105	64	55.10	55.10	NUM
aiua-8115	105	65	±	±	NOUN
aiua-8115	105	66	37.32	37.32	NUM
aiua-8115	105	67	(	(	PUNCT
aiua-8115	105	68	17	17	NUM
aiua-8115	105	69	-	-	SYM
aiua-8115	105	70	120	120	NUM
aiua-8115	105	71	)	)	PUNCT
aiua-8115	105	72	59.88	59.88	NUM
aiua-8115	105	73	±	±	NUM
aiua-8115	105	74	29.53	29.53	NUM
aiua-8115	105	75	(	(	PUNCT
aiua-8115	105	76	20	20	NUM
aiua-8115	105	77	-	-	SYM
aiua-8115	105	78	260	260	NUM
aiua-8115	105	79	)	)	PUNCT
aiua-8115	105	80	0.200	0.200	NUM
aiua-8115	105	81	free	free	ADJ
aiua-8115	105	82	to	to	PART
aiua-8115	105	83	total	total	VERB
aiua-8115	105	84	psa	psa	NOUN
aiua-8115	105	85	ratio	ratio	NOUN
aiua-8115	105	86	(	(	PUNCT
aiua-8115	105	87	%	%	NOUN
aiua-8115	105	88	)	)	PUNCT
aiua-8115	105	89	19	19	NUM
aiua-8115	105	90	±	±	NUM
aiua-8115	105	91	7	7	NUM
aiua-8115	105	92	(	(	PUNCT
aiua-8115	105	93	3	3	NUM
aiua-8115	105	94	-	-	SYM
aiua-8115	105	95	55	55	NUM
aiua-8115	105	96	)	)	PUNCT
aiua-8115	105	97	16	16	NUM
aiua-8115	105	98	±	±	NUM
aiua-8115	105	99	8	8	NUM
aiua-8115	105	100	(	(	PUNCT
aiua-8115	105	101	4	4	NUM
aiua-8115	105	102	-	-	SYM
aiua-8115	105	103	58	58	NUM
aiua-8115	105	104	)	)	PUNCT
aiua-8115	105	105	0.738	0.738	NUM
aiua-8115	105	106	psad	psad	NOUN
aiua-8115	105	107	0.15	0.15	NUM
aiua-8115	105	108	±	±	NOUN
aiua-8115	105	109	0.06	0.06	NUM
aiua-8115	105	110	(	(	PUNCT
aiua-8115	105	111	0.03	0.03	NUM
aiua-8115	105	112	-	-	SYM
aiua-8115	105	113	0.35	0.35	NUM
aiua-8115	105	114	)	)	PUNCT
aiua-8115	105	115	0.17	0.17	NUM
aiua-8115	105	116	±	±	NUM
aiua-8115	105	117	0.12	0.12	NUM
aiua-8115	105	118	(	(	PUNCT
aiua-8115	105	119	0.04	0.04	NUM
aiua-8115	105	120	-	-	SYM
aiua-8115	105	121	0.85	0.85	NUM
aiua-8115	105	122	)	)	PUNCT
aiua-8115	105	123	0.490	0.490	NUM
aiua-8115	105	124	histologically	histologically	ADV
aiua-8115	105	125	-	-	PUNCT
aiua-8115	105	126	detected	detect	VERB
aiua-8115	105	127	inflammation	inflammation	NOUN
aiua-8115	105	128	rate	rate	NOUN
aiua-8115	105	129	49.1	49.1	NUM
aiua-8115	105	130	%	%	NOUN
aiua-8115	105	131	(	(	PUNCT
aiua-8115	105	132	28/57	28/57	NUM
aiua-8115	105	133	)	)	PUNCT
aiua-8115	105	134	49.6	49.6	NUM
aiua-8115	105	135	%	%	NOUN
aiua-8115	105	136	(	(	PUNCT
aiua-8115	105	137	71/143	71/143	NOUN
aiua-8115	105	138	)	)	PUNCT
aiua-8115	105	139	0.857	0.857	NUM
aiua-8115	105	140	cancer	cancer	NOUN
aiua-8115	105	141	detection	detection	NOUN
aiua-8115	105	142	rate	rate	NOUN
aiua-8115	105	143	12.3	12.3	NUM
aiua-8115	105	144	%	%	NOUN
aiua-8115	105	145	(	(	PUNCT
aiua-8115	105	146	7/57	7/57	NUM
aiua-8115	105	147	)	)	PUNCT
aiua-8115	105	148	20.1	20.1	NUM
aiua-8115	105	149	%	%	NOUN
aiua-8115	105	150	(	(	PUNCT
aiua-8115	105	151	30/143	30/143	NUM
aiua-8115	105	152	)	)	PUNCT
aiua-8115	105	153	0.248	0.248	NUM
aiua-8115	105	154	mean	mean	NOUN
aiua-8115	105	155	±	±	NUM
aiua-8115	105	156	sd	sd	ADP
aiua-8115	105	157	range	range	NOUN
aiua-8115	105	158	;	;	PUNCT
aiua-8115	105	159	‡negative	‡negative	ADJ
aiua-8115	105	160	,	,	PUNCT
aiua-8115	105	161	serum	serum	PROPN
aiua-8115	105	162	crp	crp	PROPN
aiua-8115	105	163	<	<	X
aiua-8115	105	164	0.30	0.30	NUM
aiua-8115	105	165	mg	mg	PROPN
aiua-8115	105	166	/	/	SYM
aiua-8115	105	167	dl	dl	PROPN
aiua-8115	105	168	;	;	PUNCT
aiua-8115	105	169	positive	positive	ADJ
aiua-8115	105	170	,	,	PUNCT
aiua-8115	105	171	serum	serum	PROPN
aiua-8115	105	172	crp	crp	PROPN
aiua-8115	105	173	≥	≥	NUM
aiua-8115	105	174	0.30	0.30	NUM
aiua-8115	105	175	mg	mg	PROPN
aiua-8115	105	176	/	/	SYM
aiua-8115	105	177	dl	dl	PROPN
aiua-8115	105	178	;	;	PUNCT
aiua-8115	105	179	crp	crp	PROPN
aiua-8115	105	180	,	,	PUNCT
aiua-8115	105	181	c	c	NOUN
aiua-8115	105	182	-	-	PUNCT
aiua-8115	105	183	reactive	reactive	ADJ
aiua-8115	105	184	protein	protein	NOUN
aiua-8115	105	185	;	;	PUNCT
aiua-8115	105	186	t	t	PROPN
aiua-8115	105	187	-	-	PUNCT
aiua-8115	105	188	psa	psa	NOUN
aiua-8115	105	189	,	,	PUNCT
aiua-8115	105	190	total	total	ADJ
aiua-8115	105	191	prostate	prostate	NOUN
aiua-8115	105	192	specific	specific	ADJ
aiua-8115	105	193	antigen	antigen	NOUN
aiua-8115	105	194	;	;	PUNCT
aiua-8115	105	195	psad	psad	ADJ
aiua-8115	105	196	,	,	PUNCT
aiua-8115	105	197	psa	psa	VERB
aiua-8115	105	198	density	density	NOUN
aiua-8115	105	199	.	.	PUNCT
aiua-8115	106	1	demir_stesura	demir_stesura	NOUN
aiua-8115	106	2	seveso	seveso	VERB
aiua-8115	107	1	30/09/19	30/09/19	PROPN
aiua-8115	107	2	18:21	18:21	NUM
aiua-8115	107	3	pagina	pagina	NOUN
aiua-8115	107	4	169	169	NUM
aiua-8115	107	5	archivio	archivio	NOUN
aiua-8115	107	6	italiano	italiano	X
aiua-8115	107	7	di	di	X
aiua-8115	107	8	urologia	urologia	PROPN
aiua-8115	107	9	e	e	PROPN
aiua-8115	107	10	andrologia	andrologia	NOUN
aiua-8115	107	11	2019	2019	NUM
aiua-8115	107	12	;	;	PUNCT
aiua-8115	107	13	91	91	NUM
aiua-8115	107	14	,	,	PUNCT
aiua-8115	107	15	3	3	NUM
aiua-8115	107	16	s.	s.	PROPN
aiua-8115	107	17	demir	demir	PROPN
aiua-8115	107	18	170	170	NUM
aiua-8115	107	19	vated	vate	VERB
aiua-8115	107	20	psa	psa	NOUN
aiua-8115	107	21	values	value	NOUN
aiua-8115	107	22	and	and	CCONJ
aiua-8115	107	23	prostate	prostate	NOUN
aiua-8115	107	24	inflammation	inflammation	NOUN
aiua-8115	107	25	was	be	AUX
aiua-8115	107	26	observed	observe	VERB
aiua-8115	107	27	in	in	ADP
aiua-8115	107	28	17	17	NUM
aiua-8115	107	29	%	%	NOUN
aiua-8115	107	30	of	of	ADP
aiua-8115	107	31	these	these	DET
aiua-8115	107	32	patients	patient	NOUN
aiua-8115	107	33	.	.	PUNCT
aiua-8115	108	1	the	the	DET
aiua-8115	108	2	authors	author	NOUN
aiua-8115	108	3	concluded	conclude	VERB
aiua-8115	108	4	that	that	SCONJ
aiua-8115	108	5	pca	pca	NOUN
aiua-8115	108	6	screening	screening	NOUN
aiua-8115	108	7	could	could	AUX
aiua-8115	108	8	be	be	AUX
aiua-8115	108	9	made	make	VERB
aiua-8115	108	10	more	more	ADV
aiua-8115	108	11	accurate	accurate	ADJ
aiua-8115	108	12	by	by	ADP
aiua-8115	108	13	evaluating	evaluate	VERB
aiua-8115	108	14	psa	psa	NOUN
aiua-8115	108	15	value	value	NOUN
aiua-8115	108	16	modification	modification	NOUN
aiua-8115	108	17	following	follow	VERB
aiua-8115	108	18	treatment	treatment	NOUN
aiua-8115	108	19	with	with	ADP
aiua-8115	108	20	antibiotics	antibiotic	NOUN
aiua-8115	108	21	since	since	SCONJ
aiua-8115	108	22	high	high	ADJ
aiua-8115	108	23	psa	psa	NOUN
aiua-8115	108	24	was	be	AUX
aiua-8115	108	25	determined	determine	VERB
aiua-8115	108	26	to	to	ADP
aiua-8115	108	27	a	a	DET
aiua-8115	108	28	significant	significant	ADJ
aiua-8115	108	29	extent	extent	NOUN
aiua-8115	108	30	by	by	ADP
aiua-8115	108	31	chronic	chronic	ADJ
aiua-8115	108	32	prostatitis	prostatitis	NOUN
aiua-8115	108	33	.	.	PUNCT
aiua-8115	109	1	conclusions	conclusion	NOUN
aiua-8115	109	2	male	male	ADJ
aiua-8115	109	3	individuals	individual	NOUN
aiua-8115	109	4	are	be	AUX
aiua-8115	109	5	at	at	ADP
aiua-8115	109	6	high	high	ADJ
aiua-8115	109	7	risk	risk	NOUN
aiua-8115	109	8	of	of	ADP
aiua-8115	109	9	asymptomatic	asymptomatic	ADJ
aiua-8115	109	10	prostatitis	prostatitis	NOUN
aiua-8115	109	11	if	if	SCONJ
aiua-8115	109	12	their	their	PRON
aiua-8115	109	13	levels	level	NOUN
aiua-8115	109	14	of	of	ADP
aiua-8115	109	15	psa	psa	NOUN
aiua-8115	109	16	are	be	AUX
aiua-8115	109	17	high	high	ADJ
aiua-8115	109	18	and	and	CCONJ
aiua-8115	109	19	they	they	PRON
aiua-8115	109	20	present	present	VERB
aiua-8115	109	21	normal	normal	ADJ
aiua-8115	109	22	dre	dre	NOUN
aiua-8115	109	23	outcomes	outcome	NOUN
aiua-8115	109	24	.	.	PUNCT
aiua-8115	110	1	prior	prior	ADV
aiua-8115	110	2	to	to	ADP
aiua-8115	110	3	biopsy	biopsy	NOUN
aiua-8115	110	4	,	,	PUNCT
aiua-8115	110	5	antibiotics	antibiotic	NOUN
aiua-8115	110	6	or	or	CCONJ
aiua-8115	110	7	antiphlogistics	antiphlogistic	NOUN
aiua-8115	110	8	should	should	AUX
aiua-8115	110	9	be	be	AUX
aiua-8115	110	10	given	give	VERB
aiua-8115	110	11	to	to	ADP
aiua-8115	110	12	pyuria	pyuria	PROPN
aiua-8115	110	13	patients	patient	NOUN
aiua-8115	110	14	and	and	CCONJ
aiua-8115	110	15	it	it	PRON
aiua-8115	110	16	is	be	AUX
aiua-8115	110	17	advisable	advisable	ADJ
aiua-8115	110	18	to	to	PART
aiua-8115	110	19	measure	measure	VERB
aiua-8115	110	20	psa	psa	VERB
aiua-8115	110	21	repeatedly	repeatedly	ADV
aiua-8115	110	22	as	as	ADV
aiua-8115	110	23	well	well	ADV
aiua-8115	110	24	.	.	PUNCT
aiua-8115	111	1	in	in	ADP
aiua-8115	111	2	patients	patient	NOUN
aiua-8115	111	3	without	without	ADP
aiua-8115	111	4	evidence	evidence	NOUN
aiua-8115	111	5	of	of	ADP
aiua-8115	111	6	clinical	clinical	ADJ
aiua-8115	111	7	prostatitis	prostatitis	NOUN
aiua-8115	111	8	,	,	PUNCT
aiua-8115	111	9	sterile	sterile	ADJ
aiua-8115	111	10	pyuria	pyuria	NOUN
aiua-8115	111	11	should	should	AUX
aiua-8115	111	12	be	be	AUX
aiua-8115	111	13	kept	keep	VERB
aiua-8115	111	14	in	in	ADP
aiua-8115	111	15	mind	mind	NOUN
aiua-8115	111	16	as	as	ADP
aiua-8115	111	17	a	a	DET
aiua-8115	111	18	cause	cause	NOUN
aiua-8115	111	19	of	of	ADP
aiua-8115	111	20	increased	increase	VERB
aiua-8115	111	21	psa	psa	NOUN
aiua-8115	111	22	.	.	PUNCT
aiua-8115	112	1	although	although	SCONJ
aiua-8115	112	2	urine	urine	ADJ
aiua-8115	112	3	leukocyte	leukocyte	NOUN
aiua-8115	112	4	count	count	NOUN
aiua-8115	112	5	can	can	AUX
aiua-8115	112	6	not	not	PART
aiua-8115	112	7	predict	predict	VERB
aiua-8115	112	8	non	non	ADJ
aiua-8115	112	9	-	-	ADJ
aiua-8115	112	10	palpable	palpable	ADJ
aiua-8115	112	11	prostate	prostate	NOUN
aiua-8115	112	12	cancer	cancer	NOUN
aiua-8115	112	13	,	,	PUNCT
aiua-8115	112	14	it	it	PRON
aiua-8115	112	15	should	should	AUX
aiua-8115	112	16	be	be	AUX
aiua-8115	112	17	incorporated	incorporate	VERB
aiua-8115	112	18	in	in	ADP
aiua-8115	112	19	routine	routine	ADJ
aiua-8115	112	20	urological	urological	ADJ
aiua-8115	112	21	evaluation	evaluation	NOUN
aiua-8115	112	22	to	to	PART
aiua-8115	112	23	demonstrate	demonstrate	VERB
aiua-8115	112	24	minute	minute	VERB
aiua-8115	112	25	prostatic	prostatic	ADJ
aiua-8115	112	26	inflammation	inflammation	NOUN
aiua-8115	112	27	due	due	ADP
aiua-8115	112	28	to	to	ADP
aiua-8115	112	29	its	its	PRON
aiua-8115	112	30	simplicity	simplicity	NOUN
aiua-8115	112	31	,	,	PUNCT
aiua-8115	112	32	convenience	convenience	NOUN
aiua-8115	112	33	and	and	CCONJ
aiua-8115	112	34	non	non	ADJ
aiua-8115	112	35	-	-	ADJ
aiua-8115	112	36	invasiveness	invasiveness	ADJ
aiua-8115	112	37	.	.	PUNCT
aiua-8115	113	1	author	author	NOUN
aiua-8115	113	2	contribution	contribution	PROPN
aiua-8115	113	3	selamettin	selamettin	PROPN
aiua-8115	113	4	demir	demir	PROPN
aiua-8115	113	5	:	:	PUNCT
aiua-8115	113	6	concept	concept	NOUN
aiua-8115	113	7	,	,	PUNCT
aiua-8115	113	8	design	design	NOUN
aiua-8115	113	9	,	,	PUNCT
aiua-8115	113	10	supervision	supervision	NOUN
aiua-8115	113	11	,	,	PUNCT
aiua-8115	113	12	researches	research	NOUN
aiua-8115	113	13	and	and	CCONJ
aiua-8115	113	14	material	material	NOUN
aiua-8115	113	15	,	,	PUNCT
aiua-8115	113	16	data	data	NOUN
aiua-8115	113	17	collection	collection	NOUN
aiua-8115	113	18	,	,	PUNCT
aiua-8115	113	19	literature	literature	NOUN
aiua-8115	113	20	search	search	NOUN
aiua-8115	113	21	,	,	PUNCT
aiua-8115	113	22	writing	write	VERB
aiua-8115	113	23	manuscript	manuscript	NOUN
aiua-8115	113	24	,	,	PUNCT
aiua-8115	113	25	critical	critical	ADJ
aiua-8115	113	26	review	review	NOUN
aiua-8115	113	27	,	,	PUNCT
aiua-8115	113	28	analysis	analysis	NOUN
aiua-8115	113	29	,	,	PUNCT
aiua-8115	113	30	interperation	interperation	NOUN
aiua-8115	113	31	.	.	PUNCT
aiua-8115	114	1	references	reference	NOUN
aiua-8115	114	2	1	1	NUM
aiua-8115	114	3	.	.	PUNCT
aiua-8115	114	4	cooperberg	cooperberg	PROPN
aiua-8115	114	5	mr	mr	PROPN
aiua-8115	114	6	,	,	PUNCT
aiua-8115	114	7	broering	broere	VERB
aiua-8115	114	8	jm	jm	PROPN
aiua-8115	114	9	,	,	PUNCT
aiua-8115	114	10	carroll	carroll	PROPN
aiua-8115	114	11	pr	pr	PROPN
aiua-8115	114	12	.	.	PUNCT
aiua-8115	115	1	risk	risk	NOUN
aiua-8115	115	2	assessment	assessment	NOUN
aiua-8115	115	3	for	for	ADP
aiua-8115	115	4	prostate	prostate	NOUN
aiua-8115	115	5	cancer	cancer	NOUN
aiua-8115	115	6	metastasis	metastasis	NOUN
aiua-8115	115	7	and	and	CCONJ
aiua-8115	115	8	mortality	mortality	NOUN
aiua-8115	115	9	at	at	ADP
aiua-8115	115	10	the	the	DET
aiua-8115	115	11	time	time	NOUN
aiua-8115	115	12	of	of	ADP
aiua-8115	115	13	diagnosis	diagnosis	NOUN
aiua-8115	115	14	.	.	PUNCT
aiua-8115	116	1	j	j	PROPN
aiua-8115	116	2	natl	natl	PROPN
aiua-8115	116	3	cancer	cancer	PROPN
aiua-8115	116	4	inst	inst	PROPN
aiua-8115	116	5	.	.	PUNCT
aiua-8115	116	6	2009	2009	NUM
aiua-8115	116	7	;	;	PUNCT
aiua-8115	116	8	101:878	101:878	NUM
aiua-8115	116	9	-	-	PUNCT
aiua-8115	116	10	887	887	NUM
aiua-8115	116	11	.	.	PUNCT
aiua-8115	117	1	2	2	X
aiua-8115	117	2	.	.	X
aiua-8115	117	3	pishgar	pishgar	PROPN
aiua-8115	117	4	f	f	PROPN
aiua-8115	117	5	,	,	PUNCT
aiua-8115	117	6	ebrahimi	ebrahimi	PROPN
aiua-8115	117	7	h	h	PROPN
aiua-8115	117	8	,	,	PUNCT
aiua-8115	117	9	saeedi	saeedi	VERB
aiua-8115	117	10	moghaddam	moghaddam	PROPN
aiua-8115	117	11	s	s	PROPN
aiua-8115	117	12	,	,	PUNCT
aiua-8115	117	13	et	et	PROPN
aiua-8115	117	14	al	al	PROPN
aiua-8115	117	15	.	.	PUNCT
aiua-8115	118	1	global	global	ADJ
aiua-8115	118	2	,	,	PUNCT
aiua-8115	118	3	regional	regional	ADJ
aiua-8115	118	4	and	and	CCONJ
aiua-8115	118	5	national	national	ADJ
aiua-8115	118	6	burden	burden	NOUN
aiua-8115	118	7	of	of	ADP
aiua-8115	118	8	prostate	prostate	NOUN
aiua-8115	118	9	cancer	cancer	NOUN
aiua-8115	118	10	,	,	PUNCT
aiua-8115	118	11	1990	1990	NUM
aiua-8115	118	12	to	to	ADP
aiua-8115	118	13	2015	2015	NUM
aiua-8115	118	14	:	:	PUNCT
aiua-8115	118	15	results	result	VERB
aiua-8115	118	16	from	from	ADP
aiua-8115	118	17	the	the	DET
aiua-8115	118	18	global	global	ADJ
aiua-8115	118	19	burden	burden	NOUN
aiua-8115	118	20	of	of	ADP
aiua-8115	118	21	disease	disease	NOUN
aiua-8115	118	22	study	study	NOUN
aiua-8115	118	23	2015	2015	NUM
aiua-8115	118	24	.	.	PUNCT
aiua-8115	119	1	j	j	PROPN
aiua-8115	119	2	urol	urol	PROPN
aiua-8115	119	3	.	.	PROPN
aiua-8115	119	4	2018	2018	NUM
aiua-8115	119	5	;	;	PUNCT
aiua-8115	119	6	199:1224	199:1224	NUM
aiua-8115	119	7	-	-	SYM
aiua-8115	119	8	1232	1232	NUM
aiua-8115	119	9	.	.	PUNCT
aiua-8115	120	1	3	3	X
aiua-8115	120	2	.	.	X
aiua-8115	120	3	gann	gann	PROPN
aiua-8115	120	4	ph	ph	PROPN
aiua-8115	120	5	.	.	PROPN
aiua-8115	120	6	risk	risk	NOUN
aiua-8115	120	7	factors	factor	NOUN
aiua-8115	120	8	for	for	ADP
aiua-8115	120	9	prostate	prostate	NOUN
aiua-8115	120	10	cancer	cancer	NOUN
aiua-8115	120	11	.	.	PUNCT
aiua-8115	121	1	rev	rev	PROPN
aiua-8115	121	2	urol	urol	PROPN
aiua-8115	121	3	.	.	PUNCT
aiua-8115	121	4	2002	2002	NUM
aiua-8115	121	5	;	;	PUNCT
aiua-8115	121	6	5:3	5:3	NUM
aiua-8115	121	7	-	-	SYM
aiua-8115	121	8	10	10	NUM
aiua-8115	121	9	.	.	PUNCT
aiua-8115	122	1	4	4	X
aiua-8115	122	2	.	.	X
aiua-8115	122	3	hernandez	hernandez	PROPN
aiua-8115	122	4	j	j	PROPN
aiua-8115	122	5	,	,	PUNCT
aiua-8115	122	6	thompson	thompson	PROPN
aiua-8115	122	7	i	i	PROPN
aiua-8115	122	8	m.	m.	NOUN
aiua-8115	122	9	prostate	prostate	NOUN
aiua-8115	122	10	-	-	PUNCT
aiua-8115	122	11	specific	specific	ADJ
aiua-8115	122	12	antigen	antigen	NOUN
aiua-8115	122	13	:	:	PUNCT
aiua-8115	122	14	a	a	DET
aiua-8115	122	15	review	review	NOUN
aiua-8115	122	16	of	of	ADP
aiua-8115	122	17	the	the	DET
aiua-8115	122	18	validation	validation	NOUN
aiua-8115	122	19	of	of	ADP
aiua-8115	122	20	the	the	DET
aiua-8115	122	21	most	most	ADV
aiua-8115	122	22	commonly	commonly	ADV
aiua-8115	122	23	used	use	VERB
aiua-8115	122	24	cancer	cancer	NOUN
aiua-8115	122	25	biomarker	biomarker	NOUN
aiua-8115	122	26	.	.	PUNCT
aiua-8115	123	1	cancer	cancer	NOUN
aiua-8115	123	2	.	.	PUNCT
aiua-8115	124	1	2004	2004	NUM
aiua-8115	124	2	;	;	PUNCT
aiua-8115	124	3	101:894	101:894	PROPN
aiua-8115	124	4	-	-	PUNCT
aiua-8115	124	5	904	904	NUM
aiua-8115	124	6	.	.	PUNCT
aiua-8115	125	1	5	5	NUM
aiua-8115	125	2	.	.	X
aiua-8115	126	1	gosselaar	gosselaar	PROPN
aiua-8115	126	2	c	c	PROPN
aiua-8115	126	3	,	,	PUNCT
aiua-8115	126	4	roobol	roobol	PROPN
aiua-8115	126	5	mj	mj	PROPN
aiua-8115	126	6	,	,	PUNCT
aiua-8115	126	7	schröder	schröder	PROPN
aiua-8115	126	8	fh	fh	PROPN
aiua-8115	126	9	.	.	PUNCT
aiua-8115	126	10	prevalence	prevalence	NOUN
aiua-8115	126	11	and	and	CCONJ
aiua-8115	126	12	characteristics	characteristic	NOUN
aiua-8115	126	13	of	of	ADP
aiua-8115	126	14	screen	screen	NOUN
aiua-8115	126	15	-	-	PUNCT
aiua-8115	126	16	detected	detect	VERB
aiua-8115	126	17	prostate	prostate	NOUN
aiua-8115	126	18	carcinomas	carcinoma	NOUN
aiua-8115	126	19	at	at	ADP
aiua-8115	126	20	low	low	ADJ
aiua-8115	126	21	prostatespecific	prostatespecific	ADJ
aiua-8115	126	22	antigen	antigen	ADJ
aiua-8115	126	23	levels	level	NOUN
aiua-8115	126	24	:	:	PUNCT
aiua-8115	126	25	aggressive	aggressive	ADJ
aiua-8115	126	26	or	or	CCONJ
aiua-8115	126	27	insignificant	insignificant	ADJ
aiua-8115	126	28	?	?	PUNCT
aiua-8115	127	1	bju	bju	NOUN
aiua-8115	127	2	int	int	NOUN
aiua-8115	127	3	.	.	PUNCT
aiua-8115	128	1	2005	2005	NUM
aiua-8115	128	2	;	;	PUNCT
aiua-8115	128	3	95:231	95:231	NUM
aiua-8115	128	4	-	-	SYM
aiua-8115	128	5	7	7	NUM
aiua-8115	128	6	.	.	NOUN
aiua-8115	128	7	6	6	NUM
aiua-8115	128	8	.	.	X
aiua-8115	129	1	oesterling	oesterle	VERB
aiua-8115	129	2	je	je	PROPN
aiua-8115	129	3	.	.	PUNCT
aiua-8115	130	1	prostate	prostate	NOUN
aiua-8115	130	2	specific	specific	ADJ
aiua-8115	130	3	antigen	antigen	NOUN
aiua-8115	130	4	:	:	PUNCT
aiua-8115	130	5	a	a	DET
aiua-8115	130	6	critical	critical	ADJ
aiua-8115	130	7	assessment	assessment	NOUN
aiua-8115	130	8	of	of	ADP
aiua-8115	130	9	the	the	DET
aiua-8115	130	10	most	most	ADV
aiua-8115	130	11	useful	useful	ADJ
aiua-8115	130	12	tumor	tumor	NOUN
aiua-8115	130	13	marker	marker	NOUN
aiua-8115	130	14	for	for	ADP
aiua-8115	130	15	adenocarcinoma	adenocarcinoma	NOUN
aiua-8115	130	16	of	of	ADP
aiua-8115	130	17	the	the	DET
aiua-8115	130	18	prostate	prostate	NOUN
aiua-8115	130	19	.	.	PUNCT
aiua-8115	131	1	j	j	PROPN
aiua-8115	131	2	urol	urol	PROPN
aiua-8115	131	3	.	.	PUNCT
aiua-8115	131	4	1991	1991	NUM
aiua-8115	131	5	;	;	PUNCT
aiua-8115	131	6	145:907	145:907	NUM
aiua-8115	131	7	-	-	SYM
aiua-8115	131	8	23	23	NUM
aiua-8115	131	9	.	.	PUNCT
aiua-8115	132	1	7	7	X
aiua-8115	132	2	.	.	X
aiua-8115	132	3	stamey	stamey	PROPN
aiua-8115	132	4	ta	ta	PROPN
aiua-8115	132	5	,	,	PUNCT
aiua-8115	132	6	yang	yang	PROPN
aiua-8115	132	7	n	n	PROPN
aiua-8115	132	8	,	,	PUNCT
aiua-8115	132	9	hay	hay	PROPN
aiua-8115	132	10	ar	ar	PROPN
aiua-8115	132	11	,	,	PUNCT
aiua-8115	132	12	et	et	PROPN
aiua-8115	133	1	al	al	PROPN
aiua-8115	133	2	.	.	PUNCT
aiua-8115	133	3	prostate	prostate	NOUN
aiua-8115	133	4	-	-	PUNCT
aiua-8115	133	5	specific	specific	ADJ
aiua-8115	133	6	antigen	antigen	NOUN
aiua-8115	133	7	as	as	ADP
aiua-8115	133	8	a	a	DET
aiua-8115	133	9	serum	serum	NOUN
aiua-8115	133	10	marker	marker	NOUN
aiua-8115	133	11	for	for	ADP
aiua-8115	133	12	adenocarcinoma	adenocarcinoma	NOUN
aiua-8115	133	13	of	of	ADP
aiua-8115	133	14	the	the	DET
aiua-8115	133	15	prostate	prostate	NOUN
aiua-8115	133	16	.	.	PUNCT
aiua-8115	134	1	n	n	PROPN
aiua-8115	134	2	engl	engl	PROPN
aiua-8115	134	3	j	j	PROPN
aiua-8115	134	4	med	med	PROPN
aiua-8115	134	5	.	.	PUNCT
aiua-8115	134	6	1987	1987	NUM
aiua-8115	134	7	;	;	PUNCT
aiua-8115	135	1	317:909	317:909	NOUN
aiua-8115	135	2	-	-	SYM
aiua-8115	135	3	16	16	NUM
aiua-8115	135	4	.	.	PUNCT
aiua-8115	135	5	8	8	NUM
aiua-8115	135	6	.	.	X
aiua-8115	135	7	marzo	marzo	PROPN
aiua-8115	135	8	am	be	AUX
aiua-8115	135	9	,	,	PUNCT
aiua-8115	135	10	platz	platz	NOUN
aiua-8115	135	11	ea	ea	PROPN
aiua-8115	135	12	,	,	PUNCT
aiua-8115	135	13	sutcliffe	sutcliffe	PROPN
aiua-8115	135	14	s	s	PROPN
aiua-8115	135	15	,	,	PUNCT
aiua-8115	135	16	et	et	PROPN
aiua-8115	135	17	al	al	PROPN
aiua-8115	135	18	.	.	PROPN
aiua-8115	135	19	inflammation	inflammation	NOUN
aiua-8115	135	20	in	in	ADP
aiua-8115	135	21	prostate	prostate	NOUN
aiua-8115	135	22	carcinogenesis	carcinogenesis	NOUN
aiua-8115	135	23	.	.	PUNCT
aiua-8115	136	1	nat	nat	PROPN
aiua-8115	136	2	rev	rev	PROPN
aiua-8115	136	3	cancer	cancer	NOUN
aiua-8115	136	4	.	.	PUNCT
aiua-8115	137	1	2007	2007	NUM
aiua-8115	137	2	;	;	PUNCT
aiua-8115	137	3	7:256	7:256	X
aiua-8115	137	4	-	-	SYM
aiua-8115	137	5	69	69	NUM
aiua-8115	137	6	.	.	PUNCT
aiua-8115	138	1	9	9	X
aiua-8115	138	2	.	.	X
aiua-8115	138	3	sfanos	sfanos	PROPN
aiua-8115	138	4	ks	ks	PROPN
aiua-8115	138	5	,	,	PUNCT
aiua-8115	138	6	hempel	hempel	PROPN
aiua-8115	138	7	ha	ha	PROPN
aiua-8115	138	8	,	,	PUNCT
aiua-8115	138	9	de	de	X
aiua-8115	138	10	marzo	marzo	X
aiua-8115	138	11	am	be	AUX
aiua-8115	138	12	.	.	PUNCT
aiua-8115	139	1	the	the	DET
aiua-8115	139	2	role	role	NOUN
aiua-8115	139	3	of	of	ADP
aiua-8115	139	4	inflammation	inflammation	NOUN
aiua-8115	139	5	in	in	ADP
aiua-8115	139	6	prostate	prostate	NOUN
aiua-8115	139	7	cancer	cancer	NOUN
aiua-8115	139	8	.	.	PUNCT
aiua-8115	140	1	adv	adv	PROPN
aiua-8115	140	2	exp	exp	NOUN
aiua-8115	140	3	med	med	ADJ
aiua-8115	140	4	biol	biol	NOUN
aiua-8115	140	5	.	.	PUNCT
aiua-8115	141	1	2014	2014	NUM
aiua-8115	141	2	;	;	PUNCT
aiua-8115	141	3	816:153	816:153	VERB
aiua-8115	141	4	-	-	PUNCT
aiua-8115	141	5	81	81	NUM
aiua-8115	141	6	.	.	PUNCT
aiua-8115	142	1	10	10	NUM
aiua-8115	142	2	.	.	PUNCT
aiua-8115	143	1	palapattu	palapattu	PROPN
aiua-8115	143	2	gs	gs	PROPN
aiua-8115	143	3	,	,	PUNCT
aiua-8115	143	4	sutcliffe	sutcliffe	PROPN
aiua-8115	143	5	s	s	PROPN
aiua-8115	143	6	,	,	PUNCT
aiua-8115	143	7	bastian	bastian	PROPN
aiua-8115	143	8	pj	pj	PROPN
aiua-8115	143	9	,	,	PUNCT
aiua-8115	143	10	et	et	PROPN
aiua-8115	143	11	al	al	PROPN
aiua-8115	143	12	.	.	PROPN
aiua-8115	143	13	prostate	prostate	NOUN
aiua-8115	143	14	carcinogenesis	carcinogenesis	NOUN
aiua-8115	143	15	and	and	CCONJ
aiua-8115	143	16	inflammation	inflammation	NOUN
aiua-8115	143	17	:	:	PUNCT
aiua-8115	143	18	emerging	emerge	VERB
aiua-8115	143	19	insights	insight	NOUN
aiua-8115	143	20	.	.	PUNCT
aiua-8115	144	1	carcinogenesis	carcinogenesis	NOUN
aiua-8115	144	2	.	.	PUNCT
aiua-8115	145	1	2005	2005	NUM
aiua-8115	145	2	;	;	PUNCT
aiua-8115	145	3	26:1170	26:1170	NUM
aiua-8115	145	4	-	-	SYM
aiua-8115	145	5	81	81	NUM
aiua-8115	145	6	.	.	PUNCT
aiua-8115	146	1	11	11	NUM
aiua-8115	146	2	.	.	PUNCT
aiua-8115	147	1	morote	morote	PROPN
aiua-8115	147	2	j	j	PROPN
aiua-8115	147	3	,	,	PUNCT
aiua-8115	147	4	lopez	lopez	PROPN
aiua-8115	147	5	m	m	PROPN
aiua-8115	147	6	,	,	PUNCT
aiua-8115	147	7	encabo	encabo	VERB
aiua-8115	147	8	g	g	NOUN
aiua-8115	147	9	,	,	PUNCT
aiua-8115	147	10	de	de	X
aiua-8115	147	11	torres	torre	NOUN
aiua-8115	147	12	i	i	PRON
aiua-8115	147	13	m.	m.	NOUN
aiua-8115	147	14	effect	effect	NOUN
aiua-8115	147	15	of	of	ADP
aiua-8115	147	16	inflammation	inflammation	NOUN
aiua-8115	147	17	and	and	CCONJ
aiua-8115	147	18	benign	benign	ADJ
aiua-8115	147	19	prostatic	prostatic	ADJ
aiua-8115	147	20	enlargement	enlargement	NOUN
aiua-8115	147	21	on	on	ADP
aiua-8115	147	22	total	total	ADJ
aiua-8115	147	23	and	and	CCONJ
aiua-8115	147	24	percent	percent	NOUN
aiua-8115	147	25	free	free	ADJ
aiua-8115	147	26	serum	serum	NOUN
aiua-8115	147	27	prostatic	prostatic	ADJ
aiua-8115	147	28	specific	specific	ADJ
aiua-8115	147	29	antigen	antigen	NOUN
aiua-8115	147	30	.	.	PUNCT
aiua-8115	148	1	eur	eur	PROPN
aiua-8115	148	2	urol	urol	PROPN
aiua-8115	148	3	.	.	PUNCT
aiua-8115	148	4	2000	2000	NUM
aiua-8115	148	5	;	;	PUNCT
aiua-8115	148	6	37:537	37:537	NUM
aiua-8115	148	7	-	-	SYM
aiua-8115	148	8	40	40	NUM
aiua-8115	148	9	.	.	PUNCT
aiua-8115	148	10	12	12	NUM
aiua-8115	148	11	.	.	PUNCT
aiua-8115	149	1	catalona	catalona	PROPN
aiua-8115	149	2	wj	wj	PROPN
aiua-8115	149	3	,	,	PUNCT
aiua-8115	149	4	southwick	southwick	PROPN
aiua-8115	149	5	pc	pc	PROPN
aiua-8115	149	6	,	,	PUNCT
aiua-8115	149	7	slawin	slawin	PROPN
aiua-8115	149	8	km	km	PROPN
aiua-8115	149	9	,	,	PUNCT
aiua-8115	149	10	et	et	PROPN
aiua-8115	149	11	al	al	PROPN
aiua-8115	149	12	.	.	PROPN
aiua-8115	149	13	comparison	comparison	NOUN
aiua-8115	149	14	of	of	ADP
aiua-8115	149	15	percent	percent	NOUN
aiua-8115	149	16	free	free	ADJ
aiua-8115	149	17	psa	psa	NOUN
aiua-8115	149	18	,	,	PUNCT
aiua-8115	149	19	psa	psa	VERB
aiua-8115	149	20	density	density	NOUN
aiua-8115	149	21	,	,	PUNCT
aiua-8115	149	22	and	and	CCONJ
aiua-8115	149	23	age	age	NOUN
aiua-8115	149	24	-	-	PUNCT
aiua-8115	149	25	specific	specific	ADJ
aiua-8115	149	26	psa	psa	NOUN
aiua-8115	149	27	cutoffs	cutoff	NOUN
aiua-8115	149	28	for	for	ADP
aiua-8115	149	29	prostate	prostate	NOUN
aiua-8115	149	30	cancer	cancer	NOUN
aiua-8115	149	31	detection	detection	NOUN
aiua-8115	149	32	and	and	CCONJ
aiua-8115	149	33	staging	staging	NOUN
aiua-8115	149	34	.	.	PUNCT
aiua-8115	150	1	urology	urology	NOUN
aiua-8115	150	2	.	.	PUNCT
aiua-8115	151	1	2000	2000	NUM
aiua-8115	151	2	;	;	PUNCT
aiua-8115	151	3	56:255	56:255	NUM
aiua-8115	151	4	-	-	SYM
aiua-8115	151	5	60	60	NUM
aiua-8115	151	6	.	.	PUNCT
aiua-8115	152	1	13	13	NUM
aiua-8115	152	2	.	.	PUNCT
aiua-8115	152	3	brawer	brawer	PROPN
aiua-8115	152	4	mk	mk	PROPN
aiua-8115	152	5	,	,	PUNCT
aiua-8115	152	6	cheli	cheli	PROPN
aiua-8115	152	7	cd	cd	PROPN
aiua-8115	152	8	,	,	PUNCT
aiua-8115	152	9	neaman	neaman	PROPN
aiua-8115	152	10	ie	ie	X
aiua-8115	152	11	,	,	PUNCT
aiua-8115	152	12	et	et	PROPN
aiua-8115	152	13	al	al	PROPN
aiua-8115	152	14	.	.	PROPN
aiua-8115	152	15	complexed	complexe	VERB
aiua-8115	152	16	prostate	prostate	NOUN
aiua-8115	152	17	specific	specific	ADJ
aiua-8115	152	18	antigen	antigen	NOUN
aiua-8115	152	19	provides	provide	VERB
aiua-8115	152	20	significant	significant	ADJ
aiua-8115	152	21	enhancement	enhancement	NOUN
aiua-8115	152	22	of	of	ADP
aiua-8115	152	23	specificity	specificity	NOUN
aiua-8115	152	24	compared	compare	VERB
aiua-8115	152	25	with	with	ADP
aiua-8115	152	26	total	total	ADJ
aiua-8115	152	27	prostate	prostate	NOUN
aiua-8115	152	28	specific	specific	ADJ
aiua-8115	152	29	antigen	antigen	NOUN
aiua-8115	152	30	for	for	ADP
aiua-8115	152	31	detecting	detect	VERB
aiua-8115	152	32	prostate	prostate	NOUN
aiua-8115	152	33	cancer	cancer	NOUN
aiua-8115	152	34	.	.	PUNCT
aiua-8115	153	1	j	j	PROPN
aiua-8115	153	2	urol	urol	PROPN
aiua-8115	153	3	.	.	PROPN
aiua-8115	153	4	2000	2000	NUM
aiua-8115	153	5	;	;	PUNCT
aiua-8115	153	6	163:1476	163:1476	NUM
aiua-8115	153	7	-	-	SYM
aiua-8115	153	8	80	80	NUM
aiua-8115	153	9	.	.	PUNCT
aiua-8115	154	1	14	14	NUM
aiua-8115	154	2	.	.	PUNCT
aiua-8115	155	1	krieger	krieger	PROPN
aiua-8115	155	2	jn	jn	PROPN
aiua-8115	155	3	,	,	PUNCT
aiua-8115	155	4	nyberg	nyberg	PROPN
aiua-8115	155	5	l	l	PROPN
aiua-8115	155	6	jr	jr	PROPN
aiua-8115	155	7	,	,	PUNCT
aiua-8115	155	8	nickel	nickel	PROPN
aiua-8115	155	9	jc	jc	PROPN
aiua-8115	155	10	.	.	PROPN
aiua-8115	155	11	nih	nih	PROPN
aiua-8115	155	12	consensus	consensus	PROPN
aiua-8115	155	13	definition	definition	NOUN
aiua-8115	155	14	and	and	CCONJ
aiua-8115	155	15	classification	classification	NOUN
aiua-8115	155	16	of	of	ADP
aiua-8115	155	17	prostatitis	prostatitis	NOUN
aiua-8115	155	18	.	.	PUNCT
aiua-8115	156	1	jama	jama	PROPN
aiua-8115	156	2	1999	1999	NUM
aiua-8115	156	3	;	;	PUNCT
aiua-8115	156	4	282:236	282:236	X
aiua-8115	156	5	-	-	SYM
aiua-8115	156	6	7	7	NUM
aiua-8115	156	7	.	.	NOUN
aiua-8115	156	8	15	15	NUM
aiua-8115	156	9	.	.	PUNCT
aiua-8115	157	1	wang	wang	PROPN
aiua-8115	157	2	mc	mc	PROPN
aiua-8115	157	3	,	,	PUNCT
aiua-8115	157	4	valenzuela	valenzuela	PROPN
aiua-8115	157	5	la	la	PROPN
aiua-8115	157	6	,	,	PUNCT
aiua-8115	157	7	murphy	murphy	PROPN
aiua-8115	157	8	gp	gp	PROPN
aiua-8115	157	9	,	,	PUNCT
aiua-8115	157	10	chu	chu	PROPN
aiua-8115	157	11	tm	tm	PROPN
aiua-8115	157	12	.	.	PROPN
aiua-8115	157	13	purification	purification	NOUN
aiua-8115	157	14	of	of	ADP
aiua-8115	157	15	a	a	DET
aiua-8115	157	16	human	human	ADJ
aiua-8115	157	17	prostate	prostate	NOUN
aiua-8115	157	18	specific	specific	ADJ
aiua-8115	157	19	antigen	antigen	NOUN
aiua-8115	157	20	.	.	PUNCT
aiua-8115	157	21	invest	invest	VERB
aiua-8115	157	22	urol	urol	PROPN
aiua-8115	157	23	.	.	PUNCT
aiua-8115	158	1	1979	1979	NUM
aiua-8115	158	2	;	;	PUNCT
aiua-8115	158	3	17:159	17:159	NUM
aiua-8115	158	4	-	-	SYM
aiua-8115	158	5	63	63	NUM
aiua-8115	158	6	.	.	PUNCT
aiua-8115	159	1	16	16	NUM
aiua-8115	159	2	.	.	PUNCT
aiua-8115	160	1	suzuki	suzuki	PROPN
aiua-8115	160	2	h	h	PROPN
aiua-8115	160	3	,	,	PUNCT
aiua-8115	160	4	akakura	akakura	PROPN
aiua-8115	160	5	k	k	PROPN
aiua-8115	160	6	,	,	PUNCT
aiua-8115	160	7	igarashi	igarashi	PROPN
aiua-8115	160	8	t	t	PROPN
aiua-8115	160	9	,	,	PUNCT
aiua-8115	160	10	et	et	PROPN
aiua-8115	160	11	al	al	PROPN
aiua-8115	160	12	.	.	PUNCT
aiua-8115	161	1	clinical	clinical	ADJ
aiua-8115	161	2	usefulness	usefulness	NOUN
aiua-8115	161	3	of	of	ADP
aiua-8115	161	4	serum	serum	NOUN
aiua-8115	161	5	antip53	antip53	NOUN
aiua-8115	161	6	antibodies	antibodie	VERB
aiua-8115	161	7	for	for	ADP
aiua-8115	161	8	prostate	prostate	NOUN
aiua-8115	161	9	cancer	cancer	NOUN
aiua-8115	161	10	detection	detection	NOUN
aiua-8115	161	11	:	:	PUNCT
aiua-8115	161	12	a	a	DET
aiua-8115	161	13	comparative	comparative	ADJ
aiua-8115	161	14	study	study	NOUN
aiua-8115	161	15	with	with	ADP
aiua-8115	161	16	prostate	prostate	NOUN
aiua-8115	161	17	specific	specific	ADJ
aiua-8115	161	18	antigen	antigen	ADJ
aiua-8115	161	19	parameters	parameter	NOUN
aiua-8115	161	20	.	.	PUNCT
aiua-8115	162	1	j	j	PROPN
aiua-8115	162	2	urol	urol	PROPN
aiua-8115	162	3	.	.	PUNCT
aiua-8115	162	4	2004	2004	NUM
aiua-8115	162	5	;	;	PUNCT
aiua-8115	162	6	171:182	171:182	NUM
aiua-8115	162	7	-	-	SYM
aiua-8115	162	8	6	6	NUM
aiua-8115	162	9	.	.	NOUN
aiua-8115	162	10	17	17	NUM
aiua-8115	162	11	.	.	PUNCT
aiua-8115	162	12	renehan	renehan	PROPN
aiua-8115	162	13	ag	ag	PROPN
aiua-8115	162	14	,	,	PUNCT
aiua-8115	162	15	zwahlen	zwahlen	PROPN
aiua-8115	162	16	m	m	PROPN
aiua-8115	162	17	,	,	PUNCT
aiua-8115	162	18	minder	minder	PROPN
aiua-8115	162	19	c	c	PROPN
aiua-8115	162	20	,	,	PUNCT
aiua-8115	162	21	et	et	PROPN
aiua-8115	162	22	al	al	PROPN
aiua-8115	162	23	.	.	PUNCT
aiua-8115	163	1	insulin	insulin	NOUN
aiua-8115	163	2	-	-	PUNCT
aiua-8115	163	3	like	like	ADJ
aiua-8115	163	4	growth	growth	NOUN
aiua-8115	163	5	factor	factor	NOUN
aiua-8115	163	6	(	(	PUNCT
aiua-8115	163	7	igf	igf	PROPN
aiua-8115	163	8	)	)	PUNCT
aiua-8115	163	9	-i	-i	PROPN
aiua-8115	163	10	,	,	PUNCT
aiua-8115	163	11	igf	igf	PROPN
aiua-8115	163	12	binding	bind	VERB
aiua-8115	163	13	protein-3	protein-3	PROPN
aiua-8115	163	14	,	,	PUNCT
aiua-8115	163	15	and	and	CCONJ
aiua-8115	163	16	cancer	cancer	NOUN
aiua-8115	163	17	risk	risk	NOUN
aiua-8115	163	18	:	:	PUNCT
aiua-8115	163	19	systematic	systematic	ADJ
aiua-8115	163	20	review	review	NOUN
aiua-8115	163	21	and	and	CCONJ
aiua-8115	163	22	meta	meta	ADJ
aiua-8115	163	23	-	-	PUNCT
aiua-8115	163	24	regression	regression	NOUN
aiua-8115	163	25	analysis	analysis	NOUN
aiua-8115	163	26	.	.	PUNCT
aiua-8115	164	1	lancet	lancet	NOUN
aiua-8115	164	2	.	.	PUNCT
aiua-8115	165	1	2004	2004	NUM
aiua-8115	165	2	;	;	PUNCT
aiua-8115	165	3	363:1346	363:1346	NUM
aiua-8115	165	4	-	-	SYM
aiua-8115	165	5	53	53	NUM
aiua-8115	165	6	.	.	NOUN
aiua-8115	165	7	18	18	NUM
aiua-8115	165	8	.	.	PUNCT
aiua-8115	166	1	hersh	hersh	PROPN
aiua-8115	166	2	mr	mr	PROPN
aiua-8115	166	3	,	,	PUNCT
aiua-8115	166	4	knapp	knapp	PROPN
aiua-8115	166	5	el	el	PROPN
aiua-8115	166	6	,	,	PUNCT
aiua-8115	166	7	choi	choi	PROPN
aiua-8115	166	8	j.	j.	PROPN
aiua-8115	166	9	newer	new	ADJ
aiua-8115	166	10	imaging	imaging	NOUN
aiua-8115	166	11	modalities	modality	NOUN
aiua-8115	166	12	to	to	PART
aiua-8115	166	13	assess	assess	VERB
aiua-8115	166	14	tumor	tumor	NOUN
aiua-8115	166	15	in	in	ADP
aiua-8115	166	16	the	the	DET
aiua-8115	166	17	prostate	prostate	NOUN
aiua-8115	166	18	.	.	PUNCT
aiua-8115	167	1	cancer	cancer	NOUN
aiua-8115	167	2	control	control	NOUN
aiua-8115	167	3	.	.	PUNCT
aiua-8115	168	1	2004	2004	NUM
aiua-8115	168	2	;	;	PUNCT
aiua-8115	168	3	11:353	11:353	NUM
aiua-8115	168	4	-	-	SYM
aiua-8115	168	5	7	7	NUM
aiua-8115	168	6	.	.	NOUN
aiua-8115	168	7	19	19	NUM
aiua-8115	168	8	.	.	PUNCT
aiua-8115	168	9	inahara	inahara	PROPN
aiua-8115	168	10	m	m	PROPN
aiua-8115	168	11	,	,	PUNCT
aiua-8115	168	12	suzuki	suzuki	PROPN
aiua-8115	168	13	h	h	PROPN
aiua-8115	168	14	,	,	PUNCT
aiua-8115	168	15	nakamachi	nakamachi	PROPN
aiua-8115	168	16	h	h	PROPN
aiua-8115	168	17	,	,	PUNCT
aiua-8115	168	18	et	et	PROPN
aiua-8115	168	19	al	al	PROPN
aiua-8115	168	20	.	.	PROPN
aiua-8115	169	1	clinical	clinical	ADJ
aiua-8115	169	2	evaluation	evaluation	NOUN
aiua-8115	169	3	of	of	ADP
aiua-8115	169	4	transrectal	transrectal	ADJ
aiua-8115	169	5	power	power	NOUN
aiua-8115	169	6	doppler	doppler	NOUN
aiua-8115	169	7	imaging	imaging	NOUN
aiua-8115	169	8	in	in	ADP
aiua-8115	169	9	the	the	DET
aiua-8115	169	10	detection	detection	NOUN
aiua-8115	169	11	of	of	ADP
aiua-8115	169	12	prostate	prostate	NOUN
aiua-8115	169	13	cancer	cancer	NOUN
aiua-8115	169	14	.	.	PUNCT
aiua-8115	170	1	int	int	PROPN
aiua-8115	170	2	urol	urol	ADJ
aiua-8115	170	3	nephrol	nephrol	NOUN
aiua-8115	170	4	.	.	PUNCT
aiua-8115	171	1	2004	2004	NUM
aiua-8115	171	2	;	;	PUNCT
aiua-8115	171	3	36:175	36:175	NUM
aiua-8115	171	4	-	-	SYM
aiua-8115	171	5	80	80	NUM
aiua-8115	171	6	.	.	PUNCT
aiua-8115	172	1	20	20	NUM
aiua-8115	172	2	.	.	PUNCT
aiua-8115	173	1	mantovani	mantovani	PROPN
aiua-8115	173	2	a	a	PROPN
aiua-8115	173	3	,	,	PUNCT
aiua-8115	173	4	allavena	allavena	PROPN
aiua-8115	173	5	p	p	X
aiua-8115	173	6	,	,	PUNCT
aiua-8115	173	7	sica	sica	PROPN
aiua-8115	173	8	a	a	PROPN
aiua-8115	173	9	,	,	PUNCT
aiua-8115	173	10	balkwill	balkwill	PROPN
aiua-8115	173	11	f.	f.	PROPN
aiua-8115	173	12	cancer	cancer	PROPN
aiua-8115	173	13	related	relate	VERB
aiua-8115	173	14	inflammation	inflammation	NOUN
aiua-8115	173	15	.	.	PUNCT
aiua-8115	174	1	nature	nature	NOUN
aiua-8115	174	2	.	.	PUNCT
aiua-8115	175	1	2008	2008	NUM
aiua-8115	175	2	;	;	PUNCT
aiua-8115	175	3	454:436	454:436	NOUN
aiua-8115	175	4	-	-	PUNCT
aiua-8115	175	5	444	444	NUM
aiua-8115	175	6	.	.	NOUN
aiua-8115	176	1	21	21	NUM
aiua-8115	176	2	.	.	X
aiua-8115	176	3	de	de	PROPN
aiua-8115	176	4	marzo	marzo	X
aiua-8115	176	5	am	be	AUX
aiua-8115	176	6	,	,	PUNCT
aiua-8115	176	7	platz	platz	NOUN
aiua-8115	176	8	ea	ea	PROPN
aiua-8115	176	9	,	,	PUNCT
aiua-8115	176	10	sutcliffe	sutcliffe	PROPN
aiua-8115	176	11	s	s	PROPN
aiua-8115	176	12	,	,	PUNCT
aiua-8115	176	13	et	et	PROPN
aiua-8115	176	14	al	al	PROPN
aiua-8115	176	15	.	.	PROPN
aiua-8115	177	1	inflammation	inflammation	NOUN
aiua-8115	177	2	in	in	ADP
aiua-8115	177	3	prostate	prostate	NOUN
aiua-8115	177	4	carcinogenesis	carcinogenesis	NOUN
aiua-8115	177	5	.	.	PUNCT
aiua-8115	178	1	nat	nat	PROPN
aiua-8115	178	2	rev	rev	PROPN
aiua-8115	178	3	cancer	cancer	NOUN
aiua-8115	178	4	.	.	PUNCT
aiua-8115	179	1	2007	2007	NUM
aiua-8115	179	2	;	;	PUNCT
aiua-8115	179	3	7:256	7:256	X
aiua-8115	179	4	-	-	SYM
aiua-8115	179	5	269	269	NUM
aiua-8115	179	6	.	.	PUNCT
aiua-8115	179	7	22	22	NUM
aiua-8115	179	8	.	.	PUNCT
aiua-8115	180	1	kushner	kushner	PROPN
aiua-8115	180	2	i.	i.	PROPN
aiua-8115	180	3	the	the	DET
aiua-8115	180	4	phenomenon	phenomenon	NOUN
aiua-8115	180	5	of	of	ADP
aiua-8115	180	6	the	the	DET
aiua-8115	180	7	acute	acute	ADJ
aiua-8115	180	8	phase	phase	NOUN
aiua-8115	180	9	response	response	NOUN
aiua-8115	180	10	.	.	PUNCT
aiua-8115	181	1	ann	ann	PROPN
aiua-8115	181	2	n	n	PROPN
aiua-8115	181	3	y	y	PROPN
aiua-8115	181	4	acad	acad	PROPN
aiua-8115	181	5	sci	sci	PROPN
aiua-8115	181	6	.	.	PROPN
aiua-8115	181	7	1982	1982	NUM
aiua-8115	181	8	;	;	PUNCT
aiua-8115	181	9	389:39	389:39	PROPN
aiua-8115	181	10	-	-	SYM
aiua-8115	181	11	48	48	NUM
aiua-8115	181	12	.	.	PUNCT
aiua-8115	181	13	23	23	NUM
aiua-8115	181	14	.	.	PUNCT
aiua-8115	182	1	guthrie	guthrie	PROPN
aiua-8115	182	2	gj	gj	PROPN
aiua-8115	182	3	,	,	PUNCT
aiua-8115	182	4	roxburgh	roxburgh	PROPN
aiua-8115	182	5	cs	cs	PROPN
aiua-8115	182	6	,	,	PUNCT
aiua-8115	182	7	horgan	horgan	PROPN
aiua-8115	182	8	pg	pg	PROPN
aiua-8115	182	9	,	,	PUNCT
aiua-8115	182	10	mcmillan	mcmillan	PROPN
aiua-8115	182	11	dc	dc	PROPN
aiua-8115	182	12	.	.	PROPN
aiua-8115	183	1	does	do	AUX
aiua-8115	183	2	interleukin-6	interleukin-6	PROPN
aiua-8115	183	3	link	link	VERB
aiua-8115	183	4	explain	explain	VERB
aiua-8115	183	5	the	the	DET
aiua-8115	183	6	link	link	NOUN
aiua-8115	183	7	between	between	ADP
aiua-8115	183	8	tumour	tumour	NOUN
aiua-8115	183	9	necrosis	necrosis	NOUN
aiua-8115	183	10	,	,	PUNCT
aiua-8115	183	11	local	local	ADJ
aiua-8115	183	12	and	and	CCONJ
aiua-8115	183	13	systemic	systemic	ADJ
aiua-8115	183	14	inflammatory	inflammatory	ADJ
aiua-8115	183	15	responses	response	NOUN
aiua-8115	183	16	and	and	CCONJ
aiua-8115	183	17	outcome	outcome	NOUN
aiua-8115	183	18	in	in	ADP
aiua-8115	183	19	patients	patient	NOUN
aiua-8115	183	20	with	with	ADP
aiua-8115	183	21	colorectal	colorectal	ADJ
aiua-8115	183	22	cancer	cancer	NOUN
aiua-8115	183	23	?	?	PUNCT
aiua-8115	184	1	cancer	cancer	NOUN
aiua-8115	184	2	treat	treat	NOUN
aiua-8115	184	3	rev	rev	VERB
aiua-8115	184	4	.	.	PROPN
aiua-8115	184	5	2013	2013	NUM
aiua-8115	184	6	;	;	PUNCT
aiua-8115	184	7	39:89	39:89	NUM
aiua-8115	184	8	-	-	SYM
aiua-8115	184	9	96	96	NUM
aiua-8115	184	10	.	.	PUNCT
aiua-8115	185	1	24	24	NUM
aiua-8115	185	2	.	.	PUNCT
aiua-8115	186	1	malinowska	malinowska	PROPN
aiua-8115	186	2	k	k	PROPN
aiua-8115	186	3	,	,	PUNCT
aiua-8115	186	4	neuwirt	neuwirt	PROPN
aiua-8115	186	5	h	h	PROPN
aiua-8115	186	6	,	,	PUNCT
aiua-8115	186	7	cavarretta	cavarretta	VERB
aiua-8115	186	8	it	it	PRON
aiua-8115	186	9	,	,	PUNCT
aiua-8115	186	10	et	et	PROPN
aiua-8115	186	11	al	al	PROPN
aiua-8115	186	12	.	.	PROPN
aiua-8115	187	1	interleukin-6	interleukin-6	NUM
aiua-8115	187	2	stimulation	stimulation	NOUN
aiua-8115	187	3	of	of	ADP
aiua-8115	187	4	growth	growth	NOUN
aiua-8115	187	5	of	of	ADP
aiua-8115	187	6	prostate	prostate	NOUN
aiua-8115	187	7	cancer	cancer	NOUN
aiua-8115	187	8	in	in	ADP
aiua-8115	187	9	vitro	vitro	X
aiua-8115	187	10	and	and	CCONJ
aiua-8115	187	11	in	in	ADP
aiua-8115	187	12	vivo	vivo	NOUN
aiua-8115	187	13	through	through	ADP
aiua-8115	187	14	activation	activation	NOUN
aiua-8115	187	15	of	of	ADP
aiua-8115	187	16	the	the	DET
aiua-8115	187	17	androgen	androgen	NOUN
aiua-8115	187	18	receptor	receptor	NOUN
aiua-8115	187	19	.	.	PUNCT
aiua-8115	188	1	endocr	endocr	PROPN
aiua-8115	188	2	relat	relat	PROPN
aiua-8115	188	3	cancer	cancer	NOUN
aiua-8115	188	4	.	.	PUNCT
aiua-8115	189	1	2009	2009	NUM
aiua-8115	189	2	;	;	PUNCT
aiua-8115	189	3	16:155	16:155	NUM
aiua-8115	189	4	-	-	SYM
aiua-8115	189	5	169	169	NUM
aiua-8115	189	6	.	.	PUNCT
aiua-8115	190	1	25	25	NUM
aiua-8115	190	2	.	.	PUNCT
aiua-8115	191	1	kato	kato	PROPN
aiua-8115	191	2	t	t	PROPN
aiua-8115	191	3	,	,	PUNCT
aiua-8115	191	4	suzuki	suzuki	PROPN
aiua-8115	191	5	h	h	PROPN
aiua-8115	191	6	,	,	PUNCT
aiua-8115	191	7	komiya	komiya	VERB
aiua-8115	191	8	a	a	PRON
aiua-8115	191	9	,	,	PUNCT
aiua-8115	191	10	et	et	PROPN
aiua-8115	191	11	al	al	PROPN
aiua-8115	191	12	.	.	PROPN
aiua-8115	192	1	clinical	clinical	ADJ
aiua-8115	192	2	significance	significance	NOUN
aiua-8115	192	3	of	of	ADP
aiua-8115	192	4	urinary	urinary	ADJ
aiua-8115	192	5	white	white	ADJ
aiua-8115	192	6	blood	blood	NOUN
aiua-8115	192	7	cell	cell	NOUN
aiua-8115	192	8	count	count	NOUN
aiua-8115	192	9	and	and	CCONJ
aiua-8115	192	10	serum	serum	VERB
aiua-8115	192	11	c	c	NOUN
aiua-8115	192	12	-	-	ADJ
aiua-8115	192	13	reactive	reactive	ADJ
aiua-8115	192	14	protein	protein	NOUN
aiua-8115	192	15	level	level	NOUN
aiua-8115	192	16	for	for	ADP
aiua-8115	192	17	detection	detection	NOUN
aiua-8115	192	18	of	of	ADP
aiua-8115	192	19	non	non	ADJ
aiua-8115	192	20	-	-	ADJ
aiua-8115	192	21	palpable	palpable	ADJ
aiua-8115	192	22	prostate	prostate	NOUN
aiua-8115	192	23	cancer	cancer	NOUN
aiua-8115	192	24	.	.	PUNCT
aiua-8115	193	1	int	int	PROPN
aiua-8115	193	2	j	j	PROPN
aiua-8115	193	3	urol	urol	PROPN
aiua-8115	193	4	.	.	PUNCT
aiua-8115	194	1	2006	2006	NUM
aiua-8115	194	2	;	;	PUNCT
aiua-8115	194	3	13:915	13:915	NUM
aiua-8115	194	4	-	-	SYM
aiua-8115	194	5	919	919	NUM
aiua-8115	194	6	.	.	PUNCT
aiua-8115	195	1	26	26	NUM
aiua-8115	195	2	.	.	PUNCT
aiua-8115	196	1	stancik	stancik	PROPN
aiua-8115	196	2	i	i	PRON
aiua-8115	196	3	,	,	PUNCT
aiua-8115	196	4	lüftenegger	lüftenegger	PROPN
aiua-8115	196	5	w	w	PROPN
aiua-8115	196	6	,	,	PUNCT
aiua-8115	196	7	klimpfinger	klimpfinger	NOUN
aiua-8115	196	8	m	m	PROPN
aiua-8115	196	9	,	,	PUNCT
aiua-8115	196	10	et	et	PROPN
aiua-8115	196	11	al	al	PROPN
aiua-8115	196	12	.	.	PROPN
aiua-8115	196	13	effect	effect	NOUN
aiua-8115	196	14	of	of	ADP
aiua-8115	196	15	nih	nih	PROPN
aiua-8115	196	16	-	-	PUNCT
aiua-8115	196	17	iv	iv	PROPN
aiua-8115	196	18	prostatitis	prostatitis	NOUN
aiua-8115	196	19	on	on	ADP
aiua-8115	196	20	free	free	ADJ
aiua-8115	196	21	and	and	CCONJ
aiua-8115	196	22	free	free	ADJ
aiua-8115	196	23	-	-	PUNCT
aiua-8115	196	24	to	to	ADP
aiua-8115	196	25	-	-	PUNCT
aiua-8115	196	26	total	total	NOUN
aiua-8115	196	27	psa	psa	NOUN
aiua-8115	196	28	.	.	PUNCT
aiua-8115	196	29	eur	eur	PROPN
aiua-8115	196	30	urol	urol	PROPN
aiua-8115	196	31	.	.	PUNCT
aiua-8115	197	1	2004	2004	NUM
aiua-8115	197	2	;	;	PUNCT
aiua-8115	197	3	46:760	46:760	NUM
aiua-8115	197	4	-	-	SYM
aiua-8115	197	5	4	4	NUM
aiua-8115	197	6	.	.	NOUN
aiua-8115	197	7	27	27	NUM
aiua-8115	197	8	.	.	PUNCT
aiua-8115	198	1	irani	irani	PROPN
aiua-8115	198	2	j	j	PROPN
aiua-8115	198	3	,	,	PUNCT
aiua-8115	198	4	levillain	levillain	NOUN
aiua-8115	198	5	p	p	NOUN
aiua-8115	198	6	,	,	PUNCT
aiua-8115	198	7	goujon	goujon	PROPN
aiua-8115	198	8	jm	jm	PROPN
aiua-8115	198	9	,	,	PUNCT
aiua-8115	198	10	et	et	PROPN
aiua-8115	198	11	al	al	PROPN
aiua-8115	198	12	.	.	PUNCT
aiua-8115	198	13	inflammation	inflammation	NOUN
aiua-8115	198	14	in	in	ADP
aiua-8115	198	15	benign	benign	ADJ
aiua-8115	198	16	prostatic	prostatic	ADJ
aiua-8115	198	17	hyperplasia	hyperplasia	NOUN
aiua-8115	198	18	:	:	PUNCT
aiua-8115	198	19	correlation	correlation	NOUN
aiua-8115	198	20	with	with	ADP
aiua-8115	198	21	prostate	prostate	NOUN
aiua-8115	198	22	specific	specific	ADJ
aiua-8115	198	23	antigen	antigen	NOUN
aiua-8115	198	24	value	value	NOUN
aiua-8115	198	25	.	.	PUNCT
aiua-8115	199	1	j	j	PROPN
aiua-8115	199	2	urol	urol	PROPN
aiua-8115	199	3	.	.	PUNCT
aiua-8115	200	1	1997	1997	NUM
aiua-8115	200	2	;	;	PUNCT
aiua-8115	200	3	157:1301	157:1301	NUM
aiua-8115	200	4	-	-	SYM
aiua-8115	200	5	3	3	NUM
aiua-8115	200	6	.	.	NOUN
aiua-8115	200	7	28	28	NUM
aiua-8115	200	8	.	.	PUNCT
aiua-8115	201	1	karazanashvili	karazanashvili	NOUN
aiua-8115	201	2	g	g	PROPN
aiua-8115	201	3	,	,	PUNCT
aiua-8115	201	4	managadze	managadze	PROPN
aiua-8115	201	5	l.	l.	PROPN
aiua-8115	201	6	prostate	prostate	NOUN
aiua-8115	201	7	-	-	PUNCT
aiua-8115	201	8	specific	specific	ADJ
aiua-8115	201	9	antigen	antigen	NOUN
aiua-8115	201	10	(	(	PUNCT
aiua-8115	201	11	psa	psa	NOUN
aiua-8115	201	12	)	)	PUNCT
aiua-8115	201	13	value	value	NOUN
aiua-8115	201	14	change	change	NOUN
aiua-8115	201	15	after	after	ADP
aiua-8115	201	16	antibacterial	antibacterial	ADJ
aiua-8115	201	17	therapy	therapy	NOUN
aiua-8115	201	18	of	of	ADP
aiua-8115	201	19	prostate	prostate	NOUN
aiua-8115	201	20	inflammation	inflammation	NOUN
aiua-8115	201	21	,	,	PUNCT
aiua-8115	201	22	as	as	ADP
aiua-8115	201	23	a	a	DET
aiua-8115	201	24	diagnostic	diagnostic	ADJ
aiua-8115	201	25	method	method	NOUN
aiua-8115	201	26	for	for	ADP
aiua-8115	201	27	prostate	prostate	NOUN
aiua-8115	201	28	cancer	cancer	NOUN
aiua-8115	201	29	screening	screening	NOUN
aiua-8115	201	30	in	in	ADP
aiua-8115	201	31	cases	case	NOUN
aiua-8115	201	32	of	of	ADP
aiua-8115	201	33	psa	psa	NOUN
aiua-8115	201	34	value	value	NOUN
aiua-8115	201	35	within	within	ADP
aiua-8115	201	36	4	4	NUM
aiua-8115	201	37	-	-	SYM
aiua-8115	201	38	10	10	NUM
aiua-8115	201	39	ng	ng	PROPN
aiua-8115	201	40	/	/	SYM
aiua-8115	201	41	ml	ml	NOUN
aiua-8115	201	42	and	and	CCONJ
aiua-8115	201	43	nonsuspicious	nonsuspicious	ADJ
aiua-8115	201	44	results	result	NOUN
aiua-8115	201	45	of	of	ADP
aiua-8115	201	46	digital	digital	ADJ
aiua-8115	201	47	rectal	rectal	ADJ
aiua-8115	201	48	examination	examination	NOUN
aiua-8115	201	49	.	.	PUNCT
aiua-8115	202	1	eur	eur	PROPN
aiua-8115	202	2	urol	urol	PROPN
aiua-8115	202	3	.	.	PUNCT
aiua-8115	203	1	2001	2001	NUM
aiua-8115	203	2	;	;	PUNCT
aiua-8115	203	3	39:538	39:538	NUM
aiua-8115	203	4	-	-	SYM
aiua-8115	203	5	43	43	NUM
aiua-8115	203	6	.	.	PUNCT
aiua-8115	204	1	correspondence	correspondence	NOUN
aiua-8115	204	2	selamettin	selamettin	PROPN
aiua-8115	204	3	demir	demir	PROPN
aiua-8115	204	4	,	,	PUNCT
aiua-8115	204	5	md	md	PROPN
aiua-8115	204	6	(	(	PUNCT
aiua-8115	204	7	corresponding	correspond	VERB
aiua-8115	204	8	author	author	NOUN
aiua-8115	204	9	)	)	PUNCT
aiua-8115	204	10	drselami1978@hotmail.com	drselami1978@hotmail.com	X
aiua-8115	205	1	the	the	DET
aiua-8115	205	2	ministry	ministry	PROPN
aiua-8115	205	3	of	of	ADP
aiua-8115	205	4	health	health	PROPN
aiua-8115	205	5	,	,	PUNCT
aiua-8115	205	6	university	university	NOUN
aiua-8115	205	7	of	of	ADP
aiua-8115	205	8	health	health	PROPN
aiua-8115	205	9	sciences	sciences	PROPN
aiua-8115	205	10	,	,	PUNCT
aiua-8115	205	11	van	van	NOUN
aiua-8115	205	12	education	education	NOUN
aiua-8115	205	13	and	and	CCONJ
aiua-8115	205	14	research	research	NOUN
aiua-8115	205	15	hospital	hospital	NOUN
aiua-8115	205	16	,	,	PUNCT
aiua-8115	205	17	van	van	PROPN
aiua-8115	205	18	(	(	PUNCT
aiua-8115	205	19	turkey	turkey	NOUN
aiua-8115	205	20	)	)	PUNCT
aiua-8115	205	21	demir_stesura	demir_stesura	NOUN
aiua-8115	205	22	seveso	seveso	VERB
aiua-8115	206	1	30/09/19	30/09/19	PROPN
aiua-8115	206	2	18:21	18:21	NUM
aiua-8115	206	3	pagina	pagina	NOUN
aiua-8115	206	4	170	170	NUM